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ABSTRACT
Enterococci are responsible for 12% of hospital infections. They represent a 
growing treatment problem, because of their antibiotic resistance- both 
intrinsic and acquired.
The aim of this project was to determine the role of the Enterococcus faecalis 
efaA gene product in infective endocarditis. The nucleotide sequence for the 
entire operon was obtained and analysed. Using RT-PCR it was possible to 
establish that efaA is transcribed under manganese-limited conditions. This 
confirmed that efaA belongs to a group of extracellular receptors called the 
Cluster 9 protein family. Sequence analysis of the region upstream of the 
operon identified a sequence showing homology to a DtxR box (first isolated 
in Corynebacterium diphtheriae), suggesting that efaA is upregulated as part 
of a global response to environmental metal ion concentration by E. faecalis. 
Attempts were made to construct a knockout mutant o f efaA, but these were 
unsuccessful. Analysis of preliminary sequence data from TIGR allowed 
identification of a second Cluster 9 operon in E. faecalis (adc), predicted to 
respond to zinc. Additionally, three Fur protein homologues, a DtxR 
homologue and a thiol peroxidase gene were identified.
The E. faecium efm operon, which shows homology to efa, was sequenced. 
Analysis of the operon identified a region showing homology to the SirR box 
of Staphylococcus epidermidis, encoded upstream of the operon. This again 
suggested that the operon was under metal ion control, but this could not be 
confirmed by RT-PCR.
Aggregometry was used to study platelet-aggregating abilties in two E. 
faecalis strains. The strains tested were unable to aggregate platelets. The 
heterogeneity of several E. faecalis clinical isolates was examined to 
determine the extent of sequence conservation in the efaA gene. PCR-RFLP 
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1 Introduction
It has been estimated that approximately 5% of patients admitted to hospitals 
acquire infections (known as nosocomial infections) during their stay 
(reviewed by Swartz, 1994). A number of factors contribute to this problem, 
including the increasing age of patients and treatment of formerly untreatable 
diseases with invasive surgery or intensive medical therapies.
During the 1980s a new group of bacteria, mostly gram-positive, emerged as 
dominant pathogens in the hospital environment, amongst which were 
Enterococcus spp. The enterococci are the second most common cause of 
nosocomial infections, accounting for 12% of the total. Of this 12%, E. 
faecalis has been found to account for 80% and E. faecium 5-15% (reviewed 
by Murray, 1990).
1.1 Diseases Caused bv Enterococci
Enterococci can be isolated from many polymicrobial infections but are also 
capable of causing disease on their own (Moellering, 1992). The most 
common infections caused are urinary tract infections (UTIs), particularly 
following catheterisation. Indeed catheterisation, together with broad- 
spectrum antibiotic use is thought to account for the significant increase in 
enterococcal UTIs seen since 1971 (Felmingham et al, 1992). Most 
infections are asymptomatic and are better thought of as colonisation, but 
enterococci can spread from the urinary tract to produce a generalised 
bacteraemia.
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Enterococci can also be isolated from wound infections, mostly as part of a 
polymicrobial infection. Bacteraemias are the third most common 
enterococcal infection. Infective endocarditis (IE) is often seen as a result of 
enterococcal bacteraemia and in rare cases meningitis may occur. 
Endocarditis is an infection on the endocardial surface of the heart (reviewed 
by Scheld and Sande, 1994). It usually affects the heart valves, but can be 
found on septal defects or the mural endocardium (reviewed by Scheld and 
Sande, 1994). Enterococcal IE is a virulent disease which can have an 
associated mortality rate as high as 30% (Working Party, 1985). It causes 
200 deaths per year in England and Wales (Working Party, 1985). The 
antibiotic resistance of enterococci combined with the difficulty in targeting 
antibiotic therapy to heart valves makes the disease very awkward to treat. 
This thesis will focus on enterococcal endocarditis in an effort to find novel 
strategies for tackling such infections. The pathogenicity of E. faecalis and 
E. faecium  will be studied in detail, because these are thought to account for 
the majority of cases.
1.2 Taxonomy of Enterococcus S p p
Enterococci are gram-positive, non-spore-forming facultatively-anaerobic, 
catalase-negative bacteria. Until recently they were regarded as streptococci, 
but are now recognised to be a separate genus and to belong, with 
streptococci and lactococci, to the family of lactic acid bacteria (reviewed by 
Hardie and Whiley, 1997; Morrison et al, 1997). There are currently 17 
species of enterococcus recognised (reviewed by Hardie and Whiley, 1997).
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In the past two decades, 15 new species of bacteria have been proposed to be 
members of the genus Enterococcus.
Figure 1.1 Taxonomy of Enterococcus
Genus Sub-genus Species
E. faecalis —  E. faecalis
E. faecium
E. durans 






—  E. oseudiavium 
E. malodoratus 
E. rqffinosus
E. gallinarium E. gallinarum 
E. cassiflavus 
E. flavescens
E. cecorum E. cecorum 
E. columbae
Miscellaneous E. saccharolyticus E. dispar 
E. sulfurens
Enterococci are found in many ecological niches, including the 
gastrointestinal tracts of man, mammals, birds, reptiles, insects and in plants. 
Although the lower gastrointestinal tract is thought to be the main habitat of 
enterococci they can be found in other places such as the upper GI tract, the 
genital tract and the oral cavity (reviewed by Morrison et al, 1997). They are 
able to survive for long periods on inanimate objects and in direct sunlight. 
Although they are not native to soil or water, they can live there, and their 
presence is regarded as a positive indicator of faecal pollution in the water 
supply (reviewed by Morrison et al, 1997).
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Because of their complex nutritional requirements they have always been 
difficult to cultivate and manipulate in vitro: many strains are still considered 
non-transformable. However with advances in laboratory techniques, 
particularly in molecular biology and ribotyping, our understanding of these 
organisms has improved dramatically. Perhaps the most significant advance 
has come from ribotyping, which established the enterococci as a distinct 
genus (reviewed by Hardie and Whiley, 1997; Morrison et al, 1997).
Enterococci have a natural, intrinsic resistance to many antibiotics, which 
makes them difficult to treat. In addition they are able to acquire and express 
antibiotic resistance genes from other organisms. Serious enterococcal 
infections now carry a significant risk of mortality. Therapeutic options for 
such diseases are decreasing rapidly and it is highly probable that such 
infections will be impossible to treat in the near future.
Enterococci have become significant nosocomial pathogens partly because 
they can acquire genes by conjugation. For instance, E. faecalis strains can 
carry several types of mobile genetic elements harbouring genes for 
antibiotic resistance and haemolysins or other virulence factors. These 




A conjugative transposon may be thought of as a transposable element with 
the capacity to promote its own transfer in the absence of any plasmid or 
phage. They are capable of insertion into the chromosome and can therefore 
be stably maintained. In gram-positive bacteria, conjugative transposons are 
large and all encode tetracycline resistance of the Tet (M) class (which 
encodes resistance to tetracycline and minocycline) (reviewed by Scott and 
Churchward, 1995). Many will also encode additional resistance genes. 
Examples include Tn916 (16.4Kb) which encodes Tet(M) resistance only 
and Tnl545 (23Kb) which encodes resistance to kanamycin (aphA-3 gene) 
and erythromycin (ermAM gene) as well (reviewed by Scott and 
Churchward, 1995; Caparon and Scott, 1989).
Transposons have a broad host range among gram-positive and some gram- 
negative species. They represent a highly efficient method of transfer of 
antibiotic resistance genes between unrelated bacterial genera.
1.2.2 Sex Pheromone Plasmids
Sex pheromone plasmids are almost totally exclusive to E. faecalis strains. 
Their uptake is induced by pheromones secreted by plasmid-free strains to 
cause clumping and conjugation with strains containing plasmids. Transfer 
of these elements is much more effective than with transposons (frequencies 
of up to 10'1 in sex pheromone plasmids compared with 10*6 in transposons)
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due to the clumping mechanism (reviewed by Wirth et al, 1996). They will 
be discussed in more detail in section 1.7
The ability to acquire so many different genes has undoubtedly increased the 
pathogenicity of enterococcal strains. It has also caused concern, as these 
strains are capable of passing on their acquired antibiotic resistance to other 
gram-positive species. In this respect they should be thought of as a ‘genetic 
reservoir’ of resistance genes. Transfer of these genes to other more virulent 
gram-positive species must be considered a real threat.
1.3 Pathogenesis of Enterococcal Endocarditis
1.3.1 Predisposing factors for Infective Endocarditis
Any surgical or dental procedure that damages a mucosal surface colonised 
with bacteria can enable them to enter the bloodstream (reviewed by Scheld 
and Sande, 1994). Such bacteraemias can persist for up to 15 min, which is 
sufficient to allow access to the endocardium and initiate endocarditis.
Many dental procedures carry a high risk of inducing IE and patients deemed 
to be at risk of developing the disease are often treated with prophylactic 
antibiotics. However such treatment will never prevent all cases of IE and a 
proportion of cases can be attributed to dental treatment (Dajani et al, 1997).
Intravascular devices, such as IV catheters, hyperalimentation lines and 
intracardiac pacemaker devices can all become infected and introduce
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bacteria into the bloodstream. Infections from prosthetic valves are also an 
increasingly common source of infection as these devices become more 
widely used (reviewed by Vongapatanasin et al, 1996).
IV drug abuse is a significant risk factor for IE and accounts for 
approximately 60% hospital admissions amongst this group of people. 
Cocaine use carries a particularly high risk (reviewed by Scheld and Sande, 
1994). In addition to inducing bacteraemia, IV drug users traumatise the 
endothelial surface of the valve by frequently injecting foreign particles 
(reviewed by Kaye, 1985). Most cases of this type tend to affect the right 
side of the heart (the tricuspid valve) rather than the more common left side 
(the mitral valve) and are usually caused by Staphylococcus aureus rather 
than enterococci. However as IV drug abuse accounts for so many cases of 
IE it is significant (reviewed by Lukes and Durack, 1993).
In general immunosuppression is not a major risk factor for IE. 
Neutropoenic, T-cell deficient and humorally immunodeficient patients do 
suffer from IE but other immunosuppressed patients do not. Pre-existing 
antibiotic therapy in such patients may, however, cause superinfection with 
enterococci.
While all the above factors introduce bacteria into the bloodstream, a 
structural abnormality of the heart may lead to the formation of a platelet- 
fibrin clot to which bacteria adhere. Some abnormalities carry a greater risk 
than others; mitral valve prolapse has been implicated in a many IE cases.
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Congenital heart disease (e.g. patent ductus arteriosis) is responsible for 6- 
24% of IE cases whilst degenerative cardiac lesions (e.g. post-myocardial 
infarction thrombus) contribute to 30-40% of cases where no other lesions 
are seen (reviewed by Scheld and Sande, 1994).
Although endocarditis used to be more commonly seen in younger patients it 
is now more often seen in the elderly - perhaps because of pre-existing 
cardiac lesions and increased hospitalisation or surgery in this patient group.
1.3.2 Adhesion
In order for a circulating bacterium to persist on the endocardium and cause 
infection, it must adhere to the tissue. This will prevent removal by the local 
high-velocity blood circulation and circumvent killing by host defence 
mechanisms (reviewed by Doig and Trust, 1993; Ford and Douglas, 1997). 
Adhesion is therefore a virulence factor, since a successful infection depends 
on its efficiency (reviewed by Baddour, 1994; Doig and Trust, 1993).
Attachment is believed to occur via a combination of high cell surface 
hydrophobicity and specific receptor interactions (Zareba et al, 1997). Most 
successful infections occur where there has been trauma to the endothelium. 
This denudes the upper endothelial cell layers and exposes the underlying 
extracellular matrix. Platelets and fibrin are deposited at the site of trauma to 
aid healing and both these and the extracellular matrix become targets for 
specific bacterial adhesins (reviewed by Baddour, 1994; Patti and Hook,
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1994). Infective endocardial vegetations are therefore largely composed of 
fibrin, platelets, and bacterial colonies. Fibrin affords the bacteria some 
degree of protection against phagocytosis (reviewed by Ford and Douglas, 
1997).
The extracellular matrix gives a basic structure for tissues, separating the 
epithelial cells from the underlying connective tissue. It mediates many 
biological signalling processes (reviewed by Patti and Hook, 1994). Because 
of its complex nature the extracellular matrix offers many targets for 
bacteria, including proteins, glycoproteins and carbohydrates. The most 
commonly cited targets for adherence are the integrins laminin, fibrinogen, 
collagens and vitronectin. They are involved in the adhesion of eukaryotic 
cells to each other and hence have a complex structure with multiple binding 
sites. Equally often microbial adhesins (e.g. pili) show a lectin-like activity. 
They bind to host carbohydrate structures on glycolipids and glycoproteins, 
in some cases recognising galactosyl-containing carbohydrates (reviewed by 
Jenkinson, 1994a).
There is very little understood of the microbial structures that bind 
extracellular matrix components, or their receptor targets in the extracellular 
matrix (reviewed by Doig and Trust, 1993). Studying the extracellular 
targets for enterococci in vitro has proved complex, as it appears that the 
expression of appropriate adhesins is highly dependent on growth conditions. 
Many studies show conflicting results and it is difficult to ascertain the true* 
picture.
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There are many structures on the cell surface of enterococci which could 
interact with host tissues, including polysaccharides and polypeptides. The 
polypeptides involved in adherence may be multifunctional. They can also 
be involved'in nutrient transport, enzymatic activities such as synthesis and 
degradation or may be structural components of cell surface layers. 
Polysaccharides are adhesins and may have additional protective functions 
(reviewed by Jenkinson, 1995).
A study of enterococcal binding by Zareba et al (1997) showed that both E. 
faecalis and E. faecium bound poorly to fibronectin and collagen types I-IV. 
Both species were able to bind to vitronectin, lactoferrin (an iron source for 
bacteria) and thrombospondin (a glycoprotein found in platelets). However 
these results contrasted with Shorrock and Lambert (1989) who were able to 
demonstrate fibronectin binding by E. faecalis. This is probably due to the 
different binding assays used.
The adhesins expressed on the surface of an enterococcus are vitally 
important as this seems to determine their site of infection. Guzman et al 
(1991) found that E. faecalis strains isolated from endocarditis adhered better 
to endocardial cells than those isolated from infections of the urinary tract. 
However growth of urinary tract isolates in human serum greatly improved 
their binding to endocardial cells because it increased the expression of D- 
galactose and D-fucose-containing residues on the surface of E. faecalis. 
The D-galactose residues were also found to mediate internalisation of
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enterococcus into human culture cells, which is a phenotype more often seen 
in endocarditis isolates. Lipoteichoic acid is thought to contain the sugar 
moiety involved in adherence. Interestingly, Xiao et al (1998) carried out all 
their binding studies after growth at 46°C and found that under these 
conditions E. faecalis was able to adhere to laminin and collagen types I-IV 
but not to fibronectin, fibrinogen or collagen type V. They postulated that 
increasing the growth temperature induces a stress response in E. faecalis, 
causing it to express different cell surface proteins.
1.3.3 Platelet Adhesion and Aggregation
The adhesion of bacteria to platelets has been closely studied since adhesion 
is thought to be the initial step in endocardial infection (reviewed by 
Baddour, 1994; Bayer et al, 1995). It is also possible for bacteria to bind to 
platelets in the blood circulation and then be deposited at a site of 
endocardial damage (reviewed by Murphy and Steckelberg, 1995). It is 
important to differentiate between the initial binding of bacteria to platelets 
and the subsequent platelet aggregation, which may be induced by the 
bacteria, leading to larger vegetations. Adhesion has no effect on the 
aggregation reaction, indeed some bacteria are able to adhere strongly to 
platelets but are unable to induce platelet aggregation (Bayer et al, 1995).
Once bacteria have adhered to platelets they must endure a range of 
processes designed to remove them. These include phagocytosis and 
antimicrobial factors released by thrombin-stimulated platelets. All of the
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platelet factors have low molecular weight, are cationic and heat stable. 
They include p-lysins, platelet bactericidal protein, thrombodefensins and 
platelet microbicidal protein (reviewed by Murphy and Steckelberg, 1995; 
Dankert et al, 1995). Following bacterial adhesion, more platelets and fibrin 
will be deposited on the vegetation and the deposition of fibrin is a good 
indicator of thrombin activity. Therefore as well as having efficient adhesion 
a bacterium must be resistant to these thrombin-induced agents in order to 
cause a successful endocardial infection (Dankert et al, 1995). The 
endocardial vegetation is not static. Vegetation growth occurs by a complex, 
dynamic process, involving platelet aggregation and release, fibrin 
deposition, bacterial removal and then reseeding with circulating micro­
organisms and loss of material via embolisation (reviewed by Ford and 
Douglas, 1997). Eventually the vegetation may grow and the bacteria may 
be held within the platelet-rich thrombus where they can reproduce, 
effectively protected from the host immune system.
1.3.4 Progression of Disease
An infected vegetation will have multiple consequences for the patient. 
Cardiac valves will be distorted or destroyed by ulceration, resulting in 
regurgitation of the blood flow. Even after antibiotic treatment valves may be 
so badly damaged that they require surgical repair (reviewed by Murphy and 
Steckleberg, 1985).
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A persistent bacteraemia will cause the clinical signs of fever, rigours, night 
sweats, lethargy, anorexia and anaemia. The resulting bacteraemia will 
activate the host defence mechanisms resulting in immune complexes formed 
from associations of bacterial antigens with antibodies. The complexes may 
be deposited in any vessel causing inflammation (vasculitis) or vascular 
lesions. These can be seen in the skin as ‘Osier’s nodes’ (small, painful, 
nodular lesions found on the pads of fingers or toes) or ‘Roth spots’ (seen in 
the eye where they are deposited in the nerve fibre layer of the retina). 
Immune complexes may also accumulate at joints where they will cause 
arthritis (Kumar and Clark, 1990; Stamboulian and Carbone, 1997). Parts of 
the vegetation can break up and be deposited in any organ (embolisms). In 
the skin, ‘Janeway lesions’ are seen on the palms of the hands or soles of the 
feet. Myocardial infarction or splenic and renal infarcts are commonly seen. 
The brain and lungs may also be affected. I f  left untreated the disease will 
progress to septicaemia. It is always fatal without antibiotic therapy.
1.4 Enterococcal Antibiotic Resistance
The treatment of enterococci has always been a problem as they are 
intrinsically resistant to many agents. These include cephalosporins, 
aminoglycosides, quinolones, lincosamides, semi-synthetic penicillinase 
resistant penicillins (e.g. oxacillin) and clindamycin (reviewed by Cormican 
and Jones, 1996; Murray, 1998, Leclerq, 1997). In comparison with 
streptococci they are also relatively resistant to penicillin, ampicillin and 
ureidopenicillins (Murray et al, 1998).
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Treatment of endocarditis should be bactericidal not bacteriostatic to ensure 
sterilisation of the cardiac valve. This usually means combination therapy 
for four to six weeks (Gavalda et al, 1996; Stamboulian and Carbonne, 
1997). For resistant organisms the duration of treatment may have to be 
extended to eight to twelve weeks (Stamboulian and Carbonne, 1997). 
Antibiotic penetration into vegetations is typically poor, especially with 
agents such as teicoplanin, making therapy additionally difficult (Aslangul et 
al., 1997; Murphy and Steckelberg, 1995). Infections associated with 
prosthetic devices, cannulae and other foreign bodies also show poor 
antibiotic penetration, presenting an additional treatment problem (Morrison 
et al, 1997).
In addition to intrinsic resistance, enterococci have acquired resistance to 
many other antibiotics. The species now has documented cases of resistance 
to chloramphenicol, tetracyclines, macrolides, streptogramins, lincosamides, 
glycopeptides and high level resistance to aminoglycosides and penicillins 
(Morrison et al, 1997).
The enterococci are an important reservoir of resistance genes (Leclerq, 
1997) and they can pass their resistance on to other species. Staphylococci 
and enterococci can exchange genetic material and one of the biggest issues 
facing medicine today is the prospect that the enterococcal vancomycin 
resistance gene cluster will be passed on to methicillin resistant 
Staphylococcus aureus (MRSA). This has been shown to be possible in vitro 
(Noble et al, 1992). Isolated cases of vancomycin-resistant MRSA have been
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documented in Japan and the USA (Tabaqchali, 1997; Hiramutsak et al, 
1997; Smith et al, 1999), but these were due to cell wall thickening and 
increases in penicillin binding protein (PBP) 2 and murein monomer 
precursor, rather than the altered peptidoglycan precursors seen in 
enterococcal vancomycin resistance. The emergence of VanA resistance in 
MRSA would usher in a post-antibiotic era where infections can no longer be 
treated with any known antibiotics.
Conventional treatment of enterococcal endocarditis involves combination 
therapy with a penicillin and an aminoglycoside. Penicillins inhibit cell wall 
synthesis to allow the aminoglycoside to reach its ribosomal target more 
efficiently (reviewed by Swartz, 1994). Some controversy exists over the 
timing of doses, but it is generally accepted that divided daily dosings give 
the best results (Gavalda et al, 1996; Marangos et al, 1997).
1.4.1 Aminoglycoside Resistance
During the 1950s the aminoglycoside of choice was streptomycin but by the 
early 1970s 25-50% of clinical isolates showed high level resistance to 
streptomycin and kanamycin. In consequence gentamicin was substituted 
and worked well until 1979 when a strain with high level gentamicin 
resistance was isolated in Paris. Today greater than 50% of enterococci 
worldwide show resistance to penicillin-gentamicin therapy (reviewed by 
Swartz, 1994).
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All enterococci show an intrinsic moderate level resistance to 
aminoglycosides (minimum inhibitory concentration, MIC 62-500 |ag/ml), 
but this is a permeability problem normally overcome by combination 
therapy with a cell wall active agent. High-level resistance to streptomycin 
and gentamicin occurs by different mechanisms and hence it is important to 
test for both in the clinic.
Streptomycin resistance occurs either by a plasmid-encoded adenyl- 
transferase (which causes nucleotidylation of the hydroxyl group) or through 
a chromosomal mutation which alters the affinity of the ribosome for 
streptomycin (reviewed by Swartz, 1994; Leclerq, 1997; Gin and Zhanel, 
1996). It does not, however confer resistance to gentamicin.
Gentamicin resistance can occur by two mechanisms but is usually via a 
plasmid-encoded enzyme which has both 2”-phosphotransferase and 6’- 
acetyltransferase activity (reviewed by Swartz, 1994). This phosphorylates 
the hydroxyl group on the aminoglycoside, using phosphate from ATP and 
acetylates the amino group using acetyl from acetyl-CoA (reviewed by 
Leclerq, 1997). The enzyme confers resistance to gentamicin, tobramycin, 
netilimicin, amikacin and cell-wall active agents, but not to streptomycin. 
Recently a second enzyme has been isolated which confers resistance by 2”- 
acetylphosphotransferase activity (reviewed by Murray, 1998). Fortunately 
46% of high-level gentamicin-resistant E. faecalis isolates are susceptible to 
streptomycin.
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E. faecium tends to be more resistant to aminoglycosides because it carries a 
6’-acetyltransferase enzyme on its chromosome which renders all 
aminoglycosides except streptomycin and gentamicin inactive (reviewed by 
Swartz, 1994; Leclerq, 1997). In the early 1990s 70% of E. faecium  isolates 
showed high-level resistance to gentamicin (reviewed by Swartz, 1994).
1.4.2 Penicillin Resistance
Enterococci are intrinsically more resistant to penicillins (MIC 2.5-5 jig/ml) 
than streptococci (MIC 0.02-0.08 pg/ml) (Swartz, 1994; Murray, 1998). For 
example, E. faecalis is 10-100 times less susceptible to penicillin than most 
streptococci, whilst E. faecium is 4-10 times less susceptible than E. faecalis 
(Gin and Zhanel, 1996). High-level penicillin resistance (MIC 8-64 pg/ml) 
has begun to emerge, p-lactamase-producing enterococci were first seen in 
the early 1980s but have remained at a low level with only a few isolated 
cases seen since then (Murray, 1998; Landman and Quale, 1997).
A far more significant cause of high-level penicillin resistance is the 
increased production of low affinity PBPs. These were first described in E. 
hirae, but have since been isolated in E. faecalis and E. faecium  (Zorzi et al, 
1996). PBPs are situated in the cell wall and are involved in cell wall 
peptidoglycan synthesis through transpeptidase and carboxypeptidase 
activities (Michel and Gutmann, 1997). They are two-domain proteins with a 
C terminal penicillin-binding domain and an N-terminal catalytic domain. 
Penicillins inactivate high molecular weight PBPs (i.e. PBPs 1, 2 and 3) but
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they are unable to bind to the chromosomally-encoded PBP5 of E hirae, 56R 
of E. faecalis, PBP5fm of E. faecium or the plasmid-borne PBP3r of E. hirae. 
All these proteins show strong homology suggesting a common ancestor. 
They are induced in the presence of penicillin and are able to carry out all the 
functions of the other PBPs when these are saturated or inhibited by 
penicillins. Their transcription is negatively controlled. by the PBP5 
synthesis repressor (psr) gene, located lkb upstream of PBP5, which controls 
expression of several other cell-wall related properties (e.g. autolysis and 
sugar expression in the cell wall) (Massida et al, 1996; Massida et al, 1998).
1.4.3 Glvcopeptide Resistance
Vancomycin resistance was first reported in the UK by Uttley et al (1988). It 
has since spread to become a significant problem worldwide. It is a 
particular problem in intensive care units where it can create havoc with the 
treatment of severely ill patients. In one estimate, 13.6% of enterococci from 
intensive care patients were vancomycin resistant (Cars, 1997). The 
mortality associated with vancomycin-resistant enterococci (VRE) can 
approach 70%. Many isolates also show multiple resistance profiles (Gin 
and Zhanel, 1996).
Two forms of transferable vancomycin resistance have been described. The 
VanA type confers high level resistance to both vancomycin (MIC > 64 
pg/ml) and teicoplanin (MIC > 1 6  jig/ml); whilst the VanB type confers 
variable resistance to vancomycin only (MIC 4 - > 1024 jig/ml). The low
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level of resistance it confers makes it difficult to detect and it may be more 
prevalent than was first thought. Although both systems are homologous 
they are not identical and differ particularly in their induction. VanA 
resistance is switched on in the presence of vancomycin and teicoplanin but 
VanB resistance is induced only by vancomycin.
Figure 1.2 VanA Gene Cluster (after Arthur et ah 1998)
Regulation Required for resistance Accessory proteins
4 ------------------► 4 -------------------------------------- ► <4------------------------ ►
vanR vanS vanH vanA vanX vanY vanZ 
Regulator Kinase Dehydrogenase Ligase Dipeptidase Carboxypeptidase Unknown
Figure 1.3 VanB Cluster (After Evers and Courvalin. 1996)
vanRB vanSB vanYB vcmW vcmHB vanB vanXB 
Regulator Kinase Carboxypeptidase Unknown Dehydrogenase Ligase Dipeptidase
The vanA and vanB genes and the vanH and vanX genes show approximately 
70% homology to each other, whilst vanS and vanR show 30% homology 
(Evers and Courvalin, 1996).
Glycopeptides have a bracelet configuration and inhibit cell wall synthesis by 
binding the D-alanine-D-alanine portion of peptidoglycan peptide precursors 
in the pocket formed by its structure. This prevents subsequent
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transglycosylation and transpeptidation reactions which cross link 
peptidoglycan (Reynolds et al, 1994).
The VanA and VanB resistance operons contain a transmembrane receptor 
protein (VanS or VanSs) which binds glycopeptides directly. Following 
activation of VanS the response regulator VanR or VanRs is phosphorylated 
and can then direct the transcription of vanA (vanB) and vanH (vanHg) 
(Evers and Courvalin, 1996). VanH and VanHs are a-ketoacid reductases 
which generate D-lactate from pyruvate (Reynolds et al, 1994; Swartz, 
1994). VanA and VanB are ligases which incorporate the D-lactate into the 
terminal portion of the peptidoglycan precursors to create D-ala-D-lac- 
containing residues (Michel and Gutman, 1997). This ester linkage replaces 
the D-ala-D-ala amide linkage that forms a crucial hydrogen bond with a 
carbonyl group on the vancomycin skeleton (reviewed by Nicas et al, 1997). 
As a result vancomycin cannot bind to D-ala-D-lac residues and the 
bacterium becomes resistant to vancomycin (Swartz, 1994; Reynolds et al, 
1994). VanX (vanXs) and VanY (VanYs) proteins form a fail-safe 
mechanism. VanX and VanXs are dipeptidases which break down D-ala-D- 
ala-containing residues in the cytoplasm so that only D-ala-D-lact residues 
are incorporated into the cell wall (Reynolds et al, 1994). VanY (VanYs) are 
also carboxypeptidases but cleave D-ala-D-ala peptides from peptidoglycan 
precursor molecules (N-acetylmuramic acid linked to the pentapeptide L-ala- 
D-glu-L-lys-D-ala-D-ala) (Chu et al, 1996). The vanZ gene of the VanA 
cluster confers low-level resistance to teicoplanin and is required for full 
virulence, although the mechanism of action is unknown (Chu et al, 1996;
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Evers and Courvalin, 1996; Murray 1998). Similarly, the function of the 
VanW gene product of the VanB operon is unknown (Murray, 1998; Evers 
and Courvalin, 1996).
Intrinsic low level resistance to glycopeptides can also occur in some 
enterococci. This is chromosomally-encoded and is designated VanC. E. 
gallinarum (VanCi), E. casselflavus (VanC2) and E. flavescens (VanCa) all 
express this phenotype. Peptidoglycan precursors terminating in D-ala-D-ser 
are produced, which vancomycin is unable to bind to (Murray, 1998). A 
fourth type of resistance, VanD has also been described, but is poorly 
characterised (Chu et al, 1996).
1.5 Treatment Of Enterococcal Infections
1.5.1 Prophylaxis
Appropriate antibacterial prophylaxis can prevent 49-94% of infective 
endocarditis cases in patients undergoing procedures with a risk of 
bacteraemia (Stamboulian and Carbonne, 1997). However prophylaxis 
should be targeted to patients who are most at risk to prevent the 
development of resistance. Conditions which confer a risk of endocarditis 
are listed in Table 1.1.
26
Table 1.1 Risk Factors for Endocarditis (after Stamboulian and Carbonne, 
1997)
Assessment of risk Underlying heart condition
High Risk prosthetic valves
congenital heart disease causing 
cyanosis
previous bacterial endocarditis 
surgical systemic pulmonary shunts
Moderate Risk rheumatic and other acquired 
valvular dysfunction 
mitral valve prolapse with 
regurgitation
most congenital cardiac 
malformations
hypertrophic cardiomyopathy





Any procedures which cause bleeding can result in a bacteraemia that will 
cause endocarditis. Therefore even catheterisation could be considered a 
risky process. Appropriate hygiene measures should be taken to ensure that 
patients are not exposed to bacteria. However antibiotics are not usually 
considered necessary for most procedures. It is widely acknowledged that 
dental procedures carry the greatest risk of causing infective endocarditis 
(Stamboulian and Carbonne, 1997). Good oral health should be encouraged 
in all at-risk patients to prevent bacterial seeding during teeth cleaning. 
Antibiotic prophylaxis should be used for all dental procedures where there is 
a risk of significant bleeding. A one-off dose of amoxycillin 3g one hour 
before the procedure is the recommended regimen in Britain. Clindamycin 
600mg or occasionally clarithromycin or azithromycin can be used if the
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patient is allergic to penicillin (Dajani et al, 1997; Stamboulian and 
Carbonne, 1997; Murphy and Steckelberg, 1995).
1.5.2 Treatment Of Aminoglycoside-Resistant Enterococci
High-level gentamicin resistance represents a problem in therapy as it stops 
bactericidal therapy and bacteriostatic therapy may only just be achieved 
(Landman and Quale, 1997). In some cases high-dose ampicillin treatment 
can be sufficient, but unusual combinations of agents may be needed (e.g. 
ciprofloxacin + ampicillin) (Landman and Quale, 1997; Tripodi et al, 1996). 
A glycopeptide may be needed if the patient is allergic to penicillin but 
caution must be exercised to avoid inducing vancomycin resistance.
1.5.3 Treatment Of Penicillin-Resistant Enterococci
p-lactamase-producing enterococci can be treated with p-lactamase inhibitors 
(e.g. sulbactam, tazobactam). Resistance caused by low affinity PBPs can 
be treated with a glycopeptide + aminoglycoside. In some cases, simply 
increasing the dose of p-lactam may be sufficient (Rybak and McGrath 
1996).
1.5.4 Treatment Of Vancomvcin-Resistant Enterococci
Vancomycin-resistant enterococci represent a major therapeutic problem. As 
a reflection of the complex nature of this problem there is no generally
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accepted ‘ideal therapy.’ Treatment will usually depend on local resistance 
patterns.
VanB resistance may be treated with teicoplanin. However care should be 
exercised as these bacteria can be induced to express VanA resistance on 
longer therapy due to the selection of more resistant mutants (Aslangul et al, 
1997; Nicolau et al, 1996). Bactericidal therapy is again difficult to achieve. 
Combination therapy is useful because it usually shortens the treatment 
period and therefore reduces the risk of inducing new resistance (Nicolau et 
al, 1996; Aslangul et al, 1997). If vanB resistance confers only low level 
vancomycin resistance, a combination of vancomycin or teicoplanin with 
streptomycin can produce very good results (Nicolau et al, 1996).
VanA and amoxycillin resistance has been treated successfully with triple 
therapies. A p-lactam, a glycopeptide and gentamicin, or ciprofloxacin + 
rifampicin + gentamicin have both been used effectively (Michel and 
Gutmann, 1997).
The new streptogamin antibiotic quinupristin/dalfopristin (Synercid) has also 
been used to treat VRE. It shows 8-16 fold greater activity against E. 
faecium  than E. faecalis (Cormican and Jones, 1996). Streptogramins can 
take two forms, A and B, and each form binds to a different position on the 
bacterial ribosome. Synercid exploits this by using both forms of 
streptogamin to produce synergism. Dalfopristin binds to the ribosome and 
alters the shape to enable quinupristin to bind more efficiently. Thus the
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combination of the two agents is much more effective than either agent alone 
(reviewed by Nicolau et al, 1997; Rybak and McGrath, 1996). The 
combination can also enter human phagocytes which is vital as E. faecium  
has been shown to survive intracellular killing in phagosomes (reviewed by 
Rakita, 1998).
Nosocomial VRE infections mostly affect the severely ill who have already 
received extensive antibiotic therapy. Patients with leukaemia, bone marrow 
transplant patients and those undergoing haemodialysis or in intensive care 
are particularly at risk. To avoid the problem occurring in the first place it is 
important to avoid the overuse of vancomycin or agents which can encourage 
superinfection with resistant organisms (Cars, 1997). Previous treatment 
with vancomycin is nearly always found in VRE outbreaks and it has been 
estimated that 50-60% of vancomycin usage is inappropriate (Gin and 
Zhanel, 1996). Glycopeptides should only be used to treat enterococci when 
p-lactam resistant bacteria are known to be present, or are strongly suspected 
(Gin and Zhanel, 1997). Oral vancomycin should be a second line treatment 
after metronidazole in cases of Clostridium difficile (Gin and Zhanel, 1997; 
Rao et al, 1997). The use of broad-spectrum antibiotics should be avoided as 
this can lead to superinfection with enterococci that show intrinsic resistance 
to many antibiotics. Ciprofloxacin, metronidazole and third generation 
cephalosporins have all been implicated in this problem (Rybak and McGrath 
1996; Cars, 1997). During a VRE outbreak it is important to isolate and treat 
all carriers of VRE, partly to prevent the spread of the outbreak and partly
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because colonisation with VRE can often lead to a VRE infection if left 
untreated (McDonald et al, 1997).
Although most cases of VRE are nosocomially acquired, VRE colonisation is 
seen in the community. This may have been due at least in part to the 
unrestricted use of glycopeptides in animal husbandry. Vancomycin has 
never been used to treat animals, but the glycopeptide avoparcin has been 
used as a growth promoter in animal feedstuffs. This led to animals 
becoming colonised with VRE and the resistance was passed on through the 
food chain to humans. Avoparcin has now been banned in foodstuffs, but it 
is worth noting that many antibiotics are still used in agriculture. These 
include cell wall synthesis inhibitors, protein and DNA synthesis inhibitors 
and substances that moderate cation permeability (ionophores). Most of 
these substances are active against gram-positive bacteria and it is vital that 
constant surveillance occurs to avoid resistance being passed through the 
food chain again (Bates et al, 1994; Devriese et al, 1996; Helmuth and Protz, 
1997; Michel and Gutmann, 1997; Murray 1998;).
1.6 Future Targets for Therapy
With the ever-decreasing treatment options for enterococcal endocarditis it is 
important to look for new antibiotics to treat this infection. Modifications of 
existing drug structures may provide short-term relief from resistance but a 
long-term solution to the problem should be found. This may involve 
identifying new targets for antibiotics. We may also need to find more 
efficient ways of targeting drugs to cells; to reduce the treatment duration
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and the number of drugs needed for bactericidal therapy. It may even be 
necessary to find a vaccine against enterococci, to be given to patients 
considered to be at risk of developing endocarditis. Whatever course of 
action is taken, improved understanding of enterococcal processes is needed 
in order to define the virulence factors which make them pathogenic.
There are two areas of research which have been cited as possible targets for 
therapy: the sex pheromone plasmids (especially cytolysin-containing 
plasmids) and EfaA, a member of the Cluster 9 protein family.
1.7 Virulence Factors on Sex Pheromone Plasmids
Pheromones can be defined as ‘Substances which are secreted to the outside 
by an individual and received by a second individual of the same species, in 
which they release a specific action, e.g. a definite behaviour or 
developmental process. The principal of minute amounts being effective 
holds’ (reviewed by Wirth et al, 1996). Pheromones are one of the few ways 
a single bacterium can obtain information from others of the same species 
(Wirth et al, 1996). A plasmid-free cell (recipient cell) excretes a sex 
pheromone. It is detected by a plasmid-containing cell (donor cell) in the 
proximity, which then initiates conjugation (reviewed by Dunny and 
Leonard, 1997).
The E. faecalis sex pheromones are chromosomally-encoded, short, 
hydrophobic peptides and are specific for a particular plasmid. They are 
excreted in low amounts (usually 10'8 to 10'9 M) but it has been estimated
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that only 1 - 1 0  molecules per cell (about 10*11 M) are needed for induction 
(reviewed by Dunny et al, 1995; and Wirth et al, 1996). It is not easy to 
distinguish between sex pheromone plasmids, except by the pheromone that 
induces them. Over 20 different restriction profiles exist (Wirth et al, 1996). 
A strain carrying one sex pheromone plasmid is still able to act as a recipient 
for others and many clinical isolates will contain several different plasmids.
Figure 1.4 The Plasmid dADI Regulation Locus (After Fuiimoto and
Clewell. 19981
traEl traD iad traA traC traB
^  w
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Plasmid pADl is arguably the best-studied sex pheromone plasmid. It is 
induced by the pheromone cADl, which attaches to the cell via a receptor 
protein (TraC). TraC exploits the chromosomally encoded opp (oligopeptide 
permease) operon to transport the pheromone into the cell. The opp operon 
codes for an ABC transporter (see section 1.8). The internalised pheromone 
binds to the negative regulator traA, which is located at the iad promoter site. 
Bound TraA causes a conformational shift in the DNA that blocks complete 
transcription of the positive regulator TraEl (instead it terminates at the 
transcription terminators TTS1 and TTS2). When cADl binds to TraA it 
releases TraA from its binding site and allows complete transcription of 
TraEl (Fujimoto and Clewell, 1998).
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TraEl can also induce its own production through the promoter located 
within TTS2. Negative regulation occurs via the peptide iADl, which 
reduces the sensitivity of the system so that it is only switched on when 
recipient cells are very close to donors. The inhibitor iADl is transcribed 
from the iad promoter site (Bastos et al, 1997). The region contained 
between the iad promoter and the first transcription termination site TTS1 is 
known to be very complex and has not been well studied. There is evidence 
for significant secondary structure in the potential transcripts and at least 
three RNA species could be involved in promoting or repressing expression 
(Bastos et al, 1997). TraB is believed to be co-transcribed with the 
extracellular receptor TraC and it sits in the membrane to prevent self- 
induction of conjugation (Dunny and Leonard, 1997). A 23 amino acid 
peptide TraD has also been detected. It has an important, but unknown, role 
in conjugation (Fujimoto and Clewell, 1998).
TraEl promotes the transcription of ‘aggregation substance’ (AsalO). 
Aggregation substance causes the characteristic ‘clumping’ mechanism, by 
binding to enterococcal binding substance produced by recipient cells. 
Donor and recipient cells thus form aggregates to facilitate efficient 
conjugation (reviewed by Clewell, 1993). AsalO is a 142kD signal peptide. 
It is anchored to the cell membrane by its C terminus, leaving a 74kD protein 
visible on western blots. The molecule has a random coil structure and an 
amorphous appearance on the cell surface. It appears in hair-like structures 
mostly on the ‘old’ cell wall (reviewed by Wirth et al, 1996; Dunny et al,
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such as lanthionine and methyllanthionine. Class II bacteriocins are non- 
lantibiotics. They, too, are small (<13kD) proteins which are heat stable, 
cationic and hydrophobic peptides containing no modified amino acids 
(Cintas et al, 1998). Both types of bacteriocins are ribosomally synthesised 
as precursor peptides containing an N-terminal leader sequence which is 
cleaved as the bacteriocin is exported out of the cell. The leader sequences 
are often glycine-based and act as a recognition signal for the processing and 
secretion proteins (Cintas et al, 1998).
Cytolysin is a lantibiotic as shown by the presence of lanthionine and 
methyllanthionine on both peptide subunits (Booth et al, 1996). However 
cytolysin differs from other lantibiotics in many ways. It is able to lyse 
eukaryotic cells, it requires the interaction of two subunits for its activity and 
it has been implicated in virulence (Booth et al, 1996). The cytolysin 
determinant is composed of two regions encoded on five open reading 
frames. The first region (region A) is composed of cylA. CylA activates 
cytolysin and provides the bacterial cell with immunity to its effects. The 
second region (termed region L) encodes the cytolysin subunits and 
processing and secretion apparatus (Tomita et al, 1997). The two cytolysin 
peptide subunits CylLL and CylLs are synthesised ribosomally. They have a 
hydrophilic amino terminal and a hydrophobic carboxy terminal (Gilmore et 
al, 1994). They show no homology to each other except for a 26 amino acid 
region on both subunits, which acts as a recognition sequence for export. 
After synthesis the two subunits are modified in the cytoplasm by CylM. • 
This may be the stage at which lanthionine and its derivatives are formed
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(Gilmore et al, 1994). The two subunits are now exported through CylB, 
which is an ABC transporter. Further modification is believed to occur 
during transport. The two subunits are externalised with an amino terminal 
truncation (CylLi/ and CylLs’) (Booth et al, 1996).
The fifth protein in the cytolysin operon is transcribed separately from the 
others (Gilmore et al, 1994). CylA is involved in the final activation of the 
two subunits to give mature cytolysin. It is a serine protease and is thought 
to cleave the two subunits again (CylLL” and CylLs” ) before they are 
assembled and become active (Segarra et al, 1991). CylA is also thought to 
confer immunity to cytolysin. As immunity is a function of CylA 
concentration, it is thought most likely that the high concentration of 
component A in the microenvironment around the cell protects it from lysis 
(Segarra et al, 1991).
Haemolysins are needed by bacteria in vivo to inhibit leukocyte function and 
lyse erythrocytes to provide iron and other nutrients to bacterial cells (Chow 
et al, 1993). The role of cytolysin in virulence has remained controversial 
and is often blurred with the role of aggregation substance. The binding of 
aggregation substance to eukaryotic cells may bring cytolysin closer to its 
target and thus aid its activity. Cytolysin is believed to help enterococci in 
invasive diseases by altering leukocyte function to aid the early and 
uncontrolled release of inflammatory agents from damaged tissue of 
phagocytes (Jett et al, 1992). It may initiate endocarditis by injuring 
endocardial cells (Huycke and Gilmore, 1995).
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In a mouse peritonitis model, transposon insertion mutants of pADl were 
significantly less virulent than wild-type strains exhibiting full cytolysin 
activity (Chow et al, 1993). Similarly in an endophthalmitis model of 
enterococcal infection, cytolysin-producing strains caused a much more 
serious disease. Cytolysin was found to penetrate and destroy cells deep 
within the retina to cause faster and more serious, devastating damage to 
vision than cytolysin-free strains (Jett et al, 1992).
It would therefore seem feasible to target the pADl plasmid for therapy. 
Inhibition of cytolysin and aggregation substance would reduce the virulence 
of enterococci and perhaps even render them incapable of causing disease. 
However these promising findings have been hard to reproduce in models of 
endocarditis infection. One study showed that 84% of endocarditis isolates 
and 68% of blood isolates had no haemolytic activity (Coque et al, 1995). 
More hopefully, a rabbit endocarditis model showed aggregation substance 
could mediate adhesion to cardiac cells and hence increase vegetation 
weight. Cells containing both aggregation substance and cytolysin were 
found to be more virulent. However mutants containing cytolysin but no 
aggregation substance were found to have no greater virulence than plasmid- 
free cells, leading to speculation that cytolysin may not be essential for 
virulence (Chow et al, 1993).
Therefore whilst aggregation substance- and cytolysin-producing strains do 
seem to cause a more virulent infection when present, neither plasmid-
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encoded factor appears to be essential for virulence. About 45% of isolates 
contain neither factor (Coque et al, 1995), suggesting that eukaryotic cell 
damage and adherence must arise through other mechanisms. Although 
targeting sex pheromone plasmids would be an attractive and specific 
mechanism for controlling diseases caused by enterococci, it appears that it 
will not be an effective treatment for endocarditis.
1.8 Cluster 9 Proteins
Aitchison et al (1987) identified a 37/40 kl) E. faecalis antigen that is only 
expressed during endocarditis. Since that time the protein has been cloned 
and sequenced (Lowe et al, 1995) and has been designated EfaA (for 
Enterococcus faecalis antigen A). Work by Xu et al (1997) confirmed the 
importance of EfaA in virulence. Singh et al (1998) created a knockout 
mutation of EfaA, which showed reduced virulence in a mouse model of 
peritonitis.
EfaA shows homology to streptococcal surface proteins that have been 
implicated in adhesion. These include FimA from Streptococcus 
parasanguis, ScaA from Streptococcus gordonii, SsaB from Streptococcus 
sanguis and AdcA from Streptococcus pneumoniae. All of these proteins are 
believed to be ATP binding cassette (ABC) transporters. They form a family 
of proteins that do not correspond to any of the eight groups of extracellular 
receptors defined by Tam and Saier (1993). Dintilhac and Claverys (1997) 
therefore designated this group ‘Cluster 9 proteins.’ They have previously
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been called the lipoprotein receptor antigen 1 (Lral) family (reviewed by 
Jenkinson, 1994a,b).
Table 1.2 Cell Surface Transport Proteins (After Tam and Saier. 1993).
Grouo Transport Function
Cluster 1 Oligosaccharides, glycerol-3-phosphate
Cluster 2 pentoses and hexoses
Cluster 3 polar amino acids and opines
Cluster 4 alipathic, hydrophobic amino acids
Cluster 5 peptides and nickel
Cluster 6 multivalent inorganic anion binding
Cluster 7 divergent, multivalent organic polyanion binding
Cluster 8 organic iron complexes
Table 1.3 Cluster 9 Proteins (After Dintilhac et al. 1997)
Key
(not yet proven)
? = Classification 
unclear
Name Snecies Substrate
PsaAv Streptococcus pneumoniae Manganese
SsaB S. sanguis (Manganese)
ScbA S. crista (Manganese)
ScaA S. gordonii (Manganese)
FimA S. parasanguis (Manganese)
PsaA S. pneumoniae ? (Manganese)
SpyP S. pyogenes (Manganese)
EfaA E. faecalis (Manganese)
Step Staphylococcus epidermidis Iron ?
H I0362 Haemophilus influenzae Iron ?
YfeA Yersinia pestis Iron
MntC Synechocystis Manganese
Spy9 Staph, epidermidis (Zinc ?)
AdcA S. pneumoniae zinc




H10119 H. influenzae (zinc)
Syn9 synechocystis (zinc)
EwlA Erysipelothrix rhusiopathiae ?
Trompl Treponema pallidum ?
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The function of these proteins is only just beginning to be characterised. 
Whilst some members of the family have been shown to be involved in 
adhesion it has become clear that this is not their only role.
1.8.1 Structure Of Cluster 9 Protein Transport Qperons
All ABC-like proteins have common components: one or two cytoplasmic 
ATP-binding proteins (ATPases), one or two hydrophobic membrane 
proteins and one extracellular solute binding protein. In gram-negative 
bacteria the solute binding protein is situated in the periplasm whereas gram- 
positive extracellular proteins are lipid-modified at their N-terminus to 
enable them to be anchored to the cell membrane (Reviewed by Jenkinson, 
1994a, b).
The lipoprotein moiety of the gram-positive ABC transporter has four 
regions. The first 32 amino acids including the 19-or 20-residue ‘leader 
sequence’ are the least well conserved. This sequence is believed to direct 
transport of the protein across the cytoplasmic membrane. At the end of the 
leader peptide is the signal L S/A, A/G,i, C, S, G which is the cleavage site 
for the enzyme signal peptidase II. The N terminal cysteine of the mature 
protein is anchored to palmatic acid of the cell membrane via an acyl- 
glyceride bond. Signal peptidase then cleaves the hydrophobic tail of the 
leader sequence. This maintains the binding protein close to the cell 
membrane components of the transport system (Tam and Saier, 1993; 
Kolenbrander et al, 1994). The lipid modification of the N terminus blocks
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specific channel with the ATP binding proteins providing the energy for 
transport (Tam and Saier, 1993).
The cytoplasmic ATPases are evolutionally the most conserved proteins 
among the ABC transporters. Again, it is thought that there are two ATPases 
for each receptor protein. They are probably anchored to the membrane via a 
single transmembrane helix (Tam and Saier, 1993). The proteins have two 
conserved domains, known as Walker motifs A and B, which are thought to 
be the binding site for the nucleotide ATP.
Figure 1.6 shows the basic structure of all ATPases. The ‘linker peptide’ is 
the signature sequence and is unique to the ABC family. It is involved in 
ATP binding whilst the rest of the helical domain is not. Instead it is thought 
to interact with the membrane protein. The aspartate residues in the Walker 
A and B sites play a role in directing Mg which is needed for ATP activity 
and in the correct positioning of ATP for catalysis. The ‘switch region’ is 
thought to be involved in signal transport following ATP hydrolysis 
(Schneider and Hunke, 1998).
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1996). More recently it became clear that these receptors are also closely 
connected with metal ion transport.
1.8.2 Metal Ion Transport
Dintilhac et al (1997) concluded that the Adc operon was an ABC-type zinc 
permease; whilst the Psa operon was an ABC-type manganese permease. 
From phylogeny studies they grouped the cluster 9 family into transporters of 
zinc, manganese or iron (see table 1.3). Work by other groups has confirmed 
the metal binding properties of some of these lipoproteins (Kolenbrander et 
al, 1998; Bearden et al, 1998; Bartsevich and Pakrasi, 1995). EfaA was 
presumed to transport manganese in these reports.
1.8.2.1 Manganese
Manganese is an important element for bacteria. It is used in the synthesis of 
secondary metabolites, bacterial sporulation and in the production of many 
antigens and toxins. It is implicated in the adhesion of some mutans group 
Streptococci (Kolenbrander et al, 1998). Several enzymes use manganese as 
a cofactor in their reactions. These include redox enzymes (Mn-superoxide 
dismutase and Mn catalase) and metabolic enzymes (pyruvate carboxylase 
and phosphoenolpyruvate carboxylase) (Bartsevich and Pakrasi, 1995). 
Manganese is most needed at elevated oxygen concentrations where 
manganese superoxide dismutase is most active.
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1.8.2.2 Zinc
Zinc (and to a lesser extent manganese) affects competence. S. pneumoniae 
cells which are starved of zinc do not respond to the pheromone competence 
stimulating peptide. Zinc is most likely required during the transcription of 
competence genes (Dintilhac et al, 1997).
1.8.2.3 Iron
Although iron is the fourth most abundant element in the earth’s crust it is 
easily oxidised to insoluble ferric hydroxide and thereby becomes 
unavailable to bacteria. Many iron-scavenging agents have been identified, 
particularly in gram-negative bacteria. Siderophores (iron chelators), 
extracellular lactoferrin and transferrin and haemolysins (which release iron 
from haem and haemoglobin) are all well documented methods of obtaining 
iron (Litwin and Calderwood, 1993; Smith, 1998). The iron supply inside a 
human host is even scarcer. An inducible iron transport system, such as the 
Yfe operon in Yersinia pestis is therefore vitally important for the survival of 
the bacterium within the host (Bearden et al, 1998; Hill et al, 1998).
It is not yet clear whether the receptor proteins bind metal ions directly; 
however their expression is increased when the metal ion concentration is 
decreased. For example, ScaA is induced by decreasing the available 
manganese, or by increasing zinc. Zinc is believed to compete with 
manganese for uptake (Kolenbrander et al, 1998). It is also clear that the
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The thiol peroxidase shows homology with Upp identified by Cha et al 
(1996) in E. coli. It metabolises H2O2 and other damaging oxygen radicals to 
inert substances. As superoxide dismutase activity requires manganese in 
Streptococci, it is highly likely that increased manganese transport coupled 
with thiol peroxidase action will greatly aid the bacterium’s stress response 
(Kolenbrander et al, 1998). However a thiol peroxidase is not found 
downstream of efaA, suggesting that another form of regulation occurs in 
enterococci.
It is perhaps more appropriate to consider how metal ions are able to promote 
or repress the transcription of cluster 9 proteins. Iron dependant repressors 
regulate two recently sequenced ABC transporters, the sit operon o f S. 
epidermidis and ih&yfe operon from Y pestis.
The sit ABC operon is induced in low iron concentrations (Cockayne et al, 
1998). Regulation occurs via sirR, which is located upstream of the sit ABC  
operon. Both iron and manganese can bind to SirR and regulate sit operon 
transcription. SirR binds to the sit operon promoter (in a 19bp palindromic 
‘Sir’ box) and prevents transcription (Hill et al, 1998). SirR belongs to the 
DtxR family. DtxR represses diptheria toxin synthesis in Corynebacterium 
diptheriae. Therefore although all these repressors bind to DNA when the 
iron concentration is high, they may control the expression of many virulence 
genes, not just those involved in metal ion transport. It is therefore possible 
that SirR may regulate additional genes; perhaps ones involved in adhesion, 
or other virulence factors. As iron is severely limited in the host
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environment the metal ion concentration could be a valuable environmental 
sensor for bacteria; enabling them to detect and produce a co-ordinated 
response to their environment.
A similar regulatory system is seen in the yfe operon. Here gene expression 
is thought to be controlled by a ‘Fur homologue’; responding both to iron and 
manganese (Bearden et al, 1998). The ‘ferric uptake regulator’ or fu r  gene 
was first identified in E. coli. Its function is similar to the DtxR repressor, 
but the two are not interchangeable (Litwin et al, 1992). Both DtxR and Fur 
homologues are found in S. epidermidis, suggesting that the two systems can 
co-exist (Heidrich et al, 1996).
Some of the Cluster 9 lipoproteins have been investigated as possible target 
vaccinogens. A specific antibody to one of these proteins may confer 
immunity by increasing the clearance of bacteria and preventing adherence. 
An anti-FimA antibody was found to confer immunity against S. parasanguis 
endocarditis (Viscount et al, 1997). This immunity was thought to be caused 
by inhibiting adhesion of bacteria to platelets and fibrin. Recent work with 
PsaA has called into question the wisdom of using these proteins (Novak et 
al, 1998). PsaA was found to be a penicilllin tolerance gene. Tolerance, 
which should be distinguished from resistance, occurs when a strain stops 
growing in the presence of an antibiotic, but does not go on to die rapidly. In 
pneumococci this is dependant on autolysin (which lyses the cell wall), that 
is either not triggered or is not present. As previously mentioned the Psa 
operon affects the expression of choline binding proteins on the cell surface.
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LytA, the major autolysin, is a choline binding protein and is absent in psa  
mutants, imparting penicillin tolerance to such strains (Novak et al, 1998). 
The use of these lipoproteins as vaccine targets should be treated with 
caution, as it is vital not to introduce further antibiotic tolerance into 
organisms that are already difficult to treat.
Whilst it is evident that the cluster 9 proteins are important virulence factors 
their precise function still needs to be clarified. The induction of all cluster 9 
proteins merits further study. If they were able to regulate the production of 
other virulence factors, they would be a very useful drug target. It is 
particularly significant that EfaA' is found in all enterococcal IE isolates 
tested (Aitchison et al, 1987). It would provide a very specific drug target 
for this disease. However further work on all these antigens is needed to 
clarify their precise function in cells and their role in pathogenesis.
1.9 Aims of This Project
This project aimed to study the role of E. faecalis EfaA in infective 
endocarditis. The effect of metal ions on the transcription of efaA would be 
studied. The entire efa operon needed to be sequenced and, additionally, the 
homologous operon in E. faecium needed to be identified and sequenced. 
Detailed studies on EfaA required inactivation of this gene, so attempts were 
made to construct a mutant by insertional inactivation.
In addition to these main aims, the project also tried to study the occurrence 
of EfaA in several clinical strains of E. faecalis. To aid laboratory work,
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EfaA was purified by ammonium sulphate precipitation and was used to 




2.1 Bacterial Strains and Media
E. faecalis EBH1 was isolated from a patient (GP) with severe enterococcal 
endocarditis at Birmingham Heartlands Hospital, Birmingham, UK 
(Aitchison et al, 1986). E. faecium UB1 was isolated from the same hospital, 
but there were no details available on the type or severity of the infection it 
caused.
Enterococcal strains were grown in Brain Heart Infusion (BHI-Oxoid, 
Basingstoke, UK) broth, or M9-YE medium (M9 salts, 5 x 0.64 % 
Na2HP04.7H20 , 0.15 % KH2P 04, 0.025 % NaCl, 0.05 % NEUC1, 0.3 % 
(Sigma Chemical Co., Poole, Dorset), yeast extract (Oxoid) with 0.2 % 
glucose (Sigma) and 0.1 % casamino acids (Difco, Detroit, MI)). When an 
especially rich medium was required, cells were grown in BHI supplemented 
with 1 % yeast extract (BHY broth). For experiments requiring a minimal 
medium, cells were grown in 1 % yeast extract. Unless otherwise stated all 
enterococcal strains were grown anaerobically at 37 °C.
When a chemically defined medium was required for E. faecalis a formulae 
given by Shockman et al (1961) was used. This contained, per litre, 400 mg 
KH2P 04, 300 mg K2H P04, 26.65 g Na2HP04, 16.45 g NaH2P 0 4, 20 g 
glucose, 6 g sodium acetate, 600 mg ammonium sulphate, 200 mg 
magnesium sulphate, 10 mg NaCl, 10 mg ferrous sulphate, 10 mg manganese 
sulphate.
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2.5 Minimum Inhibitory Concentration (MIC) of an Antibiotic
To each of six test tubes was added 0.1 ml of an overnight bacterial culture 
and 1.9 ml double strength BHI broth. A solution of antibiotic was made to a 
concentration of 100 mg/ml. A series of two-fold dilutions was made to give 
six 2 ml antibiotic solutions. These solutions were added to each of the six 
test tubes to give the final concentrations of 25 pg/ml, 12.5 pg/ml, 6.25 
pg/ml, 3.125 pg/ml, 1.56 pg/ml and 0.78 pg/ml. Tubes were grown at 37 °C 
overnight and the lowest concentration of antibiotic which inhibited bacterial 
growth was designated the MIC.
2.6 Preparation of Plasmid DNA from Bacterial Cells bv Alkaline Lvsis 
(Mini-Prep).
The method used was that described by Sambrook et al (1989). A single 
bacterial colony was transferred to 10 ml LB medium containing the 
appropriate antibiotic. This was incubated overnight at 37 °C in a shaking 
incubator.
Following incubation 1.5 ml culture was transferred to a micro-centrifuge 
tube and centrifuged at 14,000-x g for 2 min. The pellet was resuspended by 
vigorous vortexing in 100 pi solution I (50 mM glucose, 25 mM tris, 10 mM 
EDTA). Two hundred microlitres of freshly prepared solution II (0.2 M 
NaOH, 1 % SDS) were added and the contents of the tube were mixed by 
inverting gently. The tubes were placed on ice for 10 min, then 150 pi 
Solution III (3 M potassium acetate, 1.9 M glacial acetic acid) was added.
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The sample was incubated at room temperature for 5 min. Neutralisation 
solution (350 pi) was added and the tube was mixed by inversion.
The bacterial lysate was centrifuged at 14,000-x g for 10 min at room 
temperature. The cleared lysate was transferred to a spin column in a 2 ml 
collection tube and was then centrifuged at 14,000-x g for 1 min at room 
temperature. The column was washed with 750 pi column wash solution and 
was centrifuged at 14,000-x g for 1 min. A further 250 pi column wash 
solution was added to the spin column and the tube was centrifuged at
14,000-x g for 2 min. The plasmid DNA was eluted in 100 pi Milli-Q water 
by centrifugation at 14,000-x g for 1 min.
2.8 Maxi Prep of Plasmid DNA
Large scale plasmid DNA extractions were carried out with the Qiagen Maxi 
Prep kit (Qiagen, GmbH, Hilden, Germany). A single colony of E coli XL1 
containing the desired plasmid was selected and inoculated into 10 ml LB 
broth containing the appropriate antibiotic. The culture was grown for 8 h 
then subcultured 1:100 into 500 ml LB broth with antibiotic, and was grown 
overnight with shaking at 37 °C. The bacteria were harvested by 
centrifugation at 6,000-x g for 10 min at 4 °C. The cell pellet was 
resuspended in 10 ml Buffer PI (4 °C). Buffer P2 (10 ml) was added and 
mixed gently. The suspension was incubated at room temperature for 5 min. 
Chilled Buffer P3 (10 ml) was added and the suspension was mixed 
immediately but gently, then incubated on ice for 20 min. The suspension
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repeatedly until no precipitate formed at the interface. The solution was 
extracted once with chloroform: iso-amylalcohol.
Chromosomal DNA was precipitated by adding sodium acetate (pH 5.2) to 
0.3 M, followed by 2 vol ice-cold ethanol. The DNA was allowed to 
precipitate for 5 min at room temperature and then recovered from the 
solution by winding the thread-like precipitate onto a sterile pasteur pipette. 
The DNA was washed in 70 % ethanol, dried under vacuum and suspended 
inTE.
2.11 Chromosome Extraction with the Igi Genie Genomic Extraction Kit 
(Helena Bioscience)
Small-scale chromosome extraction was carried out using the Igi Genie 
Genomic kit from Helena Bioscience (Beaumont, Texas).
An overnight culture of bacterial cells (1.5 ml) was centrifuged at 14,000-x g 
for 2 min. The pellet was resuspended in 300 pi Gen I. Gen II (300 pi) was 
added and the suspension was vortexed vigorously. The tubes were 
incubated at 55 °C for 30 min. Gen III (150 pi) was added and the lysate was 
mixed fairly vigorously. The tubes were left to stand at room temperature for 
10 min, with occasional mixing. After centrifuging at 14,000-x g for 5 min 
the supernatant was transferred to a fresh tube. Chromosomal DNA was 
precipitated with 450 pi isopropanol (Sigma). The tubes were centrifuged at
14,000-x g for 5 min and the supernatant was discarded. The DNA pellet 
was washed with 200 pi 70 % ethanol, centrifuged for 5 min at 14,000-x g.
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The pellet was air-dried for 5 min at room temperature then dissolved in 20 
pi of TE buffer (pH 8.0).
2.12 Estimation of DNA Concentration bv Ethidium Bromide Dot 
Quantification
The following DNA standard solutions were prepared in TE buffer (pH 8.0): 
0 pg/ml, 1 pg/ml, 2.5 pg/ml, 5 pg/ml, 7.5 pg/ml, 10 pg/ml, 20 pg/ml. DNA 
was obtained from the pBR322 plasmid (Sigma)
Each standard DNA solution (4 pi) was added to 4 pi ethidium bromide 1 
pg/ml. The unknown DNA solutions were prepared in the same way. A 
piece of Saran wrap was placed on the transilluminator and the standard and 
the unknown DNA solutions were spotted side by side on the plastic wrap. 
The fluorescence of the standard and unknown DNA solutions was compared 
under UV light and this was used to estimate DNA concentration of the 
unknown solutions.
2.13 Ethanol Precipitation of DNA
A 100 pi DNA sample was taken and 50 pi of 7.5M ammonium acetate with 
375 pi 95 % ethanol was added. The reaction was centrifuged at 14,000-x g 
for 15 min at room temperature. The supernatant was discarded. The pellet 
was rinsed briefly in 250 pi 70 % ethanol then was centrifuged at 14,000-x g 
for 5 min. The ethanol was removed and the pellet was air-dried for 3-5 min. 
The DNA was resuspended in
61
10-25 pi Milli-Q water. The procedure could be scaled up or down as 
required.
2.14 Restriction of Plasmid DNA
DNA restrictions were carried out using New England Biolabs (Beverly, 
MA) enzymes. The sample, enzyme and appropriate buffer were added to a 
final volume of 20 pi. Plasmid restrictions were incubated at 37 °C for 1 h, 
whilst chromosomal restrictions were incubated overnight. The reaction was 
stopped by heating the solution to 65 °C for 20 min, or by cleaning with the 
Qiaquick PCR purification kit (Qiagen, see section 2.18).
Partial digestions were performed on chromosomal DNA. Four successive 
two-fold dilutions of the enzyme were prepared, DNA and buffer were added 
and the reaction was incubated overnight.
2.15 Preparing a Horizontal Agarose Gel.
Agarose gel electrophoresis was performed in Bio-Rad DNA sub-cells (Bio- 
Rad, Richmond, Ca). Electrophoresis grade agarose (1 %) was dissolved in 
0.5 X TBE (0.045 M Tris.borate, 0.001 M EDTA) or lx  TAE (0.04 M Tris 
acetate, 0.001 M EDTA) at high temperature in a microwave oven. The 
solution was allowed to cool to approximately 60 °C then ethidium bromide 
was added to 0.5 pg/ml. The gel was poured into the casting tray and 
allowed to set at room temperature. DNA samples were mixed with 0.2 vol 
6x DNA loading buffer (0.5 % SDS, 25 % glycerol, 0.25 % bromophenol
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blue, 0.25 % xylene cyanol, 0.05 M EDTA) and electrophoresis was carried 
out at 80 V for 1.5 h. The DNA was visualised using a UV light box.
2.16 Oiaquick Gel Extraction Protocol
The Qiaquick kits from Qiagen were used to recover DNA from agarose gels, 
PCR reactions, restrictions etc (see section 2.18 for the Qiaquick PCR 
purification protocol). For both of these kits, the DNA was dissolved in a 
buffer then placed in a spin column from the kit, which contained a silica 
membrane. Under acidic or neutral pH conditions, the DNA binds to the 
silica membrane and impurities are washed through. The pH conditions are 
then changed to alkaline to elute the DNA.
The DNA fragment was extracted from the agarose gel with a scalpel. The 
weight of the agarose slice was obtained, then 3 vol of Buffer QG were 
added to 1 vol of gel. The reaction was incubated at 50 °C for 10 min with 
occasional mixing to melt the agarose sample. Isopropanol (1 vol) was 
added to the sample and the tube was mixed. The sample was applied to a 
Qiaquick column in a 2 ml collection tube and was centrifuged for 1 min at
14,000-x g. An extra 0.5 ml of Buffer QG was added to the column and 
centrifuged for 1 min at 14,000-x g to remove all traces of agarose. The 
column was washed with 0.75 ml Buffer PE, followed by centrifugation for 1 
min at 14,000-x g. The column was centrifuged empty for 1 min at 14,000-x 
g to remove all traces of wash buffer. The DNA was eluted in 50 pi buffer 
EB (10 mM Tris.Cl, pH 8.5) by centrifugation for 1 min at 14,000-x g.
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2.17 Polymerase Chain Reaction.
2.17.1 Synthesis and De-Protection of Oligonucleotides
Primers JF1 were synthesised by Dr A. Wolstenholme (School of 
Biochemistry, University of Bath). They were recovered from their synthesis 
columns by a concentrated ammonia solution. One ml of concentrated 
ammonia (0.88 M) was gradually drawn through the synthesis column with a 
5 ml syringe (0.2 ml every 20 min). The eluted oligonucleotide was 
transferred to a screw-capped microfuge tube and was placed in a glass 
universal bottle. The top was sealed with parafilm and incubated overnight 
at 55 °C. This removed the amino-protecting groups.
The tubes were spun in a vacuum rotor to remove the ammonia. Milli-Q 
water (200 pi) was added, together with 20 pi sodium acetate and 400 pi 
ethanol, and was the tubes were left at -20 °C overnight. The ethanol
precipitation was then repeated. The pellet was washed in 70 % ethanol,
vaporised dry and resuspended in 300 pi water.
2.17.2 Primers for E. faecalis and E. faecium
For amplification of a 405 bp internal region of efaA (H3 region): - 
JF1F GCG AAA GCT TCT GAA GCG GAC 
JF1R GCA TTT AAA TCA TAA GCT TTG
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Primers JCF2 to JCF6 were synthesised by Pharmacia (Uppsala, Sweden) 
and were diluted before use to 10 mM.
Degenerate primers to identify efaA homologue in E. faecium : - 
JCF2F GGA AGC TTT AYG ARC CNY TNC CNG A 
JCF2R GGA AGC TTA RRT TVY ANT TCA TCA T 
Where Y = C or T, R = A or G, N = A, C, T or G and V = A, C or G
Primer for JF1 405 bp fragment with extension of three bases past Hindi 11 
site: -
JCF3R GCA TTT AAA TCA TAA GCT TTG TGA
Primers for protein work from amino acid 20 to end of efaA gene: -
JCF4F TGC GGG AAT CAA GCC GCT G
JCF4R CGG AAT TCA TTT ACT CAT TAA GCC ATC
Reverse primer to enable more specific PCR of efaA analogue in E. faecium 
Used internal amino acid sequence YIWEINTE: - 
JCF5R ATR TAD ACC TYT ADT TRT G 
Where R = A or G, D = A, G or T and Y = C or T
Specific primers for E. faecium  homologue. JCF6F taken from ORF 122 bp 
in, JCF6R taken from ORF 432-449 bp.
Gives product of 327 bp. Product used for dig-PCR: - 
JCF6F TAT GAA CCG TTT CCG GAA 
JCF6R TTT TCC ACA TAT GTT CTG
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JCF14F: TCT TGT ACT GGG ACC GGA AGC G Concentration 450.88 
pg/ml
JCF14R: GAT GGG ATG TAC TCG CTC GCG T Concentration 383.31 
pg/ml
2.17.3 Reaction Mix for Amplification of DNA bv the Polymerase Chain 
Reaction.
PCR experiments were carried out according to the methodology of Perkin 
Elmer Cetus. Reaction mixtures (100 pi) were prepared with 200 pM each 
of dideoxynucleotides (Pharmacia), 2 mM magnesium chloride, 10 pM 
primers and 10 pi 10 x reaction buffer. Template DNA (up to lOng plasmid 
DNA, or up to 500 ng genomic) was added and 1 unit of Taq polymerase 
(Helena Bioscience) was used in each reaction. Each reaction was overlaid 
with 50 pi mineral oil (Sigma).
Dig-labelling PCR was used to generate dig -labelled probes with reagents 
from Boerhinger-Mannheim. Reaction mixtures (100 pi) were prepared with 
5 mM magnesium chloride, 10 pM primers, 10 pi 10 x reaction buffer, 10 pi 
template DNA and 0.5 pi Taq polymerase. Nucleotides dATP, dCTP and 
dGTP were added to a final concentration of 200 pM, along with 180 pM 
dTTP and 20 pM Digoxigenin-UTP.
Plasmid amplifications were carried out in a the Crocodile II thermocycler 
(Appligene, Watford, UK) with a temperature profile consisting of 94 °C for
67
2 min followed by three 1 min steps of 94 °C, 55 °C and 72 °C for 30 cycles. 
This was finished with one cycle of 72 °C for 5 min.
Amplification of chromosomal DNA required longer at 94 °C. The 
temperature profile for this consisted of one cycle of 94 °C for 3 min 
followed by three steps of 94 °C for 1 min, 55 °C for 2 min and 72 °C for 2 
min for 30 cycles. The final stage was 72 °C for 5 min.
2.17.4 Inverse PCR
This was carried out according to the method of Collins and Weissman 
(1984) and McNab et al (1994).
Templates were prepared by extracting chromosomal DNA using the Igi 
genie extraction kit (see section 2.11). DNA was digested overnight at 37 °C 
using the appropriate restriction enzyme (NEB). The digest was cleaned 
with the Qiaquick PCR purification kit (see section 2.18) and diluted to a 
concentration of 5 ng/pl in Milli-Q water. The diluted digest (4 pi) was 
ligated in a total reaction volume of 20 pi with 0.01 Weiss units pl-1 T4 
DNA ligase (Boerhinger) for 24 hours at 10°C. These conditions favour the 
recircularisation of 1.9 kb fragments. A portion of the ligation mix (5 pi) 
was used in the PCR reaction.
PCR was performed with the Expand High fidelity PCR kit from Boerhinger 
Mannheim. The reaction was prepared in two separate tubes to reduce non­
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specific priming. The template DNA was placed in the first tube and 200 
pM dNTPs and 300 nM primers were added. The second tube was prepared 
with 5 pi Expand high-fidelity buffer (10 x) containing 15 mM MgCh (to 
give a working concentration of 1.75 mM MgCb) and 2.6 U Expand high 
fidelity PCR system enzyme mix (containing Taq polymerase and pwo 
polymerase). The two tubes were vortexed and the contents of tube 2 were 
added to tube 1. The reaction mix was overlaid with mineral oil (Sigma). 
Thermocycling was performed in the Crocodile II thermocycler (Appligene) 
with the following temperature profiles: 2 min at 94 °C, then 30 cycles of 94 
°C (10 sec), 50 °C (30 sec), 68 °C (2 min), followed by a final cycle of 7 min 
at 68 °C.
Some PCR reactions were carried out using the Expand Long Template PCR 
kit (Boerhinger Mannheim). Again, two 0.5 ml microfuge tubes were 
prepared. In the first tube the template DNA was added to 350 pM dNTPs 
and 300 nM primers. The second tube contained 5 pi 10 x Expand PCR 
buffer mix (to give a working concentration of 1.75 mM MgCk) and 2.5 U 
Expand enzyme mix. The two tubes were vortexed, the contents of tube 2 
were added to tube 1 and the mix was overlaid with mineral oil. The same 
thermocycling conditions as above were used.
2.18 Qiaquick PCR Purification Protocol (Qiagen)
The Qiaquick PCR purification kit was used to clean up DNA after PCR, 
restriction digests and ligation or labelling reactions.
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Buffer PB (5 vol) was added to 1 vol of the reaction mix to be cleaned and 
the solution was mixed. The sample was added to a spin column in a 2 ml 
collection tube and the tubes were centrifuged for 1 min at 14,000-x g. The 
flow-through was discarded and the column was washed with 0.75 ml buffer 
PE, then centrifuged for 2 min at 14,000-x g. DNA was eluted into a clean 
microfuge tube with 50 pi buffer EB by centrifuging for 1 min at 14,000-x g.
2.19 Ligation of DNA Using T4 DNA Ligase
Ligation of vector and foreign DNA was carried out according to the 
protocol described by Sambrook et al (1989).
Plasmid and insert DNAs were digested with the appropriate restriction 
enzyme. The fragments were isolated by gel electrophoresis (section 2.15) 
and purified using the Qiaquick gel extraction kit (section 2.16). The 
plasmid DNA was treated with alkaline phosphatase (New England Biolabs) 
for 1 h at 37 °C to prevent re-annealing of the sticky ends.
DNA was concentrated by ethanol precipitation. It was dissolved in TE at a 
concentration of 100 pg/ml.
The ligation reaction (10 pi) was set up by transferring 0.1 pg of vector DNA 
to a microcentrifuge tube. An equimolar amount of foreign DNA was added. 
Water was added to 7.5 pi. The solution was warmed to 45 °C for 5 min to
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melt any cohesive termini that had reannealed. The mixture was then chilled 
to 0 °C again before addition of 1 pi DNA Ligase buffer (10 x) and 0.1 
Weiss unit T4 DNA ligase.
The reaction was incubated at 16 °C for 1-16 h, 1-2 pi of each of the ligation 
reactions was used to transform E. coli cells.
2.20 Preparation of Competent E. coli XL1 Blue Cells for Heat Shock.
A single fresh colony of E. coli XL1 blue or DH5a was inoculated into 5 ml 
LB broth and grown overnight at 37 °C. This primary culture was diluted 
1:100 and grown until the OD550 reached 0.48.
The suspension was chilled on ice for 5 min, then centrifuged at 4,000-x g 
for 5 min. The cells were suspended in 2/5th volume transforming buffer I 
(Tfbl, 30 mM KC1, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl2, 15 % v/v 
glycerol, pH 5.8). After chilling on ice for 5 min the cells were centrifuged 
at 4,000-x g for 5 min at 4 °C.
The cells were then suspended in l/25th volume of transforming buffer II 
(Tfbll, 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15 % v/v glycerol pH 
6.5). They were left on ice for 15 min.
The cell suspension was then divided into 200 pi aliquots and snap frozen on 
dry ice/ethanol and stored at -70 °C.
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2.21 Transformation of E. coli bv Heat Shock.
The competent cells were thawed at room temperature. After chilling on ice 
for 10 min, the DNA was added and the suspension was mixed gently. The 
suspensions were left on ice for 30-45 min.
Heat shock was carried out at 37 °C for 2 min, or 42 °C for 90 sec. The cells 
were returned to the ice for 2 min immediately afterwards. Four volumes of 
LB broth were added and the suspensions were incubated at 37 °C for lh.
The cells were then pelleted and suspended in 100 pi LB broth. All of the 
mixture was plated out onto LB agar plates containing appropriate antibiotic 
and seeded with 40 pi X-GAL (Sigma, 20 mg/ml in dimethyl-formamide) 
and 4 pi 0.84 M IPTG (Sigma) when the plasmid contained the lacZ gene at 
its multiple cloning site. After growth at 37 °C and incubation at 4 °C 
overnight, bacterial colonies containing the recombinant plasmid appear 
white, whilst those which still have the intact lacZ gene appear blue, enabling 
easy selection of recombinants.
2.22 Ligation and Transformation with the InVitrogen TA Cloning Kit
PCR was performed on E. faecium chromosomal DNA using the following 
cycles, 3 min at 94 °C followed by 30 cycles of 94 °C (1 min), 40 °C (1 min), 
72 °C (1 min) then 60 min at 72 °C. Fresh PCR product (1 pi) was then 
added to 50 ng pCR2.1 vector in InVitrogen ligation buffer (InVitrogen
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Corp., Carlsbad, Ca), with 4 Weiss units T4 DNA ligase. The reaction was 
incubated overnight at 14 °C.
Transformation was performed with competent cells provided in the kit. 
Competent cells were thawed on ice. p-mercaptoethanol (1.0 pM) was added 
to the cells. The ligation reaction (2 pi) was placed into the competent cells 
and mixed with a pipette tip. The cells were incubated on ice for 30 min.
The cells were subjected to heat shock for 30 sec at 42 °C followed by 2 min 
on ice. SOC medium (450 pi, InVitrogen) was added to each tube. The 
tubes were incubated at 37 °C with shaking for 1 hour. The vials were then 
placed on ice before plating out 50 pi and 200 pi onto LB plates containing 
100 pg/ml ampicillin and 1.6 mg X-Gal. The plates were incubated for 18 h 
at 37 °C, after which they were placed at 4 °C for 2-3 h to allow the colour to 
develop.
2.23 Electrotransformation of E. faecalis EBH1 or OG1RF Cells
Electroporation of E. faecalis strains EBH1 and OG1RF was carried out 
according to the protocol of Dunny et al (1991). A single colony of E. 
faecalis EBH1 or OG1RF was grown in 10 ml BHI broth overnight. This 
was used to inoculate 1:100 into M9-YE broth containing glycine from 0-10 
% in 0.5 % increments.
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These cultures were grown overnight. All cultures where the OD660 had been 
reduced by more than 60 % judged against the control tube (0 % glycine) 
were used to inoculate 300 ml M9-YE media containing the same glycine 
concentration. This was grown until the OD660 reached 0.1-0.2. The culture 
was chilled on ice and the cells were harvested by centrifugation at 8,000-x g 
for 10 min.
The ionic strength of the cell suspension was reduced by washing in 1/3 
original volume of chilled EB buffer (0.625 M sucrose, 1 mM MgCk, pH
4.0). The cells were then resuspended in 1/50 original volume EB buffer, 
divided into 40 pi aliquots and stored at -70 °C until needed.
The cell suspensions prepared above were thawed slowly on ice. The cells 
were washed three times in 40 pi sterile water and resuspended in 40 pi 
water. Chilled recombinant DNA was added and the mix was transferred to 
a pre-chilled 0.2 cm gap electroporation cuvette (Bio-Rad Laboratories). 
Electroporation was carried out in a Bio-Rad Gene Pulser apparatus using a 
2.5 kV pulse (i.e. a capacitance of 25 pF, a resistance of 200 Q and a voltage 
of 2500 V).
Following electroporation, cells were transferred into 1 ml BHI broth 
containing 0.25 M sucrose in a sterile 30 ml universal bottle. The cells were 
incubated at 30°C in a shaker for 1 h to allow plasmid-mediated resistance to 
develop. They were then plated out onto BHI agar plates containing 
erythromycin 10 pg/ml and grown overnight at 30°C.
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2.24 Electrotransformation of E. faecalis JH2-2.
E. faecalis JH2-2 was electroporated according to the method of Cruz-Rodz 
and Gilmore (1990).
E. faecalis JH2-2 inoculated into 10 ml Ml 7-glucose broth (Ml 7 broth, 
Oxoid with 0.5 % glucose) and incubated overnight at 37 °C. After 20 h, 1 
ml was subcultured into 100 ml SGM17-glucose media (Ml7-glucose + 0.5 
M sucrose and 5 % glycine). Cells were grown overnight at 37 °C.
Cells were harvested by centrifugation at 1000-x g for 15 min at 4 °C and 
washed twice with 100 ml ice-cold electroporation buffer (EPB, 0.5 M 
sucrose with 10 % glucose with 10 % glycerol) by resuspension followed by 
centrifugation. Finally the cells were resuspended in 1 ml ice-cold EPB and 
stored frozen as 50 pi aliquots.
For electrotransformation cell suspensions were thawed on ice. Up to 8 pi 
DNA was added to an ice-cold 0.2 cm electrode-gap cuvette (Bio-Rad) and 
40 pi of cell suspension was pipetted in. Cells were electroporated at 25 pF, 
200 Q and 2.5 kV in a Bio-Rad Gene Pulser apparatus. Immediately after 
electroporation 960 pi ice-cold SGM 17-glucose + 20 mM MgCk and 2 mM 
CaCh was added, cells were resuspended and transferred to a microfuge 
tube. After resting on ice for 5 min the tubes were incubated for 2 hour at 37 
°C. Serial dilutions were performed to 102 dilution factor and portions (0.1
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ml) were plated onto selective BHY agar. Serial dilutions up to a dilution 
factor of 106 were plated onto non-selective BHY agar to estimate the total 
viable count.
Plates were incubated anaerobically for 24-48 h at 37 °C
2.25 Transformation of S. sordonii (Challish
Transformation was carried out with a method supplied by H F Jenkinson 
(personal communication). S. gordonii was grown overnight in 10 ml BHY 
broth. It was subcultured 1:200 into pre-warmed BHY with 1 % foetal calf 
serum and 0.1 % glucose (BHY/FCS/Glc). The culture was grown 
anaerobically for 2 h at 37 °C. It was subcultured 1:100 into fresh pre- 
warmed BHY/FCS/Glc and grown anaerobically for 60 min at 37 °C.
To transform the cells, 1 ml of cells was added to a sterile, warm 10 ml 
capacity tube with 1-3 pg DNA. The culture was grown anaerobically for 3- 
4 h at 37 °C. A portion of cells (100 pi) were plated onto selective media, 
also 100 pi of a 10-fold dilution. Serial dilutions of the culture were made to 
a dilution factor of 106 and these were plated onto non-selective media to 
estimate total cell numbers.
2.26 RNA Extraction with the RNeasv Extraction Kit (Qiagen)
An overnight culture of bacterial cells was inoculated 1:100 into fresh media 
and grown to OD550 = 0.3. A portion of the culture (3 ml) was harvested at
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5000-x g for 3 min. The supernatant was discarded and the cells were 
resuspended in 100 pi TE buffer (pH 8.0) containing lysozyme 3 mg/ml. 
The suspension was incubated for 10 min at room temperature. Buffer RLT 
(350 pi) was added to the sample and the tube was vortexed vigorously. 
Ethanol (250 pi of 96 %) was added to the lysate and mixed by pipetting.
The sample was applied to a spin column in a 2 ml collection tube. It was 
centrifuged for 15 sec at >8000-x g. Buffer RW1 (700 pi) was pipetted onto 
the column and it was centrifuged at >8000-x g for 15 sec to wash. The 
column was transferred to a fresh collection tube. Buffer RPE (500 pi) was 
added and the sample was centrifuged for 15 sec at 8000 x g. A further 500 
pi of buffer RPE was pipetted onto the column and it was centrifuged at 
14,000-x g for 2 min to dry the membrane. RNA was eluted in 30 pi Milli-Q 
water by centrifuging for 1 min at 8000-x g.
2.27 Preparation of Gel Tanks for Formaldehyde-Agarose Gel 
Electrophoresis
Bio-Rad DNA sub cells were washed with 0.5 % SDS solution. They were 
rinsed with water and dried with ethanol. Tanks were then filled with 3 % 
H2C>2and left for 10 min at room temperature. They were rinsed thoroughly 
with Milli-Q water and allowed to dry.
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2.28 Formaldehyde-Agarose fFAl Gel Electrophoresis
A 1.2 % FA gel was prepared by dissolving agarose in FA gel buffer (10 x 
FA gel buffer, 200 mM MOPS, 50 mM sodium acetate, 10 mM EDTA, pH
7.0). After cooling the solution to 65 °C, 0.54 ml 37 % formaldehyde and 3 
pi 1 mg/ml ethidium bromide was added. The gel was poured into the gel 
support and allowed to set. The gel was equilibrated in 1 x FA gel running 
buffer (10 % 10 x FA gel buffer, 2 % 37 % formaldehyde).
RNA was mixed with an appropriate volume of 5 x RNA loading buffer 
(0.16 % saturated bromophenol blue, 0.4 mM EDTA, pH 8.0, 720 pi 37 % 
formaldehyde, 20 % glycerol, 30.84 % formamide, 40 % 10 x FA gel buffer). 
It was heated to 65 °C for 3 min then loaded onto the gel and run at 80 V for 
1 h. RNA was visualised using a UV light box.
2.29 Reverse Transcriptase PCR
Reverse transcriptase PCR (RT-PCR) was performed using the Titan One- 
Step RT-PCR kit (Boehringer Mannheim).
The reaction was prepared in two separate tubes. In the first tube 1 pg RNA 
was added to 200 pM dNTP’s, 0.4 pM primers, 5 mM DTT and 5 U RNase 
inhibitor (Promega). The second tube was prepared with lxTitan RT-PCR 
buffer containing 1.5 mM MgCk and 1 pi Titan enzyme mix (containing 
AMV and Expand High Fidelity PCR system). The contents of the second 
tube were added to the first and the reaction was overlaid with mineral oil.
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Thermocycling was carried out in a Crocodile II thermocycler using the 
following temperature profiles: 30 min at 50 °C, 2 min at 94 °C followed by 
10 cycles of 94 °C (30 sec), 50 °C (30 sec), 68 °C (45 sec). A further 20 
cycles were performed at 94 °C (1 min), 50 °C (1 min), 68 °C (1 min) 
followed by a final stage at 68 °C for 7 min.
2.30 Random Hexamer Labelling with Digoxigenin
Random hexamer labelling was performed with the Dig DNA Labelling Kit 
from Boerhinger Mannheim.
Template DNA (10 ng-3 fig) was denatured by heating at 95 °C for 10 min. 
The tubes were placed on ice and a 20 pi reaction was prepared with 2 pi 
hexanucleotide mix, 2 pi dNTP mix and 1 pi Klenow enzyme.
The reaction was incubated overnight at 37 °C. It was cleaned with the 
Qiaquick PCR Purification Kit (Qiagen) and eluted in 30 pi TE buffer.
2.31 Estimation of Labelling Yield in a Spot Test with a Dig-Labelled 
Control.
Estimation of dig-labelling yield was carried out by comparison of the dig- 
labelled sample with a dig-labelled control (Boehringer Mannheim).
Serial dilutions were carried out to a dilution factor of 105 on both sample 
and control DNA. A piece of nylon membrane (Boehringer Mannheim) was
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taken and 2 pi of each dilution was spotted onto the membrane. The 
membrane was orientated then baked for 30 min at 120 °C. 
Chemiluminescent detection was then carried out (see section 2.34).
2.32 Southern Blotting.
This was carried out according to the method of Southern (1975).
An agarose gel was prepared and run at 80 V. Before the blot was set up the 
DNA was depurinated in 0.25 M HC1 for 30 min. The gel was then 
transferred to denaturing solution (0.6 M NaCl, 0.2 M NaOH) and left for 30 
min. Neutral pH was restored with 1.5 M NaCl, 0.5 M Tris HC1 (pH 7.5) for 
30 min.
DNA fragments were blotted onto a nylon membrane (Boehringer 
Mannheim) by transfer of 20 x SSC ( 3 M NaCl, 300mM sodium citrate, pH
7.0) overnight (Southern, 1975). The DNA was fixed onto the membrane by 
baking at 120°C for 30 min. The membranes were then hybridised with 
digoxigenin, as described in section 2.34.
2.33 Colony Blotting Gram Positive Bacteria
Colonies on agar were pre-cooled to 4 °C for approximately 30 min. A piece 
of nylon membrane was cut to the size of the agar plate to be blotted. It was 
placed on to the agar and left for 1 min, then was removed and blotted onto 
dry Whatmann 3 MM paper. The membrane was placed colony side up onto
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Whatmann 3 MM paper soaked with TE saline (10 mM Tris, 1 mM EDTA, 
0.15 M NaCl) containing 1 mg/ml lysozyme. After incubating for 1 min at 
room temperature the membrane was blotted briefly on Whatmann 3 MM 
paper then placed on 3 MM paper soaked with denaturation solution (0.5 M 
NaOH, 1.5 M NaCl), for 15 min. After blotting briefly it was placed on 3 
MM paper soaked with neutralisation solution (1.0 M Tris, pH 7.5, 1.5 M 
NaCl) and left for 15 min. The membrane was blotted briefly then placed on 
paper soaked with 2 x SSC (diluted from a 20 x stock) for 10 min. The 
transferred DNA was fixed by baking for 30 min at 120°C.
Proteinase K (Sigma) treatment was then carried out to digest proteins which 
might interfere with subsequent hybridisation. The membranes were placed 
on clean aluminium foil and 0.5 ml of 2 mg/ml proteinase K was pipetted 
onto each membrane. The membranes were incubated for 1 h at 37 °C. The 
membranes were placed between two wetted sheets of 3 MM paper and 
pressure was applied with a ruler to allow the cellular debris to stick to the 
top sheet of filter paper which was then removed. The membranes were then 
subjected to hybridisation as described in section 2.34
2.34 Hybridisation with Digoxigenin-Labelled Probe.
The nylon membranes were prepared and fixed as described in the previous 
sections. They were taken and soaked in high SDS buffer (7 % SDS, 50 mM 
Sodium phosphate, 2 % blocking reagent (Boehringer), 5 x SSC (diluted 
from a 20 x stock), 0.1 % N-lauryl sarcosine (Sigma), 50 % formamide) for 2 
h at 55°C. Membranes from colony blotting were hybridised in standard
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hybridisation buffer (5 x SSC, 50 % formamide, 0.1 % sodium lauryl 
sarcosine, 0.02 % SDS, 2 % blocking reagent).
The digoxigenin probe was prepared by mixing 7.5 pi of digoxigenin- 
labelled stock with 42.5 pi water. This was heated at 95°C for 5 min then 
added to 1.5 ml high SDS buffer. The membranes were incubated in this 
solution overnight at 55 °C.
Following incubation the membrane was washed twice in 2 x SSC, 0.1 % 
SDS for 5 min at 55 °C. Then the membrane was washed twice in 0.1 x 
SSC, 0.1 % SDS for 5 min at 55 °C.
The membrane was placed in wash buffer ( 0.3 % Tween-20 in Buffer 1 (0.1 
M maleic acid, 0.15 M NaCl, pH 7.5) for 5 min at room temperature, then 
blocked in buffer 2 (10 % Blocking Reagent in Buffer 1) for 30 min at room 
temperature.
Anti-Digoxigenin-AP antibody (Boehringer Mannheim) was diluted 1:10,000 
in buffer 2 and incubated with the membrane for 1 h. The membrane was 
then washed three times in wash buffer for 10 min. It was then washed in 
buffer 3 (100 mM Tris.HCl, pH 9.5, 100 mM NaCl) for 2-5 min at room 
temperature.
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The lumigen (CSPD-Boehringer Mannheim) was diluted 1:100 in buffer 3 
and spread evenly over the membrane. This was then covered and left for 5 
min in the dark, followed by incubation at 37 °C for 30 min.
Kodak X-Omat AR film was exposed to the membrane for 30 min and then 
developed according to the manufacturer’s instructions.
2.35 Stripping and Reprobing Nvlon Membranes
Membranes were washed in Milli-Q water for 1 min. They were then 
incubated twice for 10 min at 37 °C in 0.2 M sodium hydroxide with 0.1 % 
SDS.
They were rinsed thoroughly in 2 x SSC and either stored in 2 x SSC or used 
immediately.
2.36 Induction Of E. coli XL1:pGP19
A single colony of E. coli XLl:pGP19 was inoculated into 10 ml LB broth 
containing ampicillin and tetracycline, and grown overnight. The culture 
was then diluted 1:100 in LB and grown for a further 2.5 h.
A sample (1.5 ml) was removed and placed on ice. IPTG was added to 10 
mM. The suspension was then grown for 4 h and a sample was removed 
every hour. After 4 h the samples were spun down and resuspended in 500 
pi saline.
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The samples were run on an SDS-PAGE gel which was either stained 
directly or used for immunoblotting.
2.37 Induction of E. faecalis EBH1 with Serum.
A single colony of E. faecalis EBH1 was used to inoculate 10 ml of BHI, 
containing 1 % foetal calf serum and grown overnight. Cells from 1.5 ml of 
the culture were harvested by centrifugation at 14,000-x g for 2 min, 
followed by suspension in 0.5 ml saline. An appropriate volume of sample 
buffer was added and the samples were boiled for 10 min before loading onto 
an SDS-polyacrylamide gel.
For cell wall preparations, cells were grown overnight in 10 ml BHI broth 
without foetal calf serum. They were subcultured 1:100 the following 
morning and grown to log phase in BHI broth containing 1 % foetal calf 
serum. They were then prepared as described in section 2.40.
2.38 Lowry Protein Assay.
The Lowry protein assay was used to deter mine the amount of protein in the 
bacterial sample and hence to determine the volumes to be loaded on an 
SDS-PAGE gel. A calibration curve was prepared using various 
concentrations of bovine serum albumin (BSA, Sigma).
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A 1 mg/ml stock of BSA was prepared, and used to make a series of dilutions 
from 1 mg/ml to 100 pg/ml. A 500 pi aliquot of each of the BSA samples 
was used to construct a standard curve. The experimental samples were 
treated in the same manner. NaOH (500 pi, 0.5 M) was added to the 
samples, which were then heated to 100°C for 10 min. The samples were 
allowed to cool to room temperature, then 2.5 ml Lowry C reagent (0.5 % 
w/v Q 1SO4 / 1 % w/v NaK tartrate solution with 48 ml Lowry A (5 % w/v 
Na2CC>3)) was added. The samples were mixed and left for 10 min.
Folin and Ciocalteau’s phenol reagent (Sigma, 0.5 ml) was added and the 
samples were vortexed. The samples were left for 30 min then the OD750 
was measured.
2.39 Protein Separation Using SDS-Polvacrvlamide Gel Electrophoresis
SDS-PAGE was carried out using the Bio-Rad mini-protean system. A 12 % 
denaturing gel and sample buffer were prepared as shown in the table below:
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Table 2.1 Solutions for Preparation of SDS-PAGE Gels
Constituent Running Gel Stacking Gel Samble Buffer
acrylamide/bis stock 3.0 ml 1.25 ml
(Sigma)
10 % SDS 0.1 ml 0.125 ml 5 ml
1.5 M tris (pH 8.8) 2.5 ml
0.5 M Tris(pH 6.8) 3.15 ml 2.5 ml
water 4.35 ml 7.95 ml 5 ml
TEMED (Sigma) 5 pi 12.5 pi
10 % AMPS (Sigma) 50 pi 62.5 pi
glycerol 2.5 ml
2 mercaptoethanol 0.25 ml
(Sigma)
5 % bromophenol blue 0.2 ml
(Sigma)
In some cases a 5:1 protein: SDS sample buffer was used to enable more 
protein to be loaded onto the gel. This consisted of 0.5 M Tris.Cl, 0.4 % 
SDS, pH 6.8, 3 ml glycerol, 1 g SDS, 0.9 g DTT, 1.2 mg bromophenol blue.
The tank was filled with SDS tank buffer (SDS 0.1 %, Tris 0.3 %, glycine 
1.43%, pH 8.3).
The samples were prepared by boiling an equal volume of cell suspension in 
sample buffer for 10 min. Samples (5-15 pi) were loaded into the wells and 
electrophoresed at 80 V until the dye front had run through the stacking gel 
and at 180 V until the dye front had reached the bottom of the separating gel. 
Cell wall preparations were also used and were prepared as described below.
86
2.40 Extraction of Gram Positive Cell Walls for Protein Gels
Enterococcal cell walls were extracted with glass beads, using a method 
supplied by H F Jenkinson (personal communication).
An overnight culture (0.5 ml) of enterococcal cells in BHY broth was 
inoculated into 10 ml of fresh medium. This was grown until OD550 = 1.0. 
The cells were harvested by centrifugation at 8000-x g for 10 min. Milli-Q 
water (5 ml) was used to wash the cells. The cell pellet was suspended in 0.4 
ml TE buffer containing 0.2 mM phenylmethylsuphonyl flouride (PMSF, 
Sigma). Lysozyme (0.2 mg/ml) was added and the suspension was incubated 
for 10 min at 37 °C.
The suspension was transferred to a 1.5 ml microfuge tube and 0.2 g 0.1 mM 
glass beads (Sigma) were added. The mixture was vortexed vigorously for 1 
min. The tube was placed on ice to cool for 1 min, then the vortexing was 
repeated twice with a 1 min rest on ice in between.
The tube was rested on ice so that the beads could settle, then the top 
suspension was pipetted into a fresh 1.5 ml microfuge tube. TE buffer 0.3 ml 
was added to the beads mixed briefly and the top suspension was added to 
the first in a fresh tube. The tubes were spun at 8,000-x g for 1 min to pellet 
unbroken cells. The supernatant was extracted and centrifuged at 14,000-x g 
for 30 min at 4 °C. Both the pellet (envelope fragments) and the supernatant 
(cytoplasmic fraction) were retained.
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The pellet was resuspended in 50 pi Milli-Q water. High SDS buffer (10 pi) 
was added and the supernatant was heated at 95 °C for 10 min. The resulting 
solution was loaded onto an SDS-PAGE gel.
2.41 Coomassie Blue Staining.
The gels were stained by gentle agitation in 0.1 % Coomassie Brilliant Blue 
R-250 (w/v) in 50 % methanol/10 % acetic acid for 30-60 min, or overnight. 
The gel was destained with an aqueous solution of 10 % methanol/ 20 % 
acetic acid.
2.42 Western (Immuno-1 Blotting
Proteins separated by SDS-PAGE were transferred onto nitrocellulose 
membranes using the western blotting method of Towbin et al (1979).
Immunoblotting was carried out at 100 V for 1 h using the mini Trans-blot 
system (Bio-Rad) in ice-cold Transblot buffer (25 mM Tris, 192 mM glycine, 
20 % methanol, pH 8.3). The kit was then disassembled and the 
nitrocellulose was removed and washed for 1 h in TBS (0.9 % NaCl in 10 
mM Tris, pH 7.4) containing 1 % BSA. The procedure was carried out at 
room temperature and gentle agitation was used. The blot was probed for at 
least 3 h with serum (GP serum, diluted 1:500 in TBS). Gentle agitation at 4 
°C was required. The blot was then washed three times in TBS, then soaked 
with gentle agitation in TBS/1 % BSA containing 0.25 pg/ml protein A- 
conjugated to horse radish peroxidase for 3 h at 4 °C.
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The blot was visualised with freshly-prepared developing solution (0.01 % 
H2O2 w/v, 25 pg/ml 4-chloronaphthol in 10 mM Tris pH 7.4). The reaction 
was warmed gently and stopped with distilled water.
2.43 Protein Purification bv Ammonium Sulphate Precipitation
The EfaA protein was purified from E coli XL1: pGP19 by ammonium 
sulphate precipitation (P.A. Lambert, personal communication).
An overnight culture (50 ml) of E coli XLl:pGP19 in LB (100 pg/ml 
ampicillin and 12.5 pg/ml tetracycline) broth was centrifuged at 6,000-x g 
for 10 min. The cells were suspended in the same volume of TE buffer 
containing 4 mg/ml lysozyme (Sigma). The suspension was placed on ice 
and sonicated for 3 x 40 sec bursts with a 20 sec recovery in between.
The suspension was centrifuged at 20,000-x g for 10 min at room 
temperature to remove the cell walls and membranes. The cytoplasmic 
supernatant was extracted and used in subsequent steps.
Nucleic acids were removed by precipitation with 20 mg/ml streptomycin 
(Sigma). After 30 min at room temperature the suspension was centrifuged 
at 15,000-x g for 10 min at room temperature and the supernatant was 
retained.
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Table 2.2 Nomogram for Ammonium Sulphate
AMMONIUM SULPHATE. GRAMS TO BE ADDED TO 1 LITRE
From To 5%  10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
----------------------------------------------------------------------------------------------------
84 113 144 176 208 242 277 314 351 390 430 472 516 561 608 657 708 761
56 85 115 146 179 212 246 282 319 357 397 439 481 526 572 621 671 723
28 57 86 117 149 182 216 251 287 325 364 405 447 491 537 584 634 685
28 58 88 119 151 185 219 255 292 331 371 413 456 501 548 596 647
20 29 59 89 121 154 188 223 260 298 337 378 421 465 511 559 609
25 29 60 91 123 157 191 227 265 304 344 386 429 475 522 571
30 30 61 92 126 160 195 232 270 309 351 393 438 485 533
35 30 62 94 128 163 199 236 275 316 358 402 447 495
40 31 63 96 130 166 202 241 281 322 365 410 457
45 31 64 97 132 169 206 245 286 329 373 419
50 32 65 99 135 172 210 250 292 335 381
55 33 66 101 138 175 215 256 298 343
60 33 67 103 140 179 219 261 305
65 34 69 105 143 183 224 266
70 34 70 107 146 186 228
75 35 72 n o 149 190
80 36 73 112 152
85 37 75 114
90 37 76
95 38
Using the nomogram above, ammonium sulphate was added to produce a 30 
% saturated solution. The suspension was stirred for 30 min at room 
temperature, then centrifuged at 15,000-x g for 10 min. The pellet produced 
was suspended in the same volume of Milli-Q water, dialysed against 
distilled water and stored frozen.
The supernatant from the 30 % precipitate was used to produce a 60 % 
saturated solution in the same method as above. The spin and dialysis steps 
were repeated. A 90 % precipitate was obtained in the same way. The final 
supernatant was dialysed and stored frozen.
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2.44 Platelet Aggregation Assays
Platelet aggregation was studied using a turbidimetric method supplied by C. 
Murphy (personal communication). Light transmission was studied through 
a platelet suspension when it was exposed to an agonist. Platelet shape 
changes caused a decrease in light transmission whilst aggregation caused an 
increase.
Rabbit blood was used in all experiments. After collection, the blood was 
centrifuged at 185-x g at room temperature for 10 min. The top layer 
(platelet rich plasma, PRP) was removed from the lower layer of red blood 
cells. Prostacyclin (PGI2, from Dr Whittle, Wellcome Laboratories, Kent) 
was added to the PRP to produce a final concentration of 300 ng/ml. The 
PRP was mixed gently then centrifuged at 1256-x g for 15 min at room 
temperature to precipitate the platelet pellet. The plasma supernatant was 
removed and the platelets were resuspended in HEPES buffered Tyrode’s 
solution (10 mM HEPES, 145 mM NaCl, 5 mM KC1, 1 mM MgCl2, 0.5 mM 
Na2HPC>4, pH 7.4 with 5.5 mM glucose and 0.25 % BSA). The platelets 
were allowed to recover for 90 min to allow the increased cAMP levels to 
return to normal. PGI2 (100 ng/ml) was then added to the suspension and it 
was centrifuged at 1256-x g for 15 min at room temperature. This process 
was repeated once more to wash the platelets before use. Following the final 
centrifugation step the platelets were resuspended to give a final 
concentration of 2 x 108/ml.
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Bacteria were grown for 20 hours at 37 °C in 5 ml Todd-Hewitt broth 
(Difco). After harvesting by centrifugation at 6,000-x g for 5 min at 4 °C, 
cells were washed three times in saline (0.9 % NaCl). They were finally 
resuspended in 5 ml phosphate buffered saline (PBS, 0.8 % NaCl, 0.02 % 
KC1, 0.144 % Na2HP04, KH2P 04).
Aggregation assays were carried out in a Chronolog dual channel ionised 
Ca aggregometer. To calibrate the light transmission a 10-fold dilution (2 x 
10 ) of washed platelets was taken to measure maximum light transmission 
(100 %). Basal level light transmission (0 %) was taken to be 2 x 108 cells. 
Platelets were stirred at 900 rpm for the duration of the experiment. Changes 
in light transmission were recorded on a potentiometric chart recorder.
2.45 Sequencing and Sequence Analysis
DNA sequencing was carried out at the automated DNA sequencing facility 
in the Department of Biology and Biochemistry at the University of Bath. 
The sequences were analysed on the University of Bath GNOME Unix 
computer, using the Wisconsin GCG package. BLAST searches were carried 
out at the NCBI database (http://www.ncbi.nlm.nih/gov). Preliminary 
sequence data for E. faecalis was obtained from The Institute for Genome 
Research (http://www.tigr.org). The PEDANT database
(http://pedant.mips.biochem.mng.de) was used for molecular weight 
calculations, and the GENEQUIZ programme
(http://columba.ebi.ac.uk:8765/ext-geneauiz/) was used for secondary 
structure predictions.
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3 Heterogeneity of the efaA gene Amongst Strains of E. faecalis
This work was carried out to determine whether efaA was present in a 
number of E. faecalis strains, and to study the degree of sequence 
conservation amongst those strains.
Previous work by Aitchison et al (1987) showed that antibodies to EfaA are 
only produced by enterococcal IE patients and not by those with enterococcal 
infections at other sites. This suggests that efaA is only expressed in 
endocarditis, although clinical isolates from other sites (e.g. UTI) can be 
induced to express EfaA by the addition of 1% foetal calf serum to the 
growth medium (Lambert et al, 1990). This reflects work by Guzman et al 
(1991) who showed that E. faecalis strains from UTIs adhered better to 
urinary tract cells, whilst those from IE adhered better to endocardial cells. 
By growing strains in serum, the expression of polysaccharide adhesins could 
be altered so that the UTI isolates expressed increased levels of D-galactose 
and L-fucose-containing adhesins, which are implicated in adhesion to heart 
cells.
One of the objectives of this present study was to study a panel of strains 
from a variety of sources, to confirm that the EfaA protein can be induced by 
growth in serum. The other purpose was to examine the heterogeneity of the 
efaA gene amongst these isolates.
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Sequence conservation is usually characterised by observing the extent of 
genetic polymorphism. Polymorphisms are either point mutations or 
rearrangements caused by insertions or deletions in DNA. Such differences 
are detected by the presence or absence of DNA bands produced by PCR, or 
by the banding patterns produced from restriction enzyme digestion (known 
as restriction fragment length polymorphism, RFLP). Strains showing a 
similar banding pattern are assumed to have a close genetic relationship. In 
this work two approaches were used to study polymorphism, PCR-RFLP and 
nested PCR.
Firstly, a combined PCR-RFLP technique was carried out. A portion of the 
gene was amplified by PCR and the resulting product was restricted with 
Hindlll. The banding patterns produced were studied on a 0.8% 
agarose/TAE gel. This method is commonly used to study genetic 
polymorphism (Laguerre et al, 1996; Denning et al, 1997; Shiroza et al, 
1998).
Secondly, a nested PCR approach was used, similar to that described by 
Joosten et al (1997) and Aslanzadeh et al (1996). PCR was performed using 
primers for a region close to the N and C terminals of efaA. The products 
were analysed on a 0.8% agarose/TAE gel. A second PCR was performed, 
using the product of the first amplification and primers for an internal portion 
of the gene. This method permits study of the degree of conservation at both 
the ends of the gene and the internal region. Sequencing was not performed • 
on these PCR products because some proof reading errors are inevitable
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during DNA amplification and therefore it would be incorrect to attribute any 
base changes seen on sequencing to polymorphism.
Table 3.1 Origins of E. faecalis strains
SDecies Strain Number Hospital Source Site of Infection
E. faecalis OG1RF Laboratory strain
E. faecalis EBH1 East Birmingham 
Heartlands Hospital
Endocarditis
E. coli XLl:pSK+GP19 Laboratory clone
E. faecalis RUH3 Royal United Hospital, 
Bath
Urinary Tract Infection
E. faecalis RUH4 Royal United Hospital, 
Bath
Urinary Tract Infection
E. faecalis RUH5 Royal United Hospital, 
Bath
Urinary Tract Infection
E. faecalis F64843 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis M63307 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis S22247 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis X9058 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis H039508 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis S222588 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis S I9494 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis H54428 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
E. faecalis T66002 John Radcliffe Hospital, 
Oxford
Bloodstream Isolate
Table 3.1 details the strains of E. faecalis used in these experiments The 
identities of new strains were confirmed with the Rapid ID32 Strep kit (see 
Table 3.2). Many classifications in a hospital setting are made out of clinical 
convenience and they may not reflect the true taxonomy of the organism. 
This can be seen with strain T66002, which was classified and treated as E.
9 5
faecalis in hospital but was shown to be Streptococcus uberis on the test 
strips. Because of this re-classification it was excluded from further 
experiments. All other strains were confirmed to be E. faecalis.





























































OGIRF + - - + + + - - + - - - - + - - -
RUH3 + - - + + + - - + - - - - + - - -
RUH4 + - - + + + - - + - - - - + - - -
RUH5 + - - + + + - - + - - - - + - - -
F64843 + - - + + + +
M63307 + - - + + +
S22247 + - - + + - - - + - - - - + - - -
X9058 + - - + + + +
H039508 - - - + + + - - + - - - - + - - -
S222588 + - - + + - - - + - - - - + - - -
SI9494 + - - + + + - - + - - - - + - - -
H54428 + - - + + + - - + - - - - + - - -
T66002 + - - + + + - - + - - - - + - - -
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Strain # M R G T M H P S G C L P U T M Strain
B I T A A I M o L D A U R R A Identification
D B A G N P A R Y E C L E E L (%
G N G X Probability)
OGIRF + + • + + + • + * ~ + “ "* + + E.
(95.2)
faecalis
RUH3 + + • + + + + + • _ + • • + + E.
(97.8)
faecalis
RUH4 + + • + + + + + • - + • • + + E.
(97.8)
faecalis
RUH5 + + • + + • + + • + + • + + E.
(99.9)
faecalis
F64843 + + • + + " + • + ■ " " + + E.
(99.9)
faecalis
M63307 + + • + + • • + • + + * • + + E.
(99.5)
faecalis
S22247 + + • + + • • + + + " + + E.
(99.9)
faecalis
X9058 + + • + + * + " + + ■ + + E.
(99.9)
faecalis
H039508 + + " + + + • + + • + + E.
(97.3)
faecalis
S222588 + + • + + • “ + + + • • + + E.
(99.9)
faecalis
SI9494 + + + + • " + " + + * “ + + E.
(99.9)
faecalis
H54428 + + - + + + • + • + ■ ■ * + + E.
(99.9)
faecalis
T66002 + + - + + - - + - - + - - + + S. uberis (93.9)
Key
ADH = Arginine dihydrolase 
PGLU = P glucosidase 
PGAR = p galactosidase 
PGUR = P glucuronidase 
a  GAL = a  galactosidase 
PAL = alkaline phosphatase 
RIB = ribose (acidification)
MAN = mannitol (acidification)
SOR = sorbitol (acidification)
LAC = lactose (acidification)
TRE = trehalose (acidification)
RAF = raffinose (acidification)
SAC = saccharose/ sucrose (acidification) 
LARA = L-arabinose (acidification) 
DARL = D-arabitol (acidification)
CDEX = cyclodextrin (acidification)
VP = acetoin production
APPA = alanine-phenylalanine-proline 
arylamidase
PGAL = p galactosidase
PYRA = pyroglutamic acid arylamidase
PNAG = N-acetyl-beta-glucosaminidase
GTA = glycyl-tryptophane arylaminidase
HIP = hydrolysis of hipurate
GLYG = glycogen (acidification)
PUL = puliulan (acidification)
MAL = maltose (acidification)
MEL = melibiose (acidificaton)
MLZ = melezitose (acidification)
MBDG = methyl-B-D glucopyranosidase 
(acidification)
TAG = tagatose (acidification)
PMAN = Pmannosidase 
URE = urease
The strains were grown overnight in BHY broth. They were subcultured the 
following morning into BHY containing \%  foetal calf serum and grown to 
log phase. The cells were harvested and wall proteins were separated on an
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SDS-PAGE gel. Figure 3.1 shows the results of western blotting these gels, 
using serum from an endocarditis patient (GP).
Figure 3.1 Western Blot Analysis of Wall Proteins from E. faecalis 
Strains, probed with patient serum (GP) diluted 1:100 in TBS. Blots were 
developed with protein A conjugated to horseradish peroxidase.
Figure 3.1a lane 1, E. faecalis X9058, lane 2, E. faecalis M63307, lane 3, E. 
faecalis S22247, lane 4, E. faecalis F64843, lane 5, E. faecalis S222588, lane 
6, E. faecalis EBH1, lane 7, E. coliXLl pSK+: GP19 (efa clone). Position o f  
EfaA marked by arrow.
1 2 3 4 5 6 7
(EfaA)
Figure 3.1b. lane 1, E coli XL1 pSK+: GP19, lane 2. E. faecalis H54428, lane 3, E. 
faecalis H039508, lane 4, E. faecalis RUH5, lane 5 E. faecalis RUH4, lane 6, E. faecalis 
RUH3, lane 7, E. faecalis OG1RF, lane 8, E. faecalis EBH1. Position o f EfaA marked by 
arrow.
1 2 3 4 5 6 7 8
37 KD 
(EfaA)
EfaA was visible in all strains tested (Figure 3.1). Thus the protein may be 
induced in strains from a variety of clinical sources, including UTI isolates 
and laboratory strains. It is not clear which component of serum is able to 
induce EfaA. Lowe et al (1995) dialysed serum against water and found that 
no efaA was transcribed suggesting that the inducing component is less than 
10 kD. However, if efaA transcription is induced by Mn depletion (see
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chapter 8) then it would seem most likely that albumin in serum is able to 
bind Mn and so decrease the amount available to E. faecalis cells, thereby 
inducing efaA.
Figure 3.2 Sequence of efaA showing primers used in the PCR reaction 
(marked in bold). JCF4 primer pair used to amplify the fragment o f efaA 
corresponding to the mature protein. Primer pair JCF1 used to amplify an 
internal portion o f the gene. The product o f the JCF4 amplification was 
cleaved with Hindlll at the sites shown, to produce three fragments o f 168, 
427, 292 bases, respectively.
GAATTCCGGCCGGAATTCCGGCTTCTGGTGCGACGATTGTTTTAACCGCCGCCTTATTCT
I ----------------+------------------+--------------- +------------------+----------------+ + 60
CTTAAGGCCGGCCTTAAGGCCGAAGACCACGCTGCTAACAAAATTGGCGGCGGAATAAGA








1 8 1 ----------------+ ------------------+--------------- +------------------+----------------+------------------ + 240
AATTGCAATCGACGAACGCCCTTAGTTCGGCGACTTTTCTTTCTTTTTAATCGTTAACAC
ACAACGAACTCGATCTTATCCGATTTAGTGAAAAATGTTGGGCAAGACAAAATTGAGCTG
241 ---------------- +------------------+--------------- +------------------+----------------+------------------ + 300
TGTTGCTTGAGCTAGAATAGGCTAAATCACTTTTTACAACCCGTTCTGTTTTAACTCGAC
CATAGTATTGTGCCAATTGGGACAGACCCTCACGAATATGAACCGTTACCAGAAGACATT
301 ---------------- +----------------- +--------------- +------------------+----------------+------------------ + 360
GTATCATAACACGGTTAACCCTGTCTGGGAGTGCTTATACTTGGCAATGGTCTTCTGTAA
H i n d i I I
^  JCF1F ^
GCGAAAGCTTCTGAAGCGGACATTTTATTCTTTAACGGCTTGAACTTAGAAACAGGCGGA361----------+----------- +----------+----------- +----------+------------+ 420
CGCTTTCGAAGACTTCGCCTGTAAAATAAGAAATTGCCGAACTTGAATCTTTGTCCGCCT
AATGGCTGGTTTAACAAATTAATGAAAACGGCCAAAAAAGTTGAGAATAAAGATTACTTT
421 ---------------- +----------------- +--------------- +------------------+----------------+------------------ + 480
TTACCGACCAAATTGTTTAATTACTTTTGCCGGTTTTTTCAACTCTTATTTCTAATGAAA
TCTACAAGCAAAAATGTTACGCCACAATATTTAACAAGTGCCGGTCAAGAACAAACAGAA
481 ---------------- +----------------- +--------------- +------------------+----------------+------------------ + 540
AGATGTTCGTTTTTACAATGCGGTGTTATAAATTGTTCACGGCCAGTTCTTGTTTGTCTT
GATCCGCATGCTTGGTTAGACATTGAAAATGGCATCAAATATGTAGAAAACATTCGTGAC
541 ---------------- +----------------- +--------------- +------------------+----------------+------------------ + 600
CTAGGCGTACGAACCAATCTGTAACTTTTACCGTAGTTTATACATCTTTTGTAAGCACTG
GTGTTAGTAGAAAAAGATCCAAAAAATAAAGATTTCTATACAGAAAACGCGAAAAATTAT




661 ---------------- +------------------+-----------------+-----------------+-----------------+ + 720
TGGCTTTTTGAATCGTTTGATGTACTCCTTCGGTTTCGATTTAAACGACTATAAGGACTA
H i n d l l l
I
GATAAAAAATTATTAGTTACAAGTGAAGGTGCCTTTAAATATTTCTCCAAAGCTTATGAT




















Figure 3.2 details the PCR strategy used for both nested PCR and PCR- 
RFLP. Primers JCF4 were designed to cover the mature portion of the 
protein after transport to the cell membrane and lipid modification. Thus the 
leader sequence was not included in PCR design. For nested PCR, primers 
JCF1 were used to amplify the internal portion of the gene. For PCR-RFLP, 
JCF4 primers were used and the resulting product was cut with HindlW to 
produce three fragments of 168,427 and 292 bases, respectively.
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Figure 3.3 PCR Analysis of efaA from Several E. faecalis Strains, Using 
Primer Pair JCF4. to amplify a the region corresponding to the mature 
protein. Lane 1, E. faecalis EBH1, lane 2, E. faecalis X9058, lane 3, E. 
faecalis M63307, lane 4 E. faecalis S22247, lane 5 E. faecalis F64843, lane 
6, E. faecalis S22588, lane 7, E.faecalis H54428, lane 8, E. faecalis 
H039508, lane 9, E. faecalis RUH5, lane 10, E. faecalis RUH4, lane 11, E. 
faecalis RUH3, lane 12 E. faecalis OG1RF, lane 13 E. faecalis EBH1, Lane 
14, E. faecalis EBH1, Lane 15, molecular weight marker.
1 2  3 4 5 6 7 8 9 10 11 12 1314 15
Figure 3.4 PCR-RFLP Analysis of efaA from several E. faecalis strains 
Using Primer Pair JCF4. a portion o f efaA corresponding to the mature 
protein was amplified by PCR and cut with Hindlll to give three fragments o f  
168, 406 and 292 bases. Lane 1, E. faecalis EBH1, lane 2, E. faecalis 
X9058, lane 3, E. faecalis M63307, lane 4, E. faecalis S22247, lane 5, E. 
faecalis F64843, lane 6, E. faecalis S22588, lane 7, E. faecalis H54428, lane 
8, E. faecalis H039508, lane 9, E. faecalis RUH5, lane 10, E. faecalis RUH4, 
lane 11, E. faecalis RUH3, lane 12, E. faecalis OG1RF, lane 13, E. faecalis 
EBH1, lane 14, molecular weight marker.




The results of the PCR-RFLP work are shown in figure 3.4. All strains 
produced an identical banding pattern when cut with Hindlll, indicating that 
the gene is very closely conserved.
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Figure 3.5 PCR Analysis of efaA from Several E. faecalis Strains, Using
Prim er pair JCF1. The PCR product obtained in figure 3.4 was used to 
amplify and internal portion of efaA with primer pair JCF1. Lane 1, 
molecular weight marker, lane 2, E. faecalis EBH1, lane 3, E. faecalis 
X9058, lane 4, E. faecalis M63307, lane 5, E. faecalis S22247, lane 6, E. 
faecalis F64843, lane 7, E. faecalis S22588, lane 8, E. faecalis H54428, lane 
9, E. faecalis H039508, lane 10, E. faecalis RUH5, lane 11, E. faecalis 
RUH4, lane 12, E. faecalis RUH3, lane 13, E. faecalis OG1RF, lane 14, E. 
faecalis EBH1, lane 15, molecular weight marker.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
The nested PCR results shown in figures 3.3 and 3.5 support the results 
obtained from PCR-RFLP. All strains were amplified with the primers. The 
poor yield of product obtained with strains H039508 and M63307 could be 
attributed to low yields from the chromosome preparations (both strains were 
very slow-growing). Both strains produced good yields on the second PCR.
In conclusion, it would seem that all strains were able to express EfaA, 
regardless of clinical origin. In addition the efaA gene appears to have a low 
degree o f polymorphism amongst the strains tested. This implies that efaA 
could be an important gene for E. faecalis and has hence been closely 
conserved during the evolution of this organism.
Similar results were seen when Sampson et al (1997) studied the 
heterogeneity of psaA. All 23 S. pneumoniae serotypes used in the vaccine 
and two additional serotypes (6A and 25) were found to express PsaA. PCR- 
RFLP studies were carried out, using ten different enzymes. Nine out of 10 
enzymes produced identical banding patterns in all strains. One enzyme 
produced a slightly different pattern with some strains but as other strains
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from the same serotype did not show these patterns when tested it was 
assumed that any differences were due to random point mutations. 
Sequencing of psaA genes from serotypes 6B and 2 showed that the two 
psaA genes were 99% identical, with only eight single base pair changes 
detected. However, several different groups observed that the original psaA 
sequence identified from strain R36A was not representative of the psaA 
sequence identified in other S. pneumoniae strains (Sampson et al , 1997, 
Berry and Paton, 1996, Dintilhac et al, 1997). The psaA gene from R36A 
possesses only about 80% homology to other strains (Sampson et al, 1997, 
Berry and Paton, 1996). This has led to speculation that strain R36A is either 
an atypical S. pneumoniae strain, or has been wrongly classified as S. 
pneumoniae (Sampson, et al, 1997, Berry and Paton, 1996, Dintilhac et al, 
1997). These speculations underline the homology observed with these 
genes, since it is so rare to see any differences between the cluster 9 proteins 
of the same species, classification could be confirmed on the basis of 
identifying the cluster 9 genes. Such a hypothesis was proposed by 
Aitchison et al (1987) who found that the 37kD antigen later identified as 
EfaA was so specific to E. faecalis endocarditis that they suggested EfaA as 
a marker for this disease, to give positive identification of E. faecalis 
infection. Singh et al (1998) used DNA from efaA and ejmA (see chapter 5) 
to probe other enterococcal species and found that the efaA probe only 
reacted with E. faecalis and the eftnA probe only reacted with E. faecium.
Streptococcal cluster 9 proteins do not always show such specificity. 
Kolenbrander et al (1994) looked for scaA homologues in 23 streptococcal
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species. They carried out southern blotting at high stringency with three 30- 
mer DNA probes, probe 1 corresponding to the N terminus of scoA, probe 2 
corresponding to the C terminus of ssaB and probe 3 to the C terminus of 
scaA. The probes did react with several other streptococcal species (although 
they did not react with an E. faecalis strain). The workers found the C 
terminals to be more closely conserved than N terminals, a fact confirmed by 
Sampson et al (1997) and Berry and Paton (1996) who found that variations 
in psaA from R36A were mostly situated at the N terminus and corresponded 
to the leader sequence. Interestingly one strain of S. gordonii (ATTC 10558) 
gave two hybridisation bands with probe 1 but only the smaller fragment 
reacted with probes 2 and 3. Whilst this suggests that the smaller fragment 
corresponded to scaA, it is interesting to speculate whether all strains carry a 
second related gene of the cluster 9 family. This is known to be the case in S. 
pneumoniae where two cluster 9 proteins have been identified: the adc 
operon which responds to environmental zinc concentrations and psaA which 
responds to manganese. It would be interesting to ascertain whether two 
such systems operate in E. faecalis.
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4 Platelet Aggregation Assays
Platelets are smooth, disc-shaped cells that circulate in the bloodstream, each 
having a life of about 10 days. In normal circumstances, they do not adhere 
to each other, or to the normal vascular endothelium. If the endothelium 
becomes damaged, the sub-endothelial layer is exposed. Platelets can then 
adhere to each other (aggregate) and to collagen, basement membrane and 
the microfibrils associated with elastin. This action is known as haemostasis 
and results in the formation of a blood clot, which is vital to the healing 
process. Following aggregation, platelets release substances from their 
organelles, such as adenosine diphosphate (ADP), adenosine triphosphate 
(ATP), 5- hydroxytryptamine (5-HT) and calcium ions.
Recent data have shown that aggregated platelets also release bactericidal 
proteins such as p-lysins and platelet microbicidal proteins, which contribute 
to host defence mechanisms (reviewed by Yeaman, 1997). Historically, the 
contribution of platelets to host defence mechanisms has been 
underestimated. In addition to releasing antimicrobial peptides, platelets can 
react with complement proteins, leucocytes and other components of the 
humoral immune defence system. They are capable of binding and 
internalising micro-organisms and are even able to release oxidative 
molecules and free radicals (e.g. superoxide anions) to aid bacterial killing 
(reviewed by Yeaman, 1997).
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The ability of some species to aggregate platelets has been considered a 
virulence factor in IE. Many species have been shown to induce platelet 
aggregation, including enterococci (Usui et al, 1991) and oral streptococci 
(Douglas et al, 1990). Whilst these strains may aggregate platelets it is not 
clear whether such a reaction would help or hinder bacterial invasion. 
Sullam et al (1993a) showed that thrombocytopoenic rabbits (i.e. rabbits with 
an abnormally low platelet count) had smaller vegetations in IE, but these 
vegetations had a significantly higher bacterial count. Similarly streptococci 
with increased exopolysaccharide on their cell surfaces show increased 
virulence, due at least in part to the inhibition of platelet aggregation (Sullam 
et al, 1993b).
It is important therefore to distinguish between the effect on virulence of 
platelet-bacteria binding and platelet aggregation. Platelet binding is 
important in the pathogenesis of IE, as shown by Sullam et al (1996) in 
Staphylococcus aureus: a mutant strain with decreased ability to bind 
platelets showed reduced virulence in an animal model of the disease. 
However it is becoming clear that platelet aggregation is also likely to be 
detrimental to bacteria.
The aim of this part of the work was to study platelet aggregation in two E. 
faecalis strains, EBH1 (a clinical isolate) and OG1RF (a laboratory strain) 
and ultimately to see if EfaA had any effect on this property.
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Platelet aggregation can be induced in vitro by adding aggregating agents 
(e.g. bacteria or thrombin) to platelet-rich plasma (PRP), which is being 
continually stirred. The rate and degree of aggregation is studied by 
measuring light transmission through the suspension using a 
spectrophotometer.
When an aggregating agent is added to the suspension, there is an initial lag 
phase, followed by a decrease in light transmission as the platelets begin to 
swell and change shape. When platelet aggregation occurs there is an 
increase in light transmission as the cells clump together.
Thrombin is used as a positive control in the reaction as it should cause all 
platelets in the sample to clot. This results in a maximal release of ADP and 
ATP from platelets (which can also be measured) and a maximum increase in 
light transmission.
107
Figure 4.1 Platelet Aggregation with Varying Thrombin Concentrations.
Rabbit platelet rich plasma (PRP) at a concentration o f 2x  JO8 cells/ml was 
added to an aggregometer and stirred at 900 rpm for the duration of the 
experiment. Thrombin was added to the cells at concentrations o f 10 U/pl 
(4), 5 U//d (M) and 1 U/jd (A).
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Platelet aggregation was induced by thrombin (Figure 4.1). As a working 
concentration of 10 U/jul produced the maximum aggregation this was used 
in subsequent experiments as a positive control.
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Figure 4.2 Effect Of Adding ~ 5 X 106 Cells Of E. faecalis To Rabbit 
Platelets.
Bacteria were grown for 20 h at 37 °C in Todd-Hewitt broth. After washing 
in saline, ~ 5 x 106 cells were added to 2 x 108 cells o f PRP. The reaction 
was stirred at 900 rpm for the duration o f the experiment. Thrombin was 
added after 2 min and the reaction was observed. The experiment was 
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Figure 4.2 shows the results of adding a bacterial suspension containing ~ 5 x 
106 cells. No aggregation was seen by either strain, although the suspension 
became denser following the addition of the bacteria. This probably 
accounts for the observed decrease in light transmission, it is unlikely to be 
caused by platelets changing shape. The addition of thrombin produced a 
reaction, showing that the platelets were capable of aggregation.
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In case the bacterial suspension was too dense and was therefore making any 
changes in light transmission difficult to see, the bacterial suspension was 
diluted several times. Each dilution was tested with PRP to see if it was 
capable of causing aggregation or platelet shape change (see Figures 4.3 and 
4.4). No response was seen from the addition of bacteria, but the platelets 
could still be aggregated by thrombin, indicating that they were still viable.
Figure 4.3 Effect Of Adding ~1 X IP6 Cells Of E. EBH1 To
Rabbit Platelets. Bacterial cells were grown for 20 h at 37 °C in TH broth. 
After washing in saline, ~ 1 x 106 cells were added to the PRP. The 
suspension was stirred at 900 rpm and any reaction was observed. 
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Figure 4.4 Effect Of Adding ~ 5 X 103 And ~ 1 X 104 Cells O fg .
To Rabbit Platelets. Bacterial cells were grown for 20 h at 37 X3 in TH 
broth. After washing in saline, ~5 x 103 cells ( 4) and ~ 1 x 104 cells (A) 
were added to PRP and the suspension was stirred at 900 rpm. Thrombin 





Bacteria were also grown in medium containing 1% foetal calf serum to see 
if this had any effect on their aggregating properties. The addition of foetal 
calf serum to E. faecalis growth medium is known to affect the production of 
several proteins (Lambert et al, 1990), so it was thought that this may have 
some effect on aggregation properties.
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Figure 4.5 Effect on Aggregation of Rabbit Platelets after Growing
Bacteria in Media Containing 1% Foetal Calf Serum. Bacteria were 
grown for 20 h at 37 °C in TH broth with 1 % foetal calf serum ( 4) and in 
media containing no serum (A). After washing in saline, ~ 5 x 106 cells were 









Figure 4.5 shows the results of the experiment: again no response was seen 
and growth in serum therefore had no effect on aggregation properties of E. 
faecalis.
In conclusion, it appears that the strains tested in these experiments are 
unable to cause platelet aggregation. Enterococcal isolates have been shown 
to aggregate platelets, although the reaction was not as vigorous as that seen 
in S. aureus or S. pyogenes (reviewed by Yeaman, 1997). Usui et al (1991) 
showed that their clinical enterococcal isolates could aggregate platelets after 
a lag time of 1 minute. However this aggregation was not seen in the strains
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tested in this work. Not all pathogenic bacteria will cause platelet 
aggregation. Douglas et al (1990) found that only half of their IE-causing 
viridans streptococci strains were able to do so.
Therefore platelet aggregation per se does not appear to be a virulence factor 
and indeed strains that are unable to cause platelet aggregation may be more 
pathogenic as they are able to avoid inducing the platelet antimicrobial 
defences. Both OG1RF and EBH1 have been shown to express EfaA (see 
chapter 3) and as neither strain aggregated platelets it is unlikely that EfaA 
has any effect on this property. However, it would be interesting to test an 
efaA mutant of E. faecalis to see if this characteristic was altered in any way.
Most aggregation experiments are carried out using recent clinical isolates 
(Usui et al, 1993; Douglas et al, 1990). It is acknowledged that repeated 
subculturing of strains could alter their surface characteristics. The strains 
used in this experiment were repeatedly subcultured and were maintained on 
Todd-Hewitt broth or BHI as opposed to blood agar, which is used in many 
clinical microbiology laboratories for enterococci. This may have had an 
effect on the surface properties of the strains tested and could possibly have 
had an effect on aggregation. There were no fresh clinical isolates available 
at the time for testing in this work.
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5 Sequencing of the E. faecium Efm Qperon
Although E. faecium only accounts for 5 -  15 % of enterococcal infections, it 
causes a considerable problem in a nosocomial setting. This is due to its high 
level of antibiotic resistance (both intrinsic and acquired). New targets for 
drug therapy are urgently needed, and as efaA has been identified as a 
significant protein in E. faecalis endocarditis, it was decided to look for a 
homologue in E. faecium. Identification of such a protein would enable 
further studies on the role of this homologue in E. faecium  endocarditis.
To isolate a portion of the efaA -homologous gene, PCR was performed with 
degenerate primers. The product was cloned into the InVitrogen cloning 
vector pCR2.1 and was sequenced. Once the first portion of the gene had 
been characterised, an inverse PCR strategy was used to sequence the 
remainder of the operon.
Figure 5.1 Nucleotide Sequence of E. faecalis efaA. showing the 
degenerate primers used to amplify the homologous cluster 9 protein gene in 
E. faecium UB1. Primer pair JCF2 (shown in bold) was used to amplify the 
initial fragment. Primer JCF5R was then used in a semi-nested strategy to 
amplify a portion o f the JCF2 fragment. The fu ll degenerate primer 
sequences are listed in section 2.17.2.
GAATTCCGGCCGGAATTCCGGCTTCTGGTGCGACGATTGTTTTAACCGCCGCCTTATTCT
1 ---------------------+ ------------------ + ------------------- + --------------------+ ------------------- + --------------------- + 60
CTTAAGGCCGGCCTTAAGGCCGAAGACCACGCTGCTAACAAAATTGGCGGCGGAATAAGA
TTTTATTGGCTTTCTTTTTCTCACCAAAGAAAGGCCTAGTATTTGTAAACCGTGAGAAAG
6 1 ---------------------+ ------------------ + ------------------- + --------------------+ ------------------- + --------------------- + 120
AAAATAACCGAAAGAAAAAGAGTGGTTTCTTTCCGGATCATAAACATTTGGCACTCTTTC
AAATGGAGGAATCAACGAATGAAAAAATTTAGTTTATTTTTTTTAACACTTTTAGCAGGG











301 -----------------+------------------+----------------- +----------------- +----------------- + + 360
GTATCATAACACGGTTAACCCTGTCTGGGAGTGCTTATACTTGGCAATGGTCTTCTGTAA
GCGAAAGCTTCTGAAGCGGACATTTTATTCTTTAACGGCTTGAACTTAGAAACAGGCGGA
361 -----------------+------------------+----------------- +----------------- +----------------- +----------------- + 420
CGCTTTCGAAGACTTCGCCTGTAAAATAAGAAATTGCCGAACTTGAATCTTTGTCCGCCT
AATGGCTGGTTTAACAAATTAATGAAAACGGCCAAAAAAGTTGAGAATAAAGATTACTTT
421 -----------------+------------------ +----------------- +----------------- +----------------- +----------------- + 480
TTACCGACCAAATTGTTTAATTACTTTTGCCGGTTTTTTCAACTCTTATTTCTAATGAAA
TCTACAAGCAAAAATGTTACGCCACAATATTTAACAAGTGCCGGTCAAGAACAAACAGAA
481 -----------  +------------------ +----------------- +----------------- +----------------- +----------------- + 540
AGATGTTCGTTTTTACAATGCGGTGTTATAAATTGTTCACGGCCAGTTCTTGTTTGTCTT
GATCCGCATGCTTGGTTAGACATTGAAAATGGCATCAAATATGTAGAAAACATTCGTGAC
541 -----------------+------------------ +----------------- +----------------- +----------------- +----------------- + 600
CTAGGCGTACGAACCAATCTGTAACTTTTACCGTAGTTTATACATCTTTTGTAAGCACTG
GTGTTAGTAGAAAAAGATCCAAAAAATAAAGATTTCTATACAGAAAACGCGAAAAATTAT
601  +------------------+----------------- +----------------- +----------------- +----------------- + 660
CACAATCATCTTTTTCTAGGTTTTTTATTTCTAAAGATATGTCTTTTGCGCTTTTTAATA
ACCGAAAAACTTAGCAAACTACATGAGGAAGCCAAAGCTAAATTTGCTGATATTCCTGAT
661 -----------------+------------------ +----------------- +----------------- +----------------- +----------------- + 720
TGGCTTTTTGAATCGTTTGATGTACTCCTTCGGTTTCGATTTAAACGACTATAAGGACTA
GATAAAAAATTATTAGTTACAAGTGAAGGTGCCTTTAAATATTTCTCCAAAGCTTATGAT
721 -----------------+------------------ +----------------- +----------------- +----------------- +----------------- + 780
CTATTTTTTAATAATCAATGTTCACTTCCACGGAAATTTATAAAGAGGTTTCGAATACTA
TTAAATGCCGCTTATATTTGGGAAATTAACACAGAAAGTCAAGGAACACCTGAACAAATG















1081 ---------  1085
CTTGG
Figure 5.1 shows the portion of the efaA gene used to design degenerate 
primers. Primers JCF2F and JCF2R were used in isolation at first but they 
showed very non-specific binding. Primer JCF5R was designed to enable 
more specific PCR of the efaA homologue. A semi-nested PCR approach
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was used and a second PCR was performed on the product of the first PCR 
using primers JCF2F and JCF5R.
This strategy allowed the first portion of the efinA gene to be sequenced. 
Inverse PCR was used for subsequent sequencing (Figure 5.2).
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Figure 5.2 Strategy of Inverse PC R  A known portion o f  the gene to be 
sequenced is used to design PCR primers, as shown. The chromosome is 
restricted overnight at 37 XI with an appropriate restriction enzyme. The 
fragments are ligated at 14 X! fo r  24 h. PCR is performed on the 
circularised fragments to produce a linear PCR product, containing a 
portion o f  known sequence and a large portion o f  unknown sequence. 




















primers to be 
used for PCR
Linear PCR fragment for sequencing 
(using same primers)
A known portion of the gene is used to design PCR primers, which are 
orientated the opposite way to normal. A restriction enzyme is selected to
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cut in the known portion of the gene. A chromosomal digest is performed 
with the enzyme to produce a multitude of fragments, some of which will 
contain the known sequence. A ligation reaction is performed for 24 h to 
circularise the fragments and thus enable PCR to be performed. The primers 
are used for PCR and the linear DNA fragment produced is sequenced.
Inverse PCR is a useful tool for sequencing as it enables sequences to be 
obtained quickly without the need for cloning. Although cloning has 
traditionally been thought to give more accurate sequencing results this may 
not always be the case. There are large differences between gram-positive 
and gram-negative bacteria and some gram-positive proteins can be toxic to 
the gram-negative bacterium E. coli. E. coli may make mistakes in 
processing gram-positive DNA and may even delete portions which are 
particularly toxic. A proof-reading polymerase was used to minimise 
mistakes from PCR.
Using the above techniques, the efm operon was sequenced and an additional 
gene upstream of the operon was partially sequenced.
Figure 5.3 Outline of the efm Operon. Putative promoters are marked in 
bold at the start o f efmC. Ribosome binding sites (RBS) are marked in bold 
at the start o f the gene. The secondary structure, where known, is indicated 
on the map.




M E R T A I V I Q D L S A Y Q G K T ^
<---  I
TTTTGAAAACTATCAACTTGACGATAAATCCACAAAAAATTACCGGTATTATCGGACCAA
L K T I N L T I N P Q K I T G I I G P N
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W alker Site A
< ►
ACGGTGCAGGAAAATCAACATTTATGAAATCTTTGCTAGAGTTGATACCAGCTACTACTG
G A G K S T F M K S L L E L I P A T T G
 »
GTAAAGTCACCTTATCTGGACAGCCGGTAAACTCAGTCCGTAAAAAAATAGCCTACGTGG
K V T L S G Q P V N S V R K K I A Y V E
__________________________________ H elical Region_________________________________^
AACAACGAAGTGAATTGGATCTTTCCTTTCCAGTGATGGTAATAGGCGTTGTACTTTTAG
Q R S E L D L S F P V M V I G V V L L G
 —  ►
GAACATATCCATCTTTACGAATTGGACAAAGACCTGGGAAACCTGGAAAAGAACGTGCAA
T Y P S L R I G Q R P G K P G K E R A R




G G Q L Q R V F I A R A L A Q G A E W  I
W alker Site B *
< ►
TCTTTTTAGATGAACCATTCGTAGGGATTGATGCGTTAAGTGAACGAAAGATCTTTGACA 
F L D E P F V G I D A L S E R K I F D I  
Switch Region
t c t t g c a g g a a t t g a a g a a t ^ : a g g a J!a a a c g a t t t t g a t c g t c c a t c a t t t t c t t c a t a
L Q E L K N S G K T I L I V H H F L H K
AAGTAGACGAATATTTCGATGAGGTTATTCTTGTAAATAAACAGCTGATCGCTTCCGGTC
V D E Y F D E V I L V N K Q L I A S G P
CAGTACAAGAGTCTTTTACATCAGAAGACCTTCAATTGCCTTATGGTGAGATCATCAGAC
V Q E S F T S E D L Q L P Y G E I I R H
RBS Efm B
ATTTAGTAAAAGGAGGAGAGAAAAAATGATCCAATCCTTTATTGATGGATTAATGAATTA
M I Q S F I D G L M N Y
L V K G G E K K
TCAATTCCTGCAATACGCTTTGGTCACTTCCATGCTTGTAGGACTTGCTTCTGGAGTCAT
Q F L Q Y A L V T S M L V G L A S G V I
CGGTTCTTTTATTATTTTACGAGGGATGTCTTTGATGGGAGACGCTATCTCTCACGCAGT 
G S F I  I L R G M S L M G D A I S H A V
TCTTCCAGGTGTAGCCATTTCTTATATGTTTGGTTTTAGTTACATCTTTGGAGCCACTGC
L P G V A I S Y M F G F S Y I F G A T A
TTTTGGGATGCTAACAGCAGCAGTGATTGGTTTCGTGACTCAGCGGAGCCGATTGAAAAA 
F G M L T A A V I  G F V T Q R S R L K N
TGATACAGCGATTGGAATTGTCTTTAGCTCCTTTTTTGCATTAGGGATTATCTTGATTTC
D T A I G I V F S S F F A L G I I L I S
ATATGCCCAGAGTGCGACAGATTTGTATCATATTTTATTTGGGAATGTCTTAGCTGTTAG
Y A Q S A T D L Y H I L F G N V L A V R
GGAAAGCGATTTGTTGCTGACAGCACTCGTTAGTGGAATCGTCTTGATATTTGTCTTTTT
E S D L L L T A L V S G I V L I F V F F
CTTTTATAAAGAATTGAAGATCACATCTTTGGATCCGACAATGGCAAAGGCTTTTTGGCT
F Y K E L K I T S L D P T M A K A F W L
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GAACACTTGGTTGATCCATTATCTTTTGATGTTCTTTTTGACATTAGTGGCTGTAGTCAG
N T W L I H Y L L M F F L T L V A V V S
TTTACAGACAGTAGGAACAATCTTGGTGATTGCCATGTTGATCACACCAGCCGCCACGGC
L Q T V G T I L V I A M L I T P A A T A
TTACTTGCTAACGAACCATTTACTGAAAATGATCATTACAGCTGCAGGAATCGGTATGCT 
Y L L T N H L L K M I  I T A A G I G M L
AAGTGCAGTTGTCGGTGTGTTTTTCAGTATAGTTACATTGGCCATCAGAGCTACGATCGT 
S A V V G V F F S  I V T L A I R A T  I V
GTTAGCATGTACCGCATTTTTTATCCTTGCTAATTTAATTTTCTCCAACAAAAGGAATTT 
L A C T A F F I L A N L I  F S N K R N F
R B S  EfmA Leader Sequence
TATTTCAGAAGGAAAGCAGATAGATGACAAAAAAATCACTCTTTTTAATCCTGGCAGTTA 
I  S E G K Q I  D D K K I T L F N P G S  *




F L V L A G C G K Q A S  D Q A D E G S K
a a g a a a a g t t g t c a g t c g t g g c t a c c a a t t c g a t c t t g g c g g a c a t g g c a a a a g a a g t J^g
E K L S V V A T N S I L A D M A K E V G
GTACAATAGATATCCACAGTATCCCGTTCGGAACAGATCCGCATGAATATGAACCATt I c
T I D I H S I P F G T D P H E Y E P L P
 ►
CAGAAGACATCAAAAAGGCAAGTGGTGCAGATGTTATTTTATACAACGGTTTGAATCTTG 
E D I K K A S G A D V I L Y N G L N L E  
______________________________ PI Region__________________________________ ^
AAACAGGTAACAGCTGGTTCGATAACTTGATGGAAACGGCTAAAAAAGAAGGGAAAGATT
T G N S W F D N L M E T A K K E G K D Y
 ►
ATTTTGCAGTTAGCAAAAATGTAGAACCTCTATATTTAACTAGCGGTGAAGAACATACAA 
F A V S K N  V E P L Y L T S G E E H T K
 1 ---------------------------------------------------------- ►
AAGCAGATCCCCACGCATGGCTAGACCTATCTAACGGAATAAAATATGTGGAGGAAATCG 
A D P H A W L D L S N G I K Y V E E I A  
_________________ a  Region________________________________________________
c a c g t a t a t t c t c t g a a a a a g a t g c a g a a a a t g c g a c a c t c t a t a a a a a a a a t g c a g a I g
R I  F S E K D A E N A T L Y K K N A E A
CATATGTGGAAAAACTAAAAGAATTAGATACCCCAGCCAAGGGAACTTTTGCTTCTATCG
Y V E K L K E L D T P A K G T F A S I E
 ►
AAGAGAACAAAAAATTATTAGTAACAAGTGAAACTGCTTTCAAGTATTTACGAGCATATG
E N K K L L V T S E T A F K Y L R A Y D
 ►
ATCTGCCAGCAGCTTATATATGGGAGATCAATACAGAAAGTCAAGGTACGCCTGATCAAA
L P A A Y I W E I N T E S Q G T P D Q M
TGAAAGCGATCATTGATCAGATAAGAGCAAAAGAAGTAGTTTTATTCGTGGAAACCAG^ 
K A I I D Q I R A K E V V L F V E T S V
P2 Region
TAGACTCAAGAAGCATGGAACGGGTAGCAAAAGAAACGGGTTTGAAAATCTATGATAAAC
D S R S M E R V A K E T G L K I Y D K L
t g t t c a c t g a t t c c a t a g c a a a a g a a g g a g a a c a a g g a g a t t c t t a c t a t c a g a t g a t I a  
F T D S  I A K E G E Q G D S Y Y Q M M K
120
AATGGAATATTGAAACGATCCATGAAGGTTTGTCACAAACAAAAGAAAGCT
W N I E T I H E G L S Q T K E S
Figure 5.3 outlines the basic layout of the efin operon. As in other 
homologous operons the ATP binding protein is transcribed first, followed 
by the membrane protein and the receptor protein. Figure 5.3 also shows 
putative ribosome binding sites and promoters for the efin operon. The 
standard promoters for genes include the -  10 TATTAA box upstream of the 
ribosome binding site. This box is marked in figure 5.3b.
Perhaps the more interesting putative promoter is the Sir box, marked 
downstream of the TATTAA box. The Sir box is related to the DtxR family 
of metal ion-dependent repressors (Lee et al, 1997). In Staphylococcus 
epidermidis, the Sir protein binds to the Sir box under metal ion-replete 
conditions and prevents transcription of the gene. When metal ion 
concentration decreases, SirR no longer binds to the Sir box to allow 
transcription. SirR was found to regulate the production of the sitABC 
operon (which is a member of the Cluster 9 family), responding most 
strongly to Mn2+ and Fe2+ concentrations (Hill et al, 1998). The Sir box in 
the efm operon has only been assigned arbitrarily and would need to be 
proved experimentally. Preliminary studies of metal ion concentration on 
transcription are described in Chapter 8.
Figures 5.4, 5.5 and 5.6 show the comparison between homologous genes as 
determined by CLUSTA analysis. As can be seen, all the proteins show a 
high degree of homology.
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Figure 5.6 CLUSTA Analysis of Cluster 9 Receptor Proteins
EFMA : 
EFA A  : 
F IM A  : 
SC A A  : 
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A recently published paper by Singh et al (1998) included a sequence of 
efaAfm and an unknown gene located upstream. Figures 5.7 and 5.8 below 
show the CLUSTA analysis of the published results and the results obtained 
in this work.
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Figure 5.7 CLUSTA Analysis to Compare efaAfn and efmA.
20
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* 140 * 160 * 180
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Figure 5.8 CLUSTA Analysis to Compare efaB(n, and efmB. The gene 
situated upstream o f efaAjm has been designated ‘unknown gene ’ by Singh et 
al (1998), but corresponds to the 3 ’ end o f efmB, as illustrated below.
* 20  * 40 * 60
EFAFMB : - :
* 80 * 100 * 120 
EFMB : FG gSY IEGATAFGMLTAAVIGFW Q R SRLKNPTAIGIVFSSFFAI ^ I I ,!CgYAQSj^DLYH : 122!
EFAFMB : - :
* 140  * 160 * 180
EFMB : IL FG N V L A V R E SD LL L TA LV SG IV IiiFW EFY K E L K IT SL I)PT |p |^^C T^^ia|j^ |^ j^ |^j : 183|
MAKA5 LNT LIHYLLMF
2 00 220 240
EFMB •: 
EFAFMB :
F L T L V A W S L Q T V G T IL V IA M L IT P A A T A Y L L T N H L L K M IIT A A G IG M  j  S A W G V F F S p
f l t l v a w s l q t v g t i l v i a m l i t p a a t a y l l t n h l l k m i i t a a g i g m I s a v i g v f f s
M i : 24 4  
Sf|Y : 79
FLTLVAWSLQTVGTILVIAMLITPAATAYLLTNHLLKMIITAAGIGM SAV6GVFFS
* 2 6 0  * 280  
EFMB : S ^ ^ E ^ i ^ d lD b ia tlT L E N P G S  : 2 9 1
EFAFMB : ^ P S g S g B ^ i T O H B W i l l giiTlilCTLFQKBsR-------------------------- : 114
ATIVLACTAF FIL A  L K G
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As can be seen the results are similar but the efaA fin gene is missing two 
sections of bases. This could be due to mistakes in processing. It should also 
be noted that this group obtained their sequence by cloning it into E. coli. 
One of the missing sections contains the lipoprotein cleavage site which is 
known to be very toxic to gram-negative bacteria, so was probably removed 
during processing of the foreign DNA. The unknown gene corresponds to a 
portion of the membrane protein.
Because of the differences obtained in this work, our version of the sequence 
was registered in GenBank under the accession number AF097414. The title 
efm operon was used to distinguish the two sequences.
In addition to the efin operon, the gene upstream of the efin operon was 
partially sequenced. Figure 5.9 shows the sequence identified.
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Figure 5.9 Map Of: Amino Acid Permease Sequence From: 1 To: 877 the
putative secondary structure is illustrated.
TATGGAAGAAAAAAAGTTAACTCGAAGTCTTAGTGCCCGTCATATCCAAATGATCGCAC^ 
M E E K K L T R S L S A R H I Q M I A L  
T ransm em brane Region
AGGTGGAACGATCGGTGTCGGTCTGTTTATGGGTGCCTCCTCAACCATACGTTGGACAGG 
G G T I G V G L F M G A S S T I R W T G  
___________________________Transm em brane Region_______________________ |
GCCCTCAGTGATGGGAGCCTATGCGATTGCAGGATTCTTTTTGTATTTGATTATGCGTGC
P S V M G A Y A I A G F F L Y L I M R A
TTTAGGCGAAATGCTTTACGTTGATCCTTCGACTGTTCTTTTGCAAATTACGCGAGCGAG
L G E M L Y V D P S T V L L Q I T R A S
TACATCCCATCTTGTGGCTGGCTACTTGACCGCATGGAGTAATATTTTTCAATATATTGT 
T S H L V A G Y L T A W S N I  F Q Y I V  
T ransm em brane Region_______ I
CGTAGGAATAAGTGAAGTGATTGCTGTAGGATCTTATATGAATTATTGGTGGCCTGATTT 
V G I S E V I A V G S Y M N Y W W P D L  
Transm em brane Region
GCCGGCAATTATTCCCGGAATCATTGTCGTCTTGTTTCTTATGCTGGCAAATCTTATTTC 
P A I  I  P G I  I V V L F L M L A N L I S
H
TGTCAAGGCGTTTGGCGAATTAGAATTTTGGTTTTCGATCATCAAAGTCATAACGATCAT 
V K A F G E L E F W F S I I K V I T I I  
Transm em brane Region
t t t g a t g a t c a t t g c a g g t c t t g g g g t a a t c t t a t t t g g a t t Lg g t a a t c a t g g t c a g g c
L M I I A G L G V I L F G F G N H G Q A
AGTAGGGATATCAAATCTTTGGAAAAATGGTGGATTCTTCACTGGAGGCGTCAAAGGATT 
V G I S N L W K N G G F F T G G V K G F  
Transm em brane Region .
TTTCTTTGCATTATCGATCGTTGTTGCTTCCTATCAAGGAATCGAACTGATCGGAATGAC
F F A L S I V V A S Y Q G I E L I G M T
 ►
TGCTGGTGAAGCAGAGAATCCTAAAAAGACGATCATTGAAGCTGTCCAGTCCACTATCGG 
A G E A E N P K K T I  I E A V Q S T I G  
___________________Transm em brane_Region_____________________________i
TCGAATCTTGATTTTTTATAATGGTGCTATATTTATCATTGTGAGTATCTATCCGTGGAA
R I L I F Y N G A I F I I V S I Y P W N
 ►
TCAATTGAGTGAGATTGGTTCACCTTTTGTACAAACTTTTTCTAAAGTCGGCATTACATT 
Q L S E I G S P F V Q T F S K V G I T F  
Transm em brane Region  
 ►
TGCTGCAGCTGTAATGATCAGGCTCAGAAATGTTCGT 
A A A V M I  R L R N V R
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From the homology studies it is possible to predict that the gene is an amino 
acid or metabolite transport protein which belongs to the amino acid 
permease family. The most homologous gene, ybdP from Bacillus subtilis 
was discovered during a project to sequence the entire B. subtilis genome 
(Kunst et al, 1997). Consequently there is no detailed information on the 
gene and it is only possible to speculate on its function and therefore the 
function of the E. faecium homologue. The SWISSPROT entry of YbdP was 
updated recently to include transmembrane domains and these have been 
shown on the E. faecium gene in figure 5.12. However it would be useful to 
examine the E. faecium gene more closely, as it may prove to have a role in 
endocarditis. A study by Coulter et al (1998) showed that peptide and amino 
acid transporters have a large impact on virulence in animal models of S. 
aureus disease. A further study by Bayer et al, (1999) showed that the PutP 
proline permease uptake system contributed towards S. aureus virulence in a 
rabbit endocarditis model. Proline is used by S. aureus to provide an 
inorganic nitrogen source and the bacterium is auxotrophic for this, and 
several other amino acids. In addition the PutP system helps to maintain 
osmotic stability by co-transporting sodium ions. Mutants in putP  show 
decreased virulence in a rabbit endocarditis model, and produce a smaller 
vegetation size. It is thought that mutants in other amino acid transporters 
would show similar effects. It would be interesting to study whether the 
amino acid permease identified in E. faecium is able to affect the organism’s 
virulence in an endocarditis model -  as this may provide another target for 
drug therapy.
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Figure 5.11 Outline of the efm  Operon and Upstream Region in E. 
faecium. The diagram summarises the sequence obtained during this project 
and indicates the direction o f  transcription o f  the genes identified.
efmC efmB efmA
  t  —    -  ►
<-------------------
ATP binding Membrane Receptor Protein
ybdP protein Protein
In summary therefore, this section of work presents the successful 
sequencing of the entire efin operon. Putative promoter sites were identified 
and the partial sequencing of the upstream amino acid permease gene was 
obtained. Further discussion of the efin promoter can be found in Chapters 6 
and 8.
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6 Sequence Analysis of the E. faecalis efa Operon
This section of work aimed to analyse the efa operon from E. faecalis. The 
initial sequencing was carried out by Lowe et al (1995). Subsequently the 
sequences of efaB and efaC were obtained from Dr Gil Choi of Human 
Genome Sciences (Maryland, USA). The entire sequence of the efa operon 
has been compiled and is shown here (figure 6.1). Additional sequence data 
were obtained from The Institute for Genome Research (TIGR) at 
http ://www.tigr.org/.
Figure 6.1 Map of the efa Operon, shows the nucleotide sequence o f the 
operon with the protein sequence aligned underneath. Putative ribosome 
binding sites (RBS) are marked. The presumed -10 (TTATTA) and -35 
(DtxR-homologue binding site) promoter regions o f the efa operon are 




- 3 5  D tx R  - 1 0  TTATTAA
TGCGCCTAAAAATTATTTGCATTTTCTTAAACTATCCCTTATACTGATTTTAAGGCAAAC 
R BS E f a C
CTAAAAAAGGAGGAATTTCATGAGAAAAAGCTTTAACTTAGCTGTTCAAGCGTTAACCGT
M R K S  F N L A V Q A L T V
TCAATATCAAGGACGGACCGCTTTAAATAATATCCACGTTACTATTCCCTCCGGTAAAAT 
Q Y Q G R T A L N N I H V T I  P S G K  I  
W a l k e r  S i t e  A  ^
<  ►
TACTGGAATTATCGGACCAAATGGTGCTGGAAAGTCAACATTTATTAAAGGGTTATTAGG 
T G I  I G P N G A G K S T F I K G L L G
 ►
C T T GAT T AAAACAAAGGAACGT GAT GT T T TGT TAAAT AAT CAAGCG AT T GACCAACAAAA 
L I  K T K E R D V L L N N Q A I  D Q Q K
 ►
AACAACCATTGCCTATGTAGAACAACGTAGCGCCTTGGATCTTAGTTTCCCAATTAGCGT 
T T  I A Y V E Q R S A L D L S  F P I  S V
H e l i c a l  R e g i o n
 ►
TTTTGAAACGGTCTTGCTAGGAACCTATCCAAACTTGGGACTATTAAAACGCCCAGGAAA
F E T V L L G T Y P N L G L L K R P G j C
GAAAGAAAAGCAAGCAGCCATGGCTGCATTAAAAATGGTGCAATTAGAAGACTATGCGCA




R Q I G E L S G G Q L Q R V F I A R V L
W a l k e r  S i t e  B
GGCCCAAGGTGCTGAGGTGATTTTTTTAGATGAACCTTTC&TCGGCA^GATATGTCTAG  
A Q G A E V I  F L D E P F V G I  D M S S
S w i t c h  R e g i o n
<4------ ►
T G AAAAAG T GAT T AT GG AT AT T C T T AAAT CAT T AAAAAAT C AAGGT AAAAT GAT TAT CAT 
E K V I M D I L K S L K N Q G K M I  I  I
TGTTCACCATGATTTGCACAAAGTGTCCCACTATTTTGATGAATTAATCGTTTTGAAAAA
V H H D L H K V S H Y F D E L I V L K N
CCGGCTAATTGCTGCGGGTCCTGTTGAACAAACATTTACTGCAGAAACGCTCCAAGAAGC 
R L  I A A G  P V E Q T F T A E T L Q E A
R BS E f a B
ATACGGTGATTTGTTAGGTGATTTATTAATACAGGGGGTTGCAAAATGATTGCTGCATTT
M I  A A F
Y G D L L G D L L I Q G V A K *
ATTGATGGTTTATTCCG
I  D G L F R
TTATCAATTTTTACAAAATGCCCTTTTGACGTCTATAATTGTCGGACTCATTTCAGGGGT 
Y Q F L Q N A L L T S I  I V G L I S G V
AATTGGTTCATTCATTATTTTACGTGGGATGTCTTTGATGGGTGATGCGATTTCACATGC
I G S F I I L R G M S L M G D A I S H A
TGTTTTACCAGGGGTCGCTGTTTCTTATATGTTTGGTTTCAATTATATTTTTGGCGCTTC 
V L  P G V A V S Y M F G F N Y I  F G A S
TATTTTTGGCTTATTAGCTGCATTATCGATCGGCTTTATTACCCAAAAAAGTCCACTAAA 
I  F G L L A A L S I G F I T Q K S P L K
AAATGATACTGCCATTGGTGTTGTCTTTAGTTCTTTTTTTGCTTTAGGGATTATTTTTAT 
N D T A I G V V F S S F F A L G I  I  F I
CTCTTTTGCAAAAAGTTCCACCGATTTATATCATATTCTGTTTGGAAATGTATTAGCGGT
S F A K S S T D L Y H I L F G N V L A V
CGCAGATACCGATATTTTAATTACTTGTGTCGTCGGTGTGATTGTTTTGATTTTTGTGGC 
A D T D I L I T C V V G V I V L I  F V A
ATTGTTTTATAAAGAGTTGCAACTCACTTCTTTTGATCCCACAATGGCTCAGGCCTACGG
L F Y K E L Q L T S F D P T M A Q A Y G
TTTAAATATTCAATTTTTCCACTATGCATTGATGTTTTTACTAACACTAGTCGCTGTTTC
L N I Q F F H Y A L M F L L T L V A V S
TTCTTTACAAACCGTCGGAACTATTTTAGTCATTGCCATGCTGATTACGCCAGCAGCAAC
S L Q T V G T I L V I A M L I T P A A T
AGCTTATCTATTAACAAATCACTTACCGACAATGATTGGCTTAGCCTCTACTTTTGGGAT
A Y L L T N H L P T M I G L A S T F G I
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TTTAAGTTCAGTGATTGGCCTATTCTTCAGTTATTCTTATAACTTAGCTTCTGGTGCGAC
L S S V I G L F F S Y S Y N L A S G A T
GATTGTTTTAACCGCCGCCTTATTCTTTTTATTGGCTTTCTTTTTCTCACCAAAGAAAGG
I V L T A A L F F L L A F F F S P K K G
RBS E faA  __________________ ^
CCTAGTATTTGTAAACCGTGAGAAAGAAATGGAGGAATCAACGAATGAAAAAATTTAGTT 
L V F V N R E K E M E E S T N E K I  *
M K K F S L
 ►
L e a d e r  S eq u en ce  C le a v a g e  S i t e
< >
TATTTTTTTTAACACTTTTAGCAGGGTTAACGTTAGCTGCTTGCGGGAATCAAGCCGCTG 
F F L T L L A G L T L A A C G N Q A  A E
AAAAG AAAG AAAAAT T AGC AAT T G T GACAAC G AAC T C GAT CC T AT C T GAT T TAG T G AAAA 
K K E K L A I V T T N S I L S D L V K N
 ►
ATGTTGGGCAAGACAAAATTGAGCTGCATAGTATTGTGCCAATTGGGACAGACCCTCACG
V G Q D K I E L H S I V P I G T D P H E
AATATGAACCGTTACCAGAAGACATTGCGAAAGCTTCTGAAGCGGACATTTTATTCTTTA
Y E P L P E D I A K A S E A D I L F F N
P i R e g io n
 ►
ACGGCTTGAACTTAGAAACAGGCGGAAATGGCTGGTTTAACAAATTAATGAAAACGGCCA
G L N L E T G G N G W F N K L M K T A K ►
AAAAAG T T G AGAAT AAAG AT T AC T T T T C T AC AAG C AAAAAT G T T AC G C C AC AAT AT T T AA 
K V E N K D Y F S T S K N V T P Q Y L T
-►
C AAG T G CC G G T C AAGAAC AAAC AG AAGAT C C AC AT GC T T G GT T AG AC AT T G AAAAT GG C A 
S A G Q E Q T E D P H A W L D I E N G I
a R e g io n
 ►
T T AAAT AT G T AG AAAAC AT T C G T G AC G T G T TAG TAG AAAAAG AT C C AAAAAAT AAAGAT T 
K Y V E N I R D V L V E K D P K N K D F
 ►
TCTATACAGAAAACGCGAAAAATTATACCGAAAAACTTAGCAAACTACATGAGGAAGCCA
Y T E N A K N Y T E K L S K L H E E A K
AAGCTAAATTTGCTGATATTCCTGATGATAAAAAATTATTAGTTACAAGTGAAGGTGCCT 
A K F A D I  P D D K K L L V T S E G A F
 ►
TTAAATATTTCTCCAAAGCTTATGATTTAAATGCCGCTTATATTTGGGAAATTAACACAG
K Y F S K A Y D L N A A Y I W E I N T E
p2 R e g io n
 ►
AAAG T C AAG G AAC AC C T G AACAAAT G ACC AC GAT TAT T GAT AC CAT T AAG AAAT C AAAAG 
S Q G T P E Q M T T I I D T I K K S K ^
CACCTGTGTTATTTGTTGAAACCAGTGTCGATAAACGTAGTATGGAACGGGTCTCAAAAG
P V L F V E T S V D K R S M E R V S K E
 ►
AAG T G AAAC G AC C AAT T T AC GAT AC AC T T T T C AC AG AC T C T C T T GC C AAAG AAGG AAC AG 
V K R P I Y D T L F T D S L A K E G T E  
 ►
AAGGCGATACGTACTACAGCATGATGAACTGGAATTTAACAAAAATCCATGATGGCTTAA




The putative promoter sites of the efa operon are shown in figure 6.1. The 
most interesting promoter site is the dtxR box seen around the -35 element. 
The DtxR promoter region was first identified in Corynebacterium 
diphtheriae where it represses the production of diphtheria toxin when iron 
concentrations are high (Boyd et al, 1990, Schmitt and Holmes, 1991). DtxR 
is presumed to act as a dimer. It binds to its recognition sequence which 
overlaps the -35 promoter and prevents RNA polymerase from binding and 
initiating transcription (Schmitt et al, 1992). Under iron-limiting conditions, 
DtxR releases its hold on the DtxR box and allows transcription to take place 
(Schmitt et al, 1992).
Since the discovery of DtxR, homologues have been found in many other 
species, including Mycobacterium tuberculosis and other mycobacteria, 
Streptomyces lividans, Streptomyces pilosus and Brevibacterium 
lactofermentum (see Table 6.1). They have been termed iron dependent 
regulators (IdeR). It is thought that they all have pleiotropic effects on gene 
expression. Insertional inactivation of ideR in Mycobacterium smegmatis 
caused de-repression of siderophore biosynthesis under high iron 
concentrations, decreased production of Mn-dependent superoxide dismutase 
and catalase/peroxidase and increased susceptibility to killing by hydrogen 
peroxide (Dussurget et al, 1996). In C. diphtheriae additional DtxR 
promoter/operators have been identified (termed IRP1-5), which have 
products varying from a 38 kD membrane-associated lipoprotein (irpl),
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thought to be a receptor for ferric siderophore, to a haem oxygenase needed 
to utilise haem and haemoglobin (Schmitt and Holmes, 1994, Lee et al, 
1997). In addition to responding to iron, DtxR can respond to Co2+ or Ni2+ 
concentrations (Schmitt et al, 1992).
The DtxR site shown in figure 6.1 is similar to three mitis group Streptococci 
analysed by Dr N. Jakubovics (personal communication, see Table 6.1). 
FimC (S. parasanguis), PsaC (S. pneumoniae) and ScaC (S. gordonii) all 
contain the sequence AAATTAACTTGACTTAATTT around the -35 
element. This is very similar to the AAATTATTTGCATTTTCTT box 
found in efaC around the -35 site. Interestingly this contrasts with the 
putative promoter sequence found in the efin operon (see Chapter 5), which 
showed greater homology to the Sir box found upstream of the sit operon in 
S. epidermidis. Whilst SirR, the repressor in S. epidermidis is a DtxR 
homologue, it is not clear if the two respond in exactly the same way. Indeed 
SirR has been shown to respond to manganese but DtxR has not been studied 
in this respect (Hill et al, 1998). The slight base changes in the promoter 
sites may also affect the response of the repressors. Lee et al (1997) found 
that one site (IRP3) showed a weaker response to iron than other promoters 
and needed higher iron concentrations to be activated. This was thought to 
be due to a T-to-C substitution at the 3’ end of the primary recognition 
sequence. The effect of metal ion concentration on the expression of the efa 
and efin operons will be discussed in Chapter 8.
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Table 6.1 DtxR Boxes
Species Name of box Sequence
S. epidermidis sir box TTAGGTTAAC- CTAAACTTT
E. faecium efm operon TTAGGTAAAC-CTAAA------
C. diphtheriae DtxR tox box T-ATAATTAGGATAGC-TTTA-CCTAATTA-TT
C. diphtheriae DtxR irpl box C-ATTTTTAGGTTAGC-CAAACCTTTGTTG-GTG
C. diphtheriae DtxR irp2 box C-CGCGC-AGGGTAGC-CTAACCTAAACCG-GCG
C. diphtheriae DtxR irp3 box GT-CTATTAGG-TGAGACGCACCC-ATCGGAATG
C. diphtheriae DtxR irp4 box TT-TCATTA—CTAACGCTAAACCTAAGTAGCATA
C. diphtheriae DtxR irp5 box TTAGCACTAGGATTGC-CTACACTT-ACTA-A
C. diphtheriae HmuO box T—G--------AGGGGAAC-CTAACCTAA
S. lividans DesA box C-GACATTAGGTTAGG-CTCACCTAAGTT----- CA
DtxR Consensus Consensus box TTAGGTTAGCCTAACCTAA
E. faecalis efa operon AAATTATTTGCATTTTCTT-
Mitis group 
Streptococci
fim operon, sea 
operon and psa 
operon
AAATTAACTTGACTTAATTT
The presence of a DtxR homologue in E. faecalis was confirmed by studying
preliminary sequence data from TIGR. The sequence of this homologue is 
shown in Figure 6.2. The predicted protein is 222 amino acids in size and 
has a molecular weight of 25.486 kD. A BLAST search revealed that it has 
39% identity to SirR from S. epidermidis and 27% identity to DtxR from C. 
diphtheriae. Unlike DtxR itself it does not appear to be auto-regulated: no 
obvious DtxR box was found upstream of the ORF. Its precise position on 
the chromosome cannot be determined yet, but a search of the 1000 bp either 
side of the sequence revealed that the only significant ORF in that area 
encodes for a glucose -  6 -  phosphate -  1- dehydrogenase enzyme 
immediately downstream.
The sequence was studied with the Gene Quiz programme at EMBL in an 
effort to determine its secondary structure. The programme did not predict 
any significant secondary structure, but a search o f the literature revealed that 
DtxR proteins are believed to act as dimers and consist of three domains. 
The first, N terminal domain, contains a helix-tum-helix DNA binding motif.
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The central dimer interface domain is thought to contain two metal binding 
sites and the third, C terminal, domain is the dimerisation/stabilisation region 
(Lee et al, 1997, Hill et al, 1998).
It would be interesting to ascertain the metal binding specificity of the E. 
faecalis DtxR protein. The SirR protein was found to be capable of binding 
iron and manganese and Hill et al (1998) hypothesised that the protein 
functioned as a manganese- rather than an iron-dependent repressor. The efa 
operon was predicted by Dintilhac et al (1997) to be a manganese transporter 
(see also Chapter 8), so it would seem probable that the E. faecalis DtxR 
homologue is also a manganese-dependent repressor. The differences 
between DtxR homologues and their DNA recognition sequences may, in 
part, reflect their different metal binding preferences. However this 
hypothesis requires experimental support.
Figure 6.2 Map of the E. faecalis dtxR Homologue The putative ribosome 




M T P N R E D Y L K L
AATTTTTGAATTAGGTGGCGACGAAGTTAAAGTGAATAATAAACAAATTGTTTCTGGACT 
I  F E L G G D E V K V N N K Q I V S G L
CGATGTTTCGGCAGCTTCGGTTAGTGAGATGATTTCAAAGTTAGTAAAAGAAGATTTGGT
D V S A A S V S E M I S K L V K E D L V
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TGAGCATTCTCCTTATCAAGGGGTACAATTAACTGAAAAAGGCTTAAAAAAAGCGAGTAC
E H S P Y Q G V Q L T E K G L K K A S T
GTTAATTCGCAAACACCGAATCTGGGAAGTCTTTTTAGTAGAGCACTTAAATTACACTTG 
L I  R K H R I W E V F L V E H L N Y T W
G AAT G AT G T G C AC G AAG AG G C AG AAG T T T T AG AAC AT G T T AC T T C AC AG AC G C T T G T G AA  
N D V H E E A E V L E H V T S Q T L V N
CCGTTTAGCGGATTATTTAAATCATCCAGAATTTTGTCCACACGGTGGTGTTATTCCCGA 
R L A D Y L N H P E F C P H G G V I  P E
AGATAATCAACCCATTCATGAGGAGAAACGCCAAACGTTAACAGACTACCCTGTTGGCAC
D N Q P I H E E K R Q T L T D Y P V G T
AAAAATTCGGATTGCACGTGTCTTAGACGAAAAAGAATTACTGGATTATTTAGTTTCCAT 
K I  R I A R V L D E K E L L D Y L V S  I
T GAT T T AAAT AT T C AAG AAG AAT AT AC GAT T AAAG AAAT T GC T G CAT AT GAAG G AC C GAT 
D L N I Q E E Y T I K E I A A Y E G P I
C AC CAT T TAT AAT GAAAAC AAAG AAT T AT CCGT C AG C T T T AAAG C AG C AAAC AC AAT T T T 
T I  Y N E N K E L S V S F K A A N T I  F
T G T T G AGC C G T T GAT TAG AG AAAG T G AGG AAAAC T AAT GAAT G AAAAAG TAGCATTATTT  
V E P L I R E S E E N *
The preliminary E. faecalis sequence data from TIGR were also used to 
study the significant ORFs on either side of the efa operon.
Two open reading frames were detected upstream of efaC (Figure 6.3). Both 
ORFs are situated on the opposite strand and therefore run in the opposite 
direction to efa. The gene closest to efaC shows significant homology to 
genes encoding 5-phospho-D-ribosyl-a-1-pyrophosphate (PRPP) synthetase. 
Such genes are usually designated prs, so this term is used here. PRPP 
synthetase catalyses the production of PRPP from ribose-5-phosphate. ATP 
is used in the reaction. PRPP is then used to synthesise purines and 
pyrimidines, the amino acids tryptophan and histidine and NAD (Nilsson et 
al, 1989). The E. faecalis PRPP synthetase shows 53% identity to the PRPP
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synthetase from L. monocytogenes and 51% identity with the B. subtilis 
protein.
The second gene, encoded upstream of prs, is a NifS protein homologue. 
The TIGR sequence appears to contain an error at the start of the gene. 
BLAST studies show that the correct start site is the one shown in Figure 6.3. 
A base change from T to A at position 1326 would mean that methionine is 
transcribed instead of leucine and the correct start site is obtained. The NifS 
protein was first identified as a component of the nitrogen-fixing operon in 
bacteria. It has subsequently been identified in non-nitrogen fixing bacteria, 
such as B. subtilis (Sun and Setlow, 1993). The E. faecalis NifS shows 53% 
identity to the B. subtilis protein. It is thought to catalyse the specific 
desulphurisation of L-cysteine to provide organic sulphide, which is then 
formed into Fe-S clusters. Fe-S clusters are used in the synthesis of enzymes 
for the production of NAD, and in tRNA processing and mitochondrial 
metabolism (Sun and Setlow, 1993). Neither of these upstream proteins 
appears to have any function linked to efa and they are unlikely to be co­
transcribed with the efa operon.
Figure 6.3 Map of the Region upstream of the efa operon. The map
shows the two genes encoded upstream o f efa operon on the opposite strand, 
therefore the map has been reversed and the position o f the efa operon is 
shown by the arrow. The DtxR box and the TTATTCpromoter are also 
indicated.
GTTTGCCTTAAAATCAGTATAAGGGATAGTTTAAGAAAATGCAAATAATTTTTAGGCGCA 
1  + + + + + +
60
CAAACGGAATTTTAGTCATATTCCCTATCAAATTCTTTTACGTTTATTAAAAATCCGCGT  
e f a  o p e r o n  D t x R  b o x
C C T AAAT AC AAG CGCTTTTTT C AC AAAG AAAAC CGTTTCTTT C AAT AAAT T AAG G AGG AT
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R BS prs
CC C AT GAT T T T T AT G AC AAAAAATGGT AGAAT AT GC AT G AAAAC G AC TAT T AT T T T AT AT
M H E N D Y Y F I L
T G AC G GAG GAT AT CAT G AC C G AAAAC TAT C AAG AT GACACCTTACG CAT CTTCAGTT T AA  
T E D I M T E N Y Q D D T L R I  F S L N
ATGCAAATCGACCACTTGCTGAAAAAATCGCAGCATCAGTAGGAACAGAATTAGGAAAAA
A N R P L A E K I A A S V G T E L G K S
GCACCGTGCGCCAATTTAGTGATGGCGAAATTCAAATTAATATTGAAGAAAGTATTCGTG
T V R Q F S D G E I Q I N I E E S I R G
G C GAT C AT G T C T AC AT CAT C C AAG C AAC G AAT GC T C C T G T AAAT GAT CAT T T G AT GGAAT 
D H V Y I  I Q A T N A P V N D H L M E L
TGCTTATTTTAATTGATGCATTAAAACGTGCTAGCGCAAAAACAGTTAATGTTATTTTGC
L I L I D A L K R A S A K T V N V I L P
CTTACTATGGTTATGCTCGCCAAGACCGCACAGCGAAACCAAGAGAACCCATTACTGCGA
Y Y G Y A R Q D R T A K P R E P I T A K
AATTAGTTGCTAATATGTTGGTAGAGGCAGGCGCAACACGTTTGTTGACATTAGACTTGC
L V A N M L V E A G A T R L L T L D L H
AT AC T G T T C AAG T C C AAGGAT T T T T T GAT AT C C C AGT AG AT AAT T TAT T T AC AAT GCC T T 
T V Q V Q G F F D I  P V D N L F T M P L
TGTTTGCTCATTATTATCGTCAACAAGCATTAGTAGGGGAAGAAATTGTGATTGTTTCGC
F A H Y Y R Q Q A L V G E E I V I V S P
CTAAAAACAGTGGCGTTCAACGCGCACGTAGTTTATCGGAGTACTTAGATGCGACCTTAG
K N S G V Q R A R S L S E Y L D A T L A
CAATTGTCGACCATGAAGAGATCGATGGGGTGCGCCAAGAAGGTTACGTTATTGGGAATG
I V D H E E I D G V R Q E G Y V I G N V
TCGCTGGGAAAAAATGTATTCTTGTTGATGACATTTTGAATACTGGTCAAACGTTAGCCA
A G K K C I L V D D I L N T G Q T L A T
CAGCGGCGGAAGTTTTAATGAAAAATGGTGCGCAAGAAGTGTATGCTTGCGCCTCGCATG
A A E V L M K N G A Q E V Y A C A S H G
GTTTGTTATCAGAAGGCGCAAAAGCAACCTTAGAAAATGCGCCAATTAAGGAAATTAGTA
L L S E G A K A T L E N A P I K E I S I
T TAC T GAC TCTGTTTATAC GACAG CAGAC C GC CAAC CAG CAAC C T T GAAT AT TATTTCTT  
T D S V Y T T A D R Q P A T L N I  I S C
GCGCTGAGTTAATGGGGGAAGCGTTACTTCGTATCCATGAAAATAAACCAATGAGTCCAT
A E L M G E A L L R I H E N K P M S P L
TATTCCGTT TAG AAC C AAAAGGAG AAT AAG T GAT T C C T T AAAC TAG AAAT AGG T C T AAC A  





L E P I Y L D H A A T T P L H P T V I
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T T CAAG C GAT GAC T G AAAAT AT G CAAACGAC T T T T G G CAAT C CAT CAAG TAT T CAT CAG T 
Q A M T E N M Q T T F G N P S S I H Q F
TTGGACGAAAGGCACACGGTCTTCTGGAAGAAGTGCGTCAAACGATTGCCGAGAGCTTAC 
G R K A H G L L E E V R Q T  I A E S L Q
AAGCCAAACCCCACGAAATTATTTTTAATAGTGGTGGCACAGAAGGGGATAACACAGCCA
A K P H E I I F N S G G T E G D N T A I
TCTTGGCAGTTGCTTTTTCTCGTCAAAAGGAAGGAAAACATATTATTACTACGGCAATTG 
L A V A F S R Q K E G K H I  I T T A I E
AACATCCCGCTGTGTTACGAACGATGGAATACTTAGAAACGTTAGGCTTTGAAGTGACTT
H P A V L R T M E Y L E T L G F E V T Y
ACTTGCCTGTGAATGAAAATGGTCAGATTTCAATGGATCAATTCAAAAAGTCTTTACGCG
L P V N E N G Q I S M D Q F K K S L R E
AAGAAACGATCTTGGTTTCAATGATGTATGGCAATAATGAAATTGGAAATCGATTACCGA
E T I L V S M M Y G N N E I G N R L P I
TTGCTGAAGTTGGTGCAATTCTTAAAAATCATTCGGCGATTTTTCATACAGATGCCGTCC 
A E V G A I L K N H S A I  F H T D A V Q
AAGCTTATGGAAGTGAAGTCATTTTACCTCATGAATTAGGGATCGACTTATTAAGTATTT
A Y G S E V I L P H E L G I D L L S I S
CCGCTCATAAAATCAATGGTCCAAAAGGCGTAGGTTTTTTATTTAAAAGCGATGCAATCC
A H K I N G P K G V G F L F K S D A I Q
AATTACCACCTCTTTTACATGGTGGGGAACAAGAAGAAAAACGACGTGCGGGCACGGAAA
L P P L L H G G E Q E E K R R A G T E N
ACTTAGCTGGAATTATTGGCATGGGTACTGCCGTTTCATTACTAACTTCTGCAGAAAAGC 
L A G I  I G M G T A V S L L T S A E K Q
AAG C AAGAAAAAC AGCC T AT C AAAG T T T T C AAAC GAT T AT T T T AAAAG C G T TAG AAG AAG 
A R K T A Y Q S F Q T I I L K A L E E A
CCAATATTGATTTTTCAATTAATGGTGAACCAACCAATCGTTTAGCGCATGTCTTAAATC
N I D F S I N G E P T N R L A H V L N L
TTCATTTAAAAGGAATTCCCAGTGATTTGCTCTTAATGCATTTGGACTTAAGAGGTATTG 
H L K G I  P S D L L L M H L D L R G I A
CGATTTCAACAGGCTCGGCTTGTACAGCGGGAACTGTGGATCCTTCGCACGTGTTGACAG 
I  S T G S A C T A G T V D P S H V L T A
CGATGTATGGAGAAAATTCCTCAGCTATTAAAGAATCAATCCGGATTAGTTTTGGCTACG
M Y G E N S S A I K E S I R I S F G Y G
G GAACACAC CAGAAGAAAT TGCGACTTTTTCT GAAG TACTAGTTG CAG T GAT T CAACAAT 













A study of the region downstream of the efa operon revealed four ORFs 
situated on the complementary strand (see Figure 6.4). All four ORFs 
showed homology to proteins in the Genbank database that have been 
identified during sequencing projects. This makes it difficult to assign a 
definite function to these proteins. However a putative structure or function 
has been assigned where possible.
The gene encoded closest to efaA is a 502 amino acid proteins which shows 
38% identity to YffnM from B. subtilis. (Yamamoto et al, 1997). YfmM was 
sequenced during the sequencing project o f the B. subtilis genome. YfmM is 
an ATP binding protein and is believed to have another protein, YfmL as its 
translation initiation factor. It is similar to hypothetical ABC transporters in 
H. influenzae, E. coli and a positive effector in Saccharomyces cerevisiae 
(gcn20). Gcn20 is activated by Gcn2 to phosphorylate the a  sub-unit of 
translation initiation factor 2 in yeast.
The gene encoded upstream of the YfmM homologue shows 35% identity to 
the B. subtilis hippurate hydrolase protein and 32% identity to an N-acyl-L-
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amino acid hydrolase from Synechocystis. The Gene Quiz programme did 
not predict any secondary structure.
The next gene upstream is a lipoprotein of unknown function. A BLAST 
search revealed 39% identity to a Pasturella haemolytica outer membrane 
lipoprotein and 42% identity to YaeC, a hypothetical lipoprotein from E. 
coli.
The last gene to be identified in this work shows homology to membrane 
permeases from B. subtilis (35% identity) and H. pylori (29% identity).
Figure 6.4 Map of the Region Downstream of the efa Operon in E.
faecalis. As the genes are encoded on the opposite strand to efa, the reverse 
complement is shown. The end o f efaA is shown at the end o f the map to 
allow orientation. The ribosome binding sites are marked (RBS) and where 
possible, secondary structure has been illustrated.
RBS M em b ra n e  P e r m e a se
T GAT T TAAAAAAGGAGTGAAC T GAG AAT G TAT C AAT TAT T T GAG AAAT AT T T T C C GAATG
M Y Q L F E K Y F P N V
TTGTCCAATTAAAACAAGAGTTTCTTCAAAGTACATGGGAAACATTATACATGGTTTTTT
V Q L K Q E F L Q S T W E T L Y M V F W
GGACAGCATTGATTGCTGGCGTGTTAGGAGTCTTGTTGGGTGTCGTGCTTGTTAGTACTG
T A L I A G V L G V L L G V V L V S T G
GCCCCAGTGGTGTTTTGAAAAATCCACCCCTGTACAGTGTCTTAGAAAAAATTATTAATG 
P S G V L K N P P L Y S V L E K I  I N V
TTTGCCGCTCTATTCCTTTCATTATTATGCTCGCACTGATTCAACCATTAACACGAATTT
C R S I P F I I M L A L I Q P L T R I L
TGGCAGGAACGACAATTGGTACAACCGCAGCGTTAGTCCCATTAGTTATTGGCGTAATCC 
A G T T I G T T A A L V P L V I G V I  P
CGTTCTTCGCGCGCCAAATTGAAAATGCGTTATTAGAAGTGGATCCTGGCGTTATTGAAG
F F A R Q I E N A L L E V D P G V I E A
CGGCAGAAGCCATGGGGACGAGTCCCTTAGGGATTATTTTTAGGGTTTATCTAATTGAAG 
A E A M G T S P L G I  I  F R V Y L I  E G
GGTTACCAAGTATTATTCGTGTTTCAGCGGTGACAATTATTAATTTGATTGGATTAACAG
L P S I I R V S A V T I I N L I G L T A
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CCATGGCAGGAGCGATTGGAGCCGGTGGTCTGGGCAACTTAGCGATTACTCGAGGATACA 
M A G A I  G A G G L G N L A I  T R G Y N
ATCGGTTTCAAACCGATGTGACATTTATGGCCACGTTAATTATTTTAATTATGGTATTTA 
R F Q T D V T F M A T L I  I  L I M V F I
RBS
T C AG T C AAG C CAT TAG T AAT C AAT T AAT C AAAAAAAC AT C AC AT T AG AAAAAAGGAGAAA 
S Q A I S N Q L I K K T S H *
Lipoprotein Leader Sequence
T G AC AAAT GAAAAAAT T T AGT AAAT T AAT T GG AC TTATTGGGGTAT T AGC T T T T AC GAT T




A G C A S G S V K D T K T E T V K L G V
G T AG G AAC AAAAAAT GAT G AAT G G G AAT C G G T C AAAG AC C G T T T G AAAAAG AAAAAT AT T 
V G T K N D E W E S V K D R L K K K N I
GAT T T AC AAT T GG T AG AAT T T AC AGAC T AT AC GCAAC C AAAC GC AG CAT T AGC AG AAAAA 
D L Q L V E F T D Y T Q P N A A L A E K
G AAAT T GAT T T AAAT GCCT T T C AG CAT C AAAT C T T T T T AG AC AAT T AC AAT AAAG AG CAT 
E l  D L N A F Q H Q I F L D N Y N K E H
G G AAC G AAAT TAG TAT C AAT T G G C AAT AC AG T C AAT G C AC C AT T G G G AAT T T AC G C T AAT 
G T  K L V S I G N T V N A P L G I  Y A N
AAAT T GAAAGAT AT C AC G AAAAT T AAAG AC GGC GGAG AAAT T G C TAT T CC T AAT G AC C C A 
K L K D I T K I K D G G E I A I  P N D P
ACGAATGGCGGGCGGGCGTTAATTTTATTACAAACTGCAGGACTGATAAAAGTAGATCCT
T N G G R A L I L L Q T A G L I K V D P
G C G AAAC AG C AAC T AC C G AC T G T C AG T GAT AT T AC T G AAAAT AAAC G C C AAT T G AAAAT A 
A K Q Q L P T V S D I T E N K R Q L K I
ACTGAATTAGATGCTACGCAAACAGCGCGCGCTTTACAAGATGTCGATGCTTCAGTGATT
T E L D A T Q T A R A L Q D V D A S V I
AATAGCGGCATGGCTGTCGATGCTGGGTATACACCAGATAAAGATGCTATTTTCTTAGAA 
N S  G M A V D A G Y T P D K D A I  F L E
CCTGTAAACGAAAAAGCGAAACCTTATGTGAACATTGTCGTGGCCCGAGAAGAAGATCAA
P V N E K A K P Y V N I V V A R E E D Q
G AGAAT AAAC T T T AT CAAAAAGT TGT AGAAGAAT AT CAACAAGAAGAAACGAAAAAG G T C 
E N K L Y Q K V V E E Y Q Q E E T K K V
ATTGCAGAAACATCAAAAGGCGCCAATGTTCCAGCCTGGGAAACATTTGGTAAAAAATAA 
I A E T S K G A N V P A W E T F G K K *  
RBS Hippurate Hydrolase
AG G AGGCAT T TAT AAT G AG T AC AAC AAC GAT T C AAACAAT C C AAGAAGC T AT T G C T AC AG 
M S T T T I Q T I Q E A I A T E
AAAAG G AAT G GAT AAT C CAT T T AAG AC G T CAT T T T C AT C AAT AT C C T G AAG C AAG T T T AA 
K E W I  I H L R R H F H Q Y P E A S L K
AAG AAT AT GAAAC G AT T AAGC GAAT T AAAG AAG AAC T AC T AG C C T TAG CTATTCCTTTTG  
E Y E T I K R I K E E L L A L A I P F V
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TAGAAGTAGGGGAAACGGGTGTTTTAGCAACCATTGAAGGAGGTCTTGGCGCTGGCAAAA
E V G E T G V L A T I E G G L G A G K T
CGATTTTGTTACGTGCAGATATTGATGCGTTGGAATTGCCAGATGCAACAGGTGCTGCCT 
I  L L R A D I  D A L E L P D A T G A A Y
ATGCTTCTAAAAATCCAGGACTCAATCATGCTTGTGGACACGATGGTCATGCGGCAGCAT
A S K N P G L N H A C G H D G H A A A L
TGCTAGGTGCAGCTAAAGTGCTCAAAAAACATCAGGATACCTTTTCAGGAACGATTAAAC 
L G A A K V L K K H Q D T  F S  G T  I K L
TGGCCTTCCAGCCAGCTGAAGAAATTGGTGCAGGCGCTCGACAATTTGTGGAAGGAAATT
A F Q P A E E I G A G A R Q F V E G N Y
ATTTAGAAGCAATCGACCAAGTGTTTGGGATTCATTTAGATTCCAGTGTGCCGGTCGGAA
L E A I D Q V F G I H L D S S V P V G K
AATTAGTCGCTACCAAAGGCGCCACCAACGCCTCTTGTGATATTTTTAAAATTGAAGTCA 
L V A T K G A T N A S C D I  F K I  E V S
GTGGTCAAAGTAGTCACGTCGCCCAACCACAGAATGGCCGGGATGCTGTTTTAGCAGCGG
G Q S S H V A Q P Q N G R D A V L A A A
CCAGTATCGTTGTGGAATTACAAAAAATTGTAGCTCGCGAGATTGATCCTTTAGATTCTG 
S I V V E L Q K I V A R E I  D P L D S V
TCGTAGTAGGAATTGGCGTTTTACAAGCAGGAACACGCTATAATATTGTAGCAAACCAGG
V V G I G V L Q A G T R Y N I V A N Q A
CAACCATTGAAGGTACTGTTCGAACATTTAGTCAGGAAACGCGCCAATTTGTTTTACAAC
T I E G T V R T F S Q E T R Q F V L Q R
GAGTCGAAGAAATTGCCCATGAAATTGCCCAGTCTAATCGCACAGAAATTGCTGATTTTT
V E E I A H E I A Q S N R T E I A D F S
CTGTTTATGCGGCAGCGAATCCATTAATTAATGAAGAACAAGCAACCAACCGTGCACAGC
V Y A A A N P L I N E E Q A T N R A Q Q
AGGTAGCCAGTGAAATTGTTGGTTTTGAAAATGTTGTGACCGATCATCCTAAAAGTTTAG 
V A S E I V G F E N V V T D H  P K S L G
GGGCGGATGATTTTGCTGATTACTTAGCGGTAATTCCTGGTATCTATGGACGGGTCGGTT 
A D D F A D Y L A V I  P G I Y G R V G S
C AC G AAAC C C T G AAAAT C C T G C T AC T CAT T T T GG AC AC CAT CAT G AAC AAT T T GAT AT T G 
R N P E N P A T H F G H H H E Q F D I D
ATGAACGTGCCTTACTTTTAGCAGCAGAGTACCACGTACGCTATGCATTAAATTATTTAT









R B S  Y fm M
AG AAAGAAGT G AC G AAAAT G AGT AT T T T AAC TAT T GAAC AT T T AAC GC AT CG AT T T GG CG 
M S I L T I E H L T H R F G E
 ►
AAAAGGTCTTGTATGAAGAGGCTTCATTGCAAGTGAATAAAGGGGATCATTTAGGCTTAA 
K V L Y E E A S L Q V N K G D H L G L T  
W a lk e r  S ite  A  
<  ►
CTGGCCAAAATGGGGTCGGCAAATCCACCTTAATTAAAATTTTAACGGGGGAAGTATTGC
G Q N G V G K S T L I K I L T G E V L P
CAGACGAAGGAACGATTCAGTGGCAAAAAAATTGCAAGATTGGGTACTTGGATCAGCACG 
D E G T I Q W Q K N C K  I G Y L D Q H V
TTTCTGTAGAACAATCACTAACGATGGTTGATTTTTTGAAACAAGCCTTTCAAGAACTTT
S V E Q S L T M V D F L K Q A F Q E L F
T T GAT AAAG AAGC G AAAC T G AC AAAGC T T TAT G AAG AAT AC AG T C AAAC G G C T T C GG AAA 
D K E A K L T K L Y E E Y S Q T A S E K
AAC T T T TAG AAC AAG C AG G C AAGT T ACAAAC AG AT T TAG AT GAAAG T AAT T T T T AC C AAA 
L L E Q A G K L Q T D L D E S N F Y Q I
TCGACACGATTATTCAGGATTTAGCCAATGGGTTAGGACTACAAGCAATTGGTTTGGATA 
D T I  I Q D L A N G L G L Q A I G L D K  
L in k er  P ep tid e  
M   ►
AAAAGTTAGGGGAGCTAAGCGGTGGTCAACGTTCAAAAGTGATTTTAGCAAAATTATTGT
K L G E L S G G Q R S K V I L A K L L L
TAGAG GC CC C T GAT G T G T TAC T T T TAGAT GAAC CCAC CAAC TAT T TAGAT GATACACATA 
E A P D V L L L D E P T N Y L D D T H I
TTCAATGGCTTGTTCGCTATCTGAATAATTTTGAAGGAAGCTTTCTATTAGTCTCCCATG
Q W L V R Y L N N F E G S F L L V S H D
ATTATCAATTTTTAAATGAAGTGACGAATTGCATCGCAGACATTGAGTTTGGCAAGTTAA
Y Q F L N E V T N C I A D I E F G K L T
C C AAAT AT AC T G G AAAT G T AG AAAAAT C T T T T GC AC AAAAAGAGC AG AAT AAAC AAACC T 
K Y T G N V E K S F A Q K E Q N K Q T Y
ATTTGAAACAGTATCAGGCCCAACAAGAAAAAATTGAAAAAATGGAAGCCTATATTCGTA
L K Q Y Q A Q Q E K I E K M E A Y I R K
AATACAAAGCTGGAAATCGAGCAACGATGGCTAAAAGTCGACAAAAACAATTGGACCGGT
Y K A G N R A T M A K S R Q K Q L D R L
TGGAACGATTGACTCCGCCTGGTTCCTTGACTAAGCCAGCGATTGAATTTCCTTATCAAG
E R L T P P G S L T K P A I E F P Y Q G
GGTTAGTTGCAACGCAAGCACTAACGACCCAGAAGTTAGTTGTCGGCTATCGGGAACCTT 
L V A T Q A L T T Q K L V V G Y R E  P L  
W a lk e r  S ite  B
< ►
TGTTAGAACCGTTAGATTTAATGGTTCATGTCGGTGAAAAAGTCGCATTGAAAGGCTTTA
L E P L D L M V H V G E K V A L K G F N
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AT G G G AT T G GC AAAT C AAC AT T AAT T AAAAC G T T G AC GAAAG T GAT T CC T T CAT TAG AT G 
G I G K S T L I K T L T K V I P S L D G
GAGAATTTCATTATCCGCTGAATACAAAAATTGCTTATTTTACCCAAGACTTAGCGTGGC
E F H Y P L N T K I A Y F T Q D L A W P
CTAATGAGCAGTTAACGCCACTAGACTATTTATCAGATCGTTTTCCAGATACAACGATTA




E R R S H L A R A G L P D K L A M Q S L
TAGCCCTGTTAAGTGGTGGTGAGCAAACAAAAGTAAAACTAGCGGAACTAATGATGCAAA
A L L S G G E Q T K V K L A E L M M Q T
C AAGT AAT TTGTTATTTT TAG AT GAG C C AAC CAAT CAT AT T GAT G AAGC G GC C AAAAAAA  
S N L L F L D E P T N H I  D E A A K K I
TTTACAAGAAGCAATTCACGTTTACCCAGGAACGGTTTTTCTGGwTTCCCATGAAGCAGA
Y K K Q F T F T Q E R F F W 7 P M K Q I
T T T T T AT GAG G AAAT T G T G GAT C GAG T AAT T G AT AT T GAG G AAT T AG T T AAAT AAAG AAG 
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^ ---------------  EfaA
The overall layout of the efa operon and surrounding region is illustrated in 
Figure 6.5
Figure 6.5 Summary of efa Operon and Surrounding Region.
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It is also worth noting that no other significant ORFs were detected 
downstream of efaA. The streptococcal cluster 9 proteins all encode a thiol 
peroxidase gene downstream of their receptor proteins and there has been 
some speculation as to whether there is transcriptional read-through to this 
gene from the cluster 9 proteins. The S. gordonii thiol peroxidase (tpx) 
encoded downstream of the sea operon was used in a BLAST search of the 
E. faecalis sequence in the TIGR database. A protein of 162 amino acids 
with a molecular weight of 59.94 kD was identified. It shows 44% identity 
to the B. subtilis hypothetical thiol peroxidase, 41% identity to PsaD and 
ScaD and 38% identity to the S. parasanguis thiol peroxidase. The region 
surrounding the thiol peroxidase was obtained and this showed that the gene 
is not located near efaA, or any other lipoprotein (data not shown). The 
sequence around the -35 promoter of the gene does show limited homology 
to the Fur boxes from other species (see Table 6.2). Fur (Ferric Uptake 
Regulator) has a homologous function to DtxR, and has been found in E. coli 
and S. epidermidis and many other bacteria. Until recently it was assumed 
that a bacterial species contained either a DtxR homologue or a Fur 
homologue. It is now recognised that both repressors can be found in the 
same species (Hill et al, 1998). Whilst DtxR and Fur have a similar function 
they are not homologous at either a nucleotide or amino acid level and are 
not functionally interchangeable. DtxR is unable to act on Fur sites and vice 
versa (Boyd et al, 1990). Fur boxes do seem to vary quite considerably, 
especially between gram-positive and gram-negative species (Heidrich et al, 
1996) and it is difficult to ascertain whether the thiol peroxidase gene is 
regulated by Fur. It is also interesting to note that B. subtilis contains three
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fur  homologue genes: yqkL codes for the Fur protein and is sensitive to low 
iron and manganese concentrations. The ygaG  product, PerR, is sensitive to 
low iron and manganese concentrations and to increased concentrations of 
H2O2 (Bsat et al, 1998). The third fur homologue, yqfV, responds to zinc 
(Gaballa and Helmann, 1998) and is similar to the E. coli Zur protein (Patzer 
and Hantke, 1998). These three proteins are produced in addition to the 
product of yqhN, a DtxR homologue. The thiol peroxidase gene illustrated 
here has not been proven to be under the control of a Fur protein. However it 
would seem logical that a gene involved in the stress response would be 
controlled by a repressor which responds to H2O2 levels (known to increase 
when a bacterium is in the aerobic environment of a host) and manganese or 
iron (which would decrease in a host environment). Table 6.2 includes 
details of the identified Zur box sequences and per box sequences found in B. 
subtilis and L. seeligeri (Chen et al, 1995, Haas et al, 1991, Gaballa and 
Helmann, 1998) to allow comparison with fur boxes. The per boxes 
identified so far have all been situated ~15 bp upstream of the -35 promoter.
It would perhaps be more correct to conclude that the E. faecalis thiol 
peroxidase gene is not controlled by DtxR and is not linked to efa 
transcription. If, however, the tpx gene is controlled by Fur, it will be 
transcribed in identical situations to the efa operon, i.e. when manganese or 
iron concentrations are low. It would certainly seem to be worth studying the 
effect of metal ion concentration on the E. faecalis thiol peroxidase.
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Figure 6.6 Thiol Peroxidase Gene in E. faecalis. with putative ribosome 




AG T G GAAAAGGAGGAT T T CAGAAT GAAT G T TACAAGAAAAGGG CAC G TAT TAGAAT T GAC
M N V T R K G H V L E L T
AGGTGAGCAGCCTAAAGTTGGCACAAAAGCTCCCGTCTTTTCTTTGAAAAATTTAAACAA
G E Q P K V G T K A P V F S L K N L N N
CCAAGAAATCAACTTGGCAGATTATAAAGGTAAAACGGTTTTAATTAGTGTGGTTCCTGA
Q E I N L A D Y K G K T V L I S V V P D
TATCGACACACGTGTTTGTTCACTGCAAACGAAACGTTTCAATCAAGAAGCGGCGAAATT 
I  D T R V C S L Q T K R F N Q E A A K L
AGACGGTGTTCAGATTATCACGATTTCCAATAACACAGTTGAAGAACAAGCAAATTGGTG
D G V Q I I T I S N N T V E E Q A N W C
TGCCGCTGAGGGTGTCGAAATGGAAATGCTTCATGATACTGAAGACTCATTTGGTGCAGC
A A E G V E M E M L H D T E D S F G A A
TTATGGTTTGTATATTCCAGAAATGGGCCGTTTAGCACGTGCTATTTTTGTGATTGACCC 
Y G L Y I  P E M G R L A R A I  F V I  D P
AGAAGGAACGTTAGTTTATGAAGAAATCGTCTCAGAAGTTTCGTCGGAACCCGATTATCA 
E G  T L V Y E E I V S E V S S E P D Y Q
ACAAGCGTTAGAATCTGCAAAAAAAGTGTAATCCCTCTAGATTACAAATTGACTTTGCTT
Q A L E S A K K V *
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Table 6.2 Fur Boxes
(After Hardham et al, 1997; Chen et al, 1995; Haas et al, 1991; Bearden et al; 
1998; Bsat et al, 1998; Litwin and Calderwood, 1993; Patzer and Hantke, 
1998; Gaballa and Helman, 1998)
Species Name of Fur box Sequence
Consensus consensus GAT AAT GAT A ATC ATT ATC
E. coli iucA, primary GAT AAT GAG A ATC ATT ATT
E. coli iucA, secondary GAT AAT TGT T ATT ATT TTA
E. coli fepA TAT TAT GAT A ACT ATT TGC
E. coli sltl GAA TAT GAT T ATC ATT TTC
E. coli irgA GAA ATT AAG A ATA ATT ATC
E. coli fhuA CTT TAT AAT A ATC ATT CTC
E. coli fur TAT AAT GAT A CGC ATT ATC
Y. pestis yfeE CAT AAG TTA T AAC CTT TAC
Y. pestis yfeA TGG TAT TGA T AAT CAT TTT
T. pallidum Tro Operon TAC TTT GAT G CAT CAA AAT
E. faecalis Thiol peroxidase 
homologue
TAC TAT ACT T TAT TAT TGA
E. faecalis AdcA homologue CAA TAA ACA A AAG AAA ATT
E. faecalis Fur homologue GAA ATA GTA T TAT TTA AGA
B. subtilis Per box consensus CTA t - T  T a t  AAT -A T T A T A A a ttA
L. seeligeri catalase gene, per 
box
GAT AAT GAA G ATT ATT TTT
B. subtilis yciC gene, Zur 
box
TTT AAA TCG TAA TCA TTC TA
B. subtilis ycdH gene, Zur 
box
ACA AAA TCG TTA TCA TTT TG
The TIGR database was used to identify Fur proteins from E. faecalis (Figure 
6.7 -  6.9). Unfortunately it was only possible to identify the complete 
sequence of the ygaG  gene homologue. The protein identified is 147 amino 
acids long and has a molecular weight of 16.945 kD. A putative Fur binding 
site was identified around the -35 element, suggesting that fur is auto­
regulated (Figure 6.7 and Table 6.2). A BLAST search revealed 63% 
identity to the PerR homologue in B. subtilis and 43% identity to the S. 
pyogenes Fur. The Gene Quiz programme did not identify any significant 
secondary structure, but a study of the literature revealed that the Fur protein 
is thought to act as a dimer and can complex with manganese, iron and cobalt 
(reviewed by Litwin and Calderwood, 1993). The N terminal domain is 
thought to be involved in binding to DNA and contains a helix-tum-helix 
motif, whilst the C terminal is involved in dimerisation and binding metals
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(Heidrich et al, 1996). As with DtxR it would be interesting to study whether 
this E. faecalis Fur would bind preferentially to iron or manganese, as this 
might give some indication of which metal is more important to E. faecalis. 
It would also be worth investigating whether it responds to raised H2O2 
levels.
Figure 6.7 Map of the vsaG Fur Homologue of E. faecalis. The putative 
Fur box is highlighted and the ribosome binding site is marked (RBS). This 
protein is believed to respond to increased environmental concentrations o f  
H2O2 and to decreased levels o f manganese and iron.
Putative Fur Box RBS
TTCTTGTCAATCGTAATAAGAAATAGTATTATTTAAGAAAGATAGACAGGGGAGGGATAC
AAAGAT GGACAAC GTAT T G G T TAAAAAT GCAC T T G C T GAAT TAAAAGAAGC CAATAT CCG 
M D N V L V K N A L A E L K E A N I  R
AAT TAC T C C GCAAC GTTATGCTATCT T GGAATAT T TAAT CGAAAAT CATACACAC C CAAC 
I T P Q R Y A I L E Y L I E N H T H P T
AG C T GAT GAAAT T TAT CGC GCAC TAGAAGAT CAT T T T C CAAATAT GAG T G TAGCAAC G G T 
A D E I Y R A L E D H F P N M S V A T V
TTACAACAATCTACGTTTATTTACTGAAATCGGTTTCGTTCAAGAAATGAGTTATGGCGA
Y N N L R L F T E I G F V Q E M S Y G D
TGCATCTAGTCGTTTTGATTTTAGTTCGAAGAAACATTATCACGTGATTTGTCAAAAATG
A S S R F D F S S K K H Y H V I C Q K C
TGGTAAAATCGTTGATTTTCATTATCCAGGGTTAGAGGACGTTGAAATGGCCGCTAGTAA
G K I V D F H Y P G L E D V E M A A S K
ATTAACAGGCTTCGAAATTAATGAACATCGTTTAGAATTATATGGATTATGTCCAGATTG
L T G F E I N E H R L E L Y G L C P D C
C CAAC AAGC ACAAC AGG AGAAT G T G T AAAAAAT TAC AT AC T G T T AAAAAT T TAT C AAAAG 
Q Q A Q Q E N V *
It was only possible to identify partial coding sequences of the other two E. 
faecalis Fur homologues. Figure 6.8 shows the start and end of the yqkL 
homologue, which responds to iron and manganese. The start of the protein 
shows 75% homology to B. subtilis yqkL product and the end of the protein
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shows 45% homology in BLASTP studies. Unfortunately the sequence 
spans two contigs and it is not possible to speculate how they will join up.
Figure 6.8a Map of the Start of the yqkL Fur homologue in E. faecalis.
This is situated on the end o f one contig, and is expected to join up to the end 
o f the sequence, situated on the start o f another contig (shown below). The 
predicted molecular weight o f this protein is 7.7 kD. If the two halves o f the 
protein were joined, they would form one protein with an approximate 
molecular weight o f 16 kD, which corresponds to the size o f most Fur 
proteins. This Fur protein is predicted to respond to decreased 
environmental concentrations o f manganese and iron.
TTGATAAATTAAGTTTCTTAATTTGTAATCATTCTAAACAgGAGCTGTAATAATGGATTC
M D S
GAC TGCTGCTT TAAAAAAGACACAAAAACAAT TACAT GAAT CACGC T T TAAAT TAACAC C 
T A A L K K T Q K Q L H E S R F K L T P
AC AAC G G GAAG C AAC CG T AC T T G T AT T AT T GG AAAAT G AAAAAG AT C AT T T AT C AGC AG A 
Q R E A T V L V L L E N E K D H L S A E
AGAAATTTACTTCCTGGTAAAACAAAAAAGTCCGGAAATTGGTCTAGCAACAGTCTATCG
E I Y F L V K Q K S P E I G L A T V Y R
AACGCTAGAAAT T TAACAGAC T T 
T L E I  *
Figure 6.8b Map of the End of the vakL Fur Homologue in E. faecalis
showing the end of the predicted yqkL homologue, situated at the start o f one 
contig. This is expected to join up with the start o f the protein, as shown 
above.
ATTGAGGAAGTGGAAGAAGACTTGCTTGGTGAAGTAGAGCAAATTGTTGAAAGTCGGTAT 
I  E E V E E D L L G E V E Q I V E S R Y
CATTTTTTAGTCAAAGATCATCGCTTAACTTTTCATGGTATTTGTCAAAGTTGTCAAAGT
H F L V K D H R L T F H G I C Q S C Q S
AAACATTAAAAAAACTGCCTTGCATTAATTTATGCAAGGCAGTTTTTTATTCATTGGAAT 
K H *
The partial sequence of the zinc repressor (yqfV) homologue is shown in
Figure 6.9. Again this is situated at the start of the contig and it is not
possible to pinpoint the beginning of the gene accurately. The identified
region shows 53% identity with YqfV on BLASTP studies.
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The presence of three Fur homologues in E. faecalis raises interesting 
questions about the regulation of genes. It is clear that metal ion 
concentration is a common environmental sensor, but it is not clear how 
sensitive the E. faecalis Fur homologues are, or which metal ions they 
respond to. Further work is needed to answer these questions and to 
determine the consensus binding sequence for each of these proteins.
Figure 6.9 Map of End of yqfV homologue (Zinc repressor) in E. faecalis
This shows the end o f the yqfV homologue (the product o f yqfV, Zur, is a zinc 
repressor in B. subtilis). This is situated at the start o f a contig and the 
beginning o f the gene is not available yet.
GCCAAGAGGTGGAACATCATCATCACTTTATTTGTACGGTTTGTGGCAAAACGGAAGAAA
Q E V E H H H H F I C T V C G K T E E I
TTCACATGTGTCCGATGAATTTTTTTGAAGAACAGTTAAAAGGTTGTTCAATTGAAGGAC
H M C P M N F F E E Q L K G C S I E G H
ATCGCTTTGAAATCCTTGGTCGTTGTGCCGATTGTTGCGAAAAATAGCGAATAAGACGAA
R F E I L G R C A D C C E K *
Studies by Dintilhac and Claverys (1997) have shown that there are two 
Cluster 9 proteins in S. pneumoniae', one, AdcA, is a zinc transporter and the 
other, PsaA, is a manganese transporter. Kolenbrander et al, (1994) also 
hypothesised from Southern blotting studies that there could be another 
homologous operon to sea in S. gordonii. It was therefore highly possible 
that there was another Cluster 9 operon in E. faecalis. A BLAST search of 
the TIGR E. faecalis sequence with AdcA revealed that there was indeed a 
protein with 56% identity to AdcA (see Figure 6.8a). The E. faecalis AdcA 
protein is 511 amino acids long and has an Mr of 57,663. There is a leader 
sequence at the start of the protein, with a cleavage site for signal peptidase 
II, suggesting that AdcA is a lipoprotein. The mature protein would have a 
molecular weight of 55,663.
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Further searches found homologues to AdcB and AdcC (Figure 6.8b). 
However the complete E. faecalis sequence has not yet been compiled in 
TIGR and the adcB and adcC genes are encoded on a different contig from 
adcA. The start of adcC is also missing. However the sequence downstream 
of adcB is available and does not contain adcA (data not shown). This 
presumably means that the operon does not follow the C-B-A order seen 
most often in Cluster 9 operons. It is possible that AdcA is encoded first. 
Significantly, this does occur in both B. subtilis and E. coli, where operons 
homologous to adc have been identified. In both the ycdH  (B. subtilis) and 
znu operons (E. coli), the receptor protein is encoded first followed by the 
ATP binding protein and the membrane protein (Gaballa and Helmann, 1998; 
Patzer and Hantke, 1998). Without viewing the complete genome sequence 
and the start o f adcC it is not possible to clarify this. Interestingly, however, 
there is an area ~ 35 bases upstream of adc A which shows limited homology 
to Fur binding sites. If AdcA is coded first, this could be a Zur site, and it 
would raise an interesting possibility that the E. faecalis Zur homologue is 
controlling transcription. The adc operon in S. pneumoniae is controlled by 
its own repressor, AdcR, encoded upstream of AdcC. However a BLAST 
search revealed no homologues to AdcR in the TIGR E. faecalis sequence. 
The recent evidence that Zur controls the ycdH  operon in B. subtilis and the 
znu operon in E. coli does add credence to the theory that the E. faecalis adc 
operon would be controlled in this way (Gaballa and Helmann, 1998, Patzer 
and Hantke, 1998).
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Figure 6.7a Map of the adcA Gene Homologue in E. faecalis, showing the 











L F G A C G K T N T S D K T A D G K E K
AACTATCCATTGTCACGACTTTTTATCCTATGTACGATTTCACTAAAAATATTGTAGGCG
L S I V T T F Y P M Y D F T K N I V G D
ATGAAGGAGACGTCAAATTGTTAATCCCTGCTGGTTCTGAACCACACGATTATGAACCAT
E G D V K L L I P A G S E P H D Y E P S
CCGCCAAAGATATGGCTACCATCCATGATGCGGATGTTTTCGTTTACCACAATGAAAATA
A K D M A T I H D A D V F V Y H N E N M
TGGAATCTTGGGTACCAAAAGCTGCTAAAGGTTGGAAAAAAGGAGCCCCGAACGTCATTA 
E S W V P K A A K G W K K G A P N V  I  K
AAGGTACCGAAAACATGGTCTTACTTCCCGGCAGTGACGAAGACGGACACGACCATGACC 
G T E N  M V L L P G S D E D G H D H D H
ACGAACATGGCGAAGAAGGCCACCACCATGAATTAGACCCGCATACTTGGGTTTCGCCTC
E H G E E G H H H E L D P H T W V S P H
ATC G T G C C AT CC AAGAAG T C AC AAAC AT C AAAG AAC AAT TAG T C AAAC T T T AC CC T AAAA 
R A I Q E V T N I K E Q L V K L Y P K K
AAGCC AAAACAT T T GAAACAAACGCAGAAAAAT ACT T AAC AAAAT T AACAGCCT T AGACA 
A K T F E T N A E K Y L T K L T A L D K
AAGAGTTCCAAACAGCTTTGAAAGACGCTAAGCAAAAAAGTTTTGTTACCCAACATGCTG  
E F Q T A L K D A K Q K S  F V T Q H A A
CATTTGGTTATCTTGCCTTAGATTACGGCTTAAAACAAGTGCCAATAGCTGGTTTAACAC
F G Y L A L D Y G L K Q V P I A G L T P
CTGAACAAGAGCCAACCGCAGGGCGCTTGGCAGAGTTGAAAAAATATGTCACAGACAACC
E Q E P T A G R L A E L K K Y V T D N Q
AAATTCGCTATATTTATTTTGAAAAAAATGCCAACGATAAAATTGCTAAAACGTTAGCTG
I R Y I Y F E K N A N D K I A K T L A D
AC G AAG C G AAT G T T C AAT T G G AAG T C C T AAAC C C G C TAG AAAG TTT G AC AC AAAAAC AAA 
E A N V Q L E V L N P L E S L T Q K Q M
TGGACAATGGCGAAGATTATCTTTCTGTAATGAAAGAAAACTTAACTGCTTTGAAAAAAA
D N G E D Y L S V M K E N L T A L K K T
C AAC AG AT AC AG C C G G G AAAG AG G T T C AG C C AG AAAC C T C T G AAAAAAC AG AAAAAAC C G 
T D T A G K E V Q P E T S E K T E K T V
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T G G C T AAC GGATATTT C AAAG AC AG T GAG G T G G C T GAG AG AAC AC T G AC AG AT T AC G C T G 
A N G Y F K D S E V A E R T L T D Y A G
GAAATTGGCAATCCGTCTATCCTTTATTAAAAGATGGCACATTAGACCAAGTCTTCGATT
N W Q S V Y P L L K D G T L D Q V F D Y
ACAAAGCGAAACTGAAAAAAGATAAAACACCAGCCGAATACAAAACCTACTATGATGCCG
K A K L K K D K T P A E Y K T Y Y D A G
GCTATCAAACCGATGTCGACCACATCAACATCACTGATTCCACCATTGAATTTCTGGTCA
Y Q T D V D H I N I T D S T I E F L V N
AT G GC AAAC C AC AAAAAT T C AC C TAT AAAG C AGC C GG T TAT AAAAT T T T AAAC T AT G CAA 
G K P Q K F T Y K A A G Y K I L N Y A K
AAGGCAACCGTGGCGTCCGTTTCCTTTTTGAAACAGACGATGCCAATGCTGGGCGGTTTA
G N R G V R F L F E T D D A N A G R F K
AATACGTCCAATTTAGCGACCACAACATCGCACCAACGAAAGCCGCTCATTTCCACATCT 
Y V Q F S D H N I A P T K A A H F H I  F
TCTTCGGCGGCGATAGCCAAGAAAGTCTGTTCAATGAAATGGACAACTGGCCAACGTATT
F G G D S Q E S L F N E M D N W P T Y Y
ATC C AAG C G AC T T AAG C AAAC AAGAAAT T G C C C AAG AAAT GAT T GC GC AT T AAG CAT T C A 
P S D L S K Q E I A Q E M I A H *
Figure 6.8b Map of adcB and adcC Analogues in E. faecalis. showing 
significant secondary structure. The ribosome binding sites are marked 
(RBS).
Walker Site A 
AdcC <4-------------------------------- ►
CTTATTTTAACAGGAGAAAATGGCGCTGCCAAGTCAACGCTGATCAAAAGTACCTTAGGG 
L I  L T G E N G A A K S T L I K S T L G
TTATTAAAACCAACAAGTGGCAAAATTACGGTCGCTAAAAAAAATAGTGCTGGTGAAAAA
L L K P T S G K I T V A K K N S A G E K
ATCAGTATTGGCTACATTCCACAACAAGTCGCTTCTTTCAATGCGGGCTTTCCTAGCACC 
I S  I G Y I  P Q Q V A S F N A G F P S T
GTCATTGAATTAGTACGTTCAGGTCGCTTTCCCAGAAATCGTTGGTTCAAACCGTTGACG 
V I  E L V R S G R F P R N R W F K P L T
AAAAAAGATCATCTTCATGTGGAAAAAGCTTTGAAATCAGTGGACATGTGGGAAATGCGC 




H K R I G E L S G G Q K Q R I S L A R V  
Walker Site B 
<  ►
T T T G C G AC C GAT C C AG AT T TAT T TAT T T TAG AT GAG C C AACAAC AGGT AT GG AT G AAC AA  
F A T D P D L F I L D E P T T G M D E Q
Switch Region
T C G CGAAACGAAT T T TAT CAAT T G T T G CAACACAG T GC G CAT GAACAT G GAAAAG C TAT T 
S R N E F Y Q L L Q H S A H E H G K A I
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TTGATGATTACGCATGATCATGAAGATATCAAAACCTATGTGGATCGTCAAATTCGTCTT
L M I T H D H E D I K T Y V D R Q I R L
GTCCGCAAAGAAGATTCGAAATGGCGTTGTTTCCATATGAGTGAAGAATCGTATACGTAA





M A E M L S Y
ATGCATTTATGCAAAAGGCCTTTTTAGCAGCACTGTTTATCTCAGTGATTGCCCCAATGC 
A F M Q K A F L A A L F I  S V I A P M L
TCGGCGTCTTTCTAGTTATTCGCCGACAATCTTTAATGGCAGATACCCTTTCACATGTGT
G V F L V I R R Q S L M A D T L S H V S
CATTAGCCGGTGTGGCACTAGGCTTCTTTTTTAATTGGAATCCTAATTTAATGACCTTAA
L A G V A L G F F F N W N P N L M T L I
TTGTCGTGATTGTGGCTGCAATCATTCTAGAATATTTACGAATGATTTATAGCACCTATT
V V I V A A I I L E Y L R M I Y S T Y S
CAGAAATTTCGATTGCTATTTTAATGTCAGGCGGTTTGGCTTTGGCGTTAGTTTTGATGA
E I S I A I L M S G G L A L A L V L M N
ATTTAACAGGAGGCAATTCAGCTGCTAGTATTCAATCGTATTTATTTGGTTCCATCGTCA 
L T G G N S A A S I Q S Y L F G S  I V T
CGATTACGTGGGATCAAGTGGTTATGTTGGCAATTTTATTCGTAGTTTTAGTTCTATTGT 
I  T W D Q V V M L A I L F V V L V L L F
TTATGTTATTTAAACGTCCAATGTATGTTTTAACATTTGATGAAGATACTGCTCATGTTG
M L F K R P M Y V L T F D E D T A H V D
ATGGGCTACCTATTCATTGGATGTCGATGCTTTTTAATGTAATTACTGGTGTGGCGATTG
G L P I H W M S M L F N V I T G V A I A
CTGTGATGATTCCGATCGCGGGAGCCTTGTTAATTTCAGCAATTATGGTCTTACCAGCTG
V M I P I A G A L L I S A I M V L P A A
CAATAGGTATGCGAATTGGTAAAGGCTTTAACACGGTGATTATTATCAGTGTGTTTATGG
I G M R I G K G F N T V I I I S V F M G
GCTTGATTGGCATGCTAACAGGGTTGACTAGCTCGTATTATTTGGAAACACCACCGAGTG
L I G M L T G L T S S Y Y L E T P P S A
CAAGTATTACCCTAATTTTTATTGGTTTATTCTTATTAGTCAATATTTATCGCCGAGTGG
S I T L I F I G L F L L V N I Y R R V V
TTGTCATGGTC C AAC G AAAAC AAAAAAT G C AAAG AAAC T AAG G AG AAAAAC G AAAG T T T T 
V M V Q R K Q K M Q R N  *
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In conclusion, therefore, analysis of the preliminary E. faecalis sequence at 
TIGR has enabled identification of the entire efa operon and surrounding 
sequence. Furthermore the thiol peroxidase gene and DtxR and Fur protein 
homologues have also been identified. This should allow intensive study of 
metal ion regulation in this pathogen.
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7 Purification of EfaA bv Salt Fractionation
Prior to the present study, all western blotting experiments had been carried 
out using serum from an endocarditis patient (GP). However, due to the 
increasing age of this serum it became necessary to generate new antibodies 
to the EfaA protein. In order to do this, EfaA had to be extracted and 
purified and then used to generate antibodies in a New Zealand white rabbit. 
Salt fractionation by ammonium sulphate precipitation was used to purify 
EfaA from E. coli XL1 pSK+: GP19.
The E. coli clone containing efaA was used because this was engineered to 
over-express EfaA and hence would give a better yield than the same number 
of E. faecalis cells. EfaA would also be present in the cytoplasm not the 
membrane in these cells. Furthermore gram-negative cell walls are much 
easier to break down than gram-positive ones thus aiding extraction of the 
cytoplasm. Some extraction protocols recommend using IPTG in the growth 
medium to induce the expression of foreign proteins. However IPTG is toxic 
to cells and as the basal concentration of EfaA in E. coli XL1 pSK+:GP19 is 
already quite high, it was decided that this was unnecessary.
The first step in protein purification is to get the desired protein into a more 
or less soluble form. Cytoplasmic proteins are soluble in aqueous media, so 
in micro-organisms it is merely necessary to lyse the cell walls and release 
the cytoplasmic extract. Cells were spun down and resuspended in TE buffer 
prior to sonication and lysozyme treatment. TE was added partly for EDTA 
to augment the action of lysozyme and partly to provide liquid for the
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extracted proteins. Some liquid needs to be added to prevent proteins being 
trapped in the cellular debris following extraction and centrifugation.
Following extraction streptomycin was added to the solubilised cell extract to 
precipitate the ribosomes and hence remove the nucleic acids. Because 
nucleic acids are polymers and carry a strong charge they may co-precipitate 
with proteins during salt fractionation and thus will not be purified. 
Furthermore they alter the solubility and adsorption properties of proteins.
As proteins will precipitate out over a range of concentrations and not at a 
particular point, collecting precipitate over a wide range (e.g. 25 %) will 
ensure that all the protein is collected. Collections over a narrow range (e.g. 
5 %) will give a small quantity of pure protein. It may be necessary to 
compromise on purity in some extractions in order to extract a sufficient 
quantity of protein. The aim of the extraction procedure in this case was to 
obtain as much EfaA as possible. The purity of the preparation was not of 
paramount importance, since it was only to be used to generate antibodies 
and would not be used for any experiments where pure protein was required. 
Thus it was initially decided to collect protein precipitated over a 30 % range 
(i.e. to collect 30 %, 60 % and 90 % precipitates).
Initial experiments showed that all the proteins tended to precipitate out of 
solution at 30 % saturation, leaving little or no protein to precipitate out at 
the 60 % or 90 % levels. This could have been caused by inadequate stirring 
in the solution leading to localised regions of high ionic strength. To try and
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remedy this the ammonium sulphate was ground in a mortar to break up large 
crystals or lumps and was added to the solution slowly (over 10 min) so that 
the desired concentration was reached slowly and evenly over time. The 
solution was stirred for a further 30 min after the ammonium sulphate had 
been added to allow the levels of precipitated and dissolved protein to 
equilibrate. However the proteins were still precipitating out together at 30 
%. It was therefore decided to add the ammonium sulphate in smaller 
increments to effect a more gradual change in ionic strength. The experiment 
was repeated, adding the ammonium sulphate in 10 % increments from 20 % 
to 90 %. The results are shown in figure 7.1. The 80 % and 90 % fractions 
contained no protein, but a gradual precipitation had been achieved over all 
the other concentration points. The 70 % fraction was used to generate 
antibodies.
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Figure 7.1 SDS-PAGE of Fractions obtained in EfaA Extraction 
Procedure,. Fractions were analysed on a 12 % SDS-PAGE gel and were 
stained with coomassie blue. Lane 1, marker; Lane 2, 20 % saturation 
fraction; Lane 3, 30 % saturation fraction; Lane 4, 40 % saturation fraction; 
Lane 5, 50 % saturation fraction; Lane 6, 60 % saturation fraction; Lane 7, 
70 % saturation fraction. The EfaA protein band (indicated by arrow) is most 
prominent in the 70 % fraction, so this fraction was used to generate 
antibodies in a rabbit.
Time constraints prevented proper testing of the antibodies generated in this 
way. However figure 7.2 compares two western blots generated using GP 
serum and the rabbit serum. Although the human serum produced the 
strongest bands on a western blot, it can be seen that the rabbit serum was 
capable of producing a response.
1 2 3 4 5 6 7
<  EfaA
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Figure 7.2 Comparison of Immunoblotting with Human and Rabbit 
Serum, figure 7.2a shows E. faecalis EBH1 (Lane 1) and E. coli XL1 pSK+: 
GP19 (Lane 2) probed for 12 hours with human serum (diluted 1:100 in 
TBS) obtained from patient GP. Figure 7.2b shows molecular weight 
markers (Lane 1) and E. faecalis EBH1 (Lane 2), probed with EfaA- 
antibody-containing serum (diluted 1:20 in TBS) generated from a New 
Zealand white rabbit injected with the 70 % saturation fraction obtained in 








8 Metal Ion Regulation of the efa and efm Operons
The recent work of Dintilhac et al (1997) and Kolenbrander et al (1998) has 
highlighted the role of metal ions in the transcription of Cluster 9 proteins. 
There is now growing interest in the metal ion regulation of Cluster 9 genes. 
It would appear from identification of DtxR-like promoter boxes upstream of 
both efa and efm operons (see chapters 5 and 6) that a similar regulation 
mechanism is likely to occur in enterococci. Dintilhac et al (1997) carried 
out some phylogeny studies on Cluster 9 proteins and predicted from this that 
efaA would act in the same way as PsaAv in S. pneumoniae and would be 
transcribed under manganese-limiting conditions (see table 1.3). In order to 
verify all of these predictions experimentally, a semi-quantitative RT-PCR 
strategy was designed to clarify the effects of some transition metal ion 
concentrations on transcription of the efa and efm operons.
RT-PCR is becoming an increasingly common tool to study RNA 
transcription. It can be performed on total RNA or mRNA. The first stage is 
the annealing of a primer to template RNA, followed by transcription to 
cDNA with a reverse transcriptase such as AMV. The reverse transcriptase 
is inactivated by heating the reaction to 94 °C, which will also melt the RNA- 
cDNA hybrid. PCR is then performed to amplify the cDNA.
RT-PCR can simply be used to detect the presence of an RNA species, or can 
be used in a more sophisticated manner to study the relative expression of 
RNA species under different experimental conditions. This latter approach
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was used in this study, where the transcription of efaA and efmA were studied 
under varying metal ion concentrations.
RT-PCR is a sensitive technique, because of linear amplification during 
PCR, so even small variations between tubes can produce dramatic 
differences in total yields. Contamination can also be a significant problem, 
especially from DNA. All known RNA extraction techniques result in some 
DNA contamination. Therefore it is not enough to assume that any 
differences observed between samples in an experiment are due to the 
parameter being tested. Controls must be included to verify that the 
differences observed are genuine.
DNase treatment was used in these experiments to degrade DNA, but care 
was needed to avoid damaging the RNA. As most damage occurs during the 
inactivation step, inactivation was carried out at 75 °C for 5 min, which has 
been found to be the lowest temperature to cause most complete inactivation 
(Boerhinger, personal communication). A DNase with low RNase activity 
was selected. The removal of DNA contamination was ascertained by 
performing a PCR without the reverse transcription step for each sample 
(data not shown).
The most reliable method of identifying sample variation in RT-PCR is to 
use an ‘internal’ control by amplifying a control mRNA in addition to the 
experimental RNA. The relative quantities of each species are then 
compared. ‘External’ controls such as OD or absorbence measurements or
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constant cell number can be easily made and would seem to eliminate the 
need for internal controls. However they would not account for errors 
introduced in the PCR reaction by pipetting, transfer to the reaction tube and 
unequal amplification due to variation in the thermal cycler.
The control genes used are usually constitutively expressed housekeeping 
genes. Ideally they should be unaffected by the experimental conditions, be 
essential cell products and be expressed at all times in the cell cycle at a 
constant level. However no single RNA species will have a constant level of 
expression and variation is inevitable between samples, not least due to the 
inherent errors in any RT-PCR technique. In these experiments the recA 
gene (involved in DNA replication and repair) was selected as the 
housekeeping gene. Figure 8.1 shows the portion of the gene used in the 
PCR reactions. The purpose of these experiments was to look for a trend in 
RNA production, not to determine the exact quantity of an RNA species 
present. Therefore a simple comparison between the target RNA and control 
RNA was sufficient.
Figure 8.1 The Partial Sequence of recA from E. faecalis. showing the 
portion o f the gene identified in the sequencing project o f Dybvig et al 
(1992). The primers used in these experiments are shown in bold.
JCF8F
1 TTTATAGACG CTGAGCACGC ATTGGATCCT CAATATGCGG AGAAA^AGG CGTTAACATT
61 GATGAATTAC TTTTATCTCA ACCAGATACG GGCGAGCAAG GCTTAGAGAT TGCCGATGCC
JCF8R 
A-----------------------------
12 1  TTAGTTTCAA GTGGTGCGAT TGACATCGTT GTCATCGACT CGGTTGCTGC GTTAGTTCCT
1 8 1  CGTGCAGAGA TTGATGGTGA GATGGGAGCG AGCCATGTCG GCTTACAAGC TCGACTAATG
2 4 1  TCTCAAGCAC TACGTAAATT ATCAGGCTCA ATTAATAAGA CAAAAACAAT TGCTATTTTC
3 0 1  ATCAACCA
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The results obtained with E. faecalis were further confirmed by western 
blotting experiments using cell walls extracted from cells in early log phase 
grown in yeast extract containing the appropriate metal ion.
Figure 8.2 RT-PCR Results for E. faecalis EBH1 Cells Grown in 1 % YE 
Containing Variable Manganese Concentrations. PCR products were 
analysed on a 0.8 % agarose gel and stained with ethidium bromide and 
viewed under UV light. Lane 1, marker, Lane 2, no template control, Lane 3, 
yeast extract medium, supplemented with 1 % foetal calf serum only 
(YE/FCS), Lane 4, YE/FCS with O.lpMMn, Lane 5, YE/FCS with 0.5 juM 
Mn, Lane 6, YE/FCS with 1 juM Mn, Lane 7, YE/FCS with 5 pM  Mn, Lane 8, 
10 juM Mn
1 2 3 4 5 6 7 8
500 bp
Figure 8.3 Western Blot Analysis of E. faecalis EBH1 Cell Walls After 
Growth in 1 % YE Containing Variable Concentrations of Manganese,
E. faecalis cell wall extracts were subjected to SDS-PAGE electrophoresis 
and then were probed with patient's serum (GP). Blots were visualised with 
protein A conjugated to horseradish peroxidase. Lane 1, E. coli XL1 pSK+ 
GP19 (EfaA Clone), lane 2, YE/FCS + 10 pM  Mn, Lane 3, YE/FCS + 5 pM  
Mn, Lane 4, YE/FCS + 1 pM  Mn, Lane 5, YE/FCS + 0.5 pM  Mn, Lane 6, 
YE/FCS + 0.1 pMMn, Lane 7, YE/FCS, Lane 8, YE.
1 2 3 4 5 6 7 8
EfaA
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Figure 8.4 RT-PCR Results for E. faecalis EBH1 Cells Grown in 
Medium Containing Variable Zinc Concentrations. PCR products were 
analysed on a 0.8 % agarose gel and stained with ethidium bromide and 
viewed under UV light. Lane 1,YE with 10 pM  Zn, lane 2, YE with 5 juM Zn, 
lane 3, YE with 1 pM  Zn, lane 4, YE with 0.5 pM  Zn, Lane 5, YE with 0.1 pM  
Zn, Lane 6, YE/FCS, Lane 8, Molecular weight marker.
1 2 3 5 6 7 8
500 bp
Figure 8.5 Western Blot Analysis of E. faecalis EBH1 Cell walls After 
Growth in 1 % YE Containing Variable Concentrations of Zinc, E.
faecalis cell wall extracts were subjected to SDS-PAGE electrophoresis and 
then were probed with patient's serum (GP). Blots were visualised with 
protein A conjugated to horseradish peroxidase. Lane 1, YE, lane 2, YE/FCS, 
lane 3, YE with 10 pM  Zn, Lane 4, YE with 5 pM  Zn, Lane 5, YE with 1 pM  
Zn, Lane 6, YE with 0.5 pM  Zn, Lane 7, YE with 0.1 pM  Zn, Lane 8, E. coli 
XL1 pSK+ GP19.
1 2 3 4 5 6 7 8
EfaA
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Figure 8.6 Analysis of RT-PCR Results from E. faecalis EBH1 Cells 
Grown in Medium Containing Manganese and Foetal Calf Serum, PCR
products were analysed on a 0.8 % agarose gel, stained with ethidium 
bromide and viewed under UV light. Densitometry was used to measure the 
relative transcription o f efaA and recA genes. The results are shown here, 
expressed as the percentage transcription o f efaA: recA.
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Figure 8.8 Analysis of RT-PCR With RNA From E. faeca lis EBH1 Cells
Grown in 1 % YE Containing Manganese Only. Cells were grown in 1 % 
YE, which was not supplemented with 1 % FCS. PCR products were 
analysed on a 0.8 % agarose gel, stained with ethidium bromide and viewed 
under UV light. Densitometry was used to measure the relative transcription 
o f efaA and recA genes. The results are shown here, expressed as the 
percentage transcription of efaA: recA.
120 ,
100 J
YE YE/FCS 0.1 0.5 1 5 10
Manganese Ion Concentration (Micromolar)
Figures 8.2-8.12 show the results of the RT-PCR experiments on E. faecalis 
EBH1. The agarose gels (figures 8.2 and 8.4) illustrate the differences in 
expression seen with the RT-PCR products and figures 8.6-8.12 show the 
results graphically. The effects of manganese are seen clearly in these 
experiments (figures 8.2, 8.3 and 8.6): the addition of manganese to the 
growth medium reverses the induction effect seen with serum. The gene 
must therefore be responsive to the environmental manganese concentration. 
If manganese is added to growth medium without foetal calf serum, efaA 
transcription remains at or below its basal level (figure 8.7).
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Figure 8.8 Analysis of RT-PCR Results from E. faecalis EBH1 Cells 
Grown in 1 % YE Containing Zinc. PCR products were analysed on a 
0.8 % agarose gel, stained with ethidium bromide and viewed under UV 
light. Densitometry was used to measure the relative transcription o f efaA 
and recA genes. The results are shown here, expressed as the percentage 
transcription o f efaA: recA.
Zinc Ion Concentration (Micromolar)
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Figure 8.10 Analysis of RT-PCR of RNA from E. faecalis  EBH1 Cells
Grown in 1 % YE Containing Variable Zinc Concentrations and 40uM 
Manganese. PCR products were analysed on a 0.8 Vo agarose gel, stained 
with ethidium bromide and viewed under UV light. Densitometry was used 
to measure the relative transcription o f efaA and recA genes. The results are 
shown here, expressed as the percentage transcription o f efaA: recA.
120  -
YE YE/FCS 0.1 0 .5  1 5 10
Zinc Ion Concentration (Micromolar)
The effects of zinc on efaA transcription are also interesting. Figures 8.4, 8.5 
and 8.8 illustrate that zinc at a concentration of 5pM or higher is able to 
induce efaA transcription. Indeed 10 pM zinc is able to induce efaA to a 
greater extent than that seen with foetal calf serum. Intriguingly, figure 8.10 
shows that adding 40 pM manganese as well as zinc can reverse the 
induction seen with 5 pM zinc or lower. These results taken together suggest 
that zinc is acting as a form of competitive inhibitor of manganese. It may be 
able to bind to the same receptor as manganese and therefore decrease the 
effective concentration of manganese available to the cell.
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Figure 8.11 Analysis of RT-PCR Results from E. faecalis EBH1 Cells 
Grown in 1 % YE Containing Iro n . PCR products were analysed on a 0.8 
% agarose gel, stained with ethidium bromide and viewed under UV light. 
Densitometry was used to measure the relative transcription o f efaA and 
recA genes. The results are shown here, expressed as the percentage 
transcription o f efaA: recA.
Ferric ion Concentration (M icromolar)
Further experiments showed that magnesium and copper have no significant 
effect on efaA transcription (data not shown). However, it is interesting to 
note that iron causes a decrease in transcription compared to both YE and 
YE/FCS controls (Figure 8.11). The presence of a DtxR promoter box (see 
Chapter 6) upstream of the efa operon suggests that iron should have an 
effect on efaA transcription and this is seen here.
The results obtained in these experiments are in agreement with those of 
Kolenbrander et al (1998). They found that ScaA in S. gordonii was up- 
regulated under manganese-depleted conditions and that zinc could compete
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with manganese to cause this up-regulation. Dintilhac et al (1997) also 
predicted that efaA would respond to manganese. Whilst Kolenbrander et al 
(1998) and Dintilhac et al (1997) proposed that their Cluster 9 proteins are 
manganese- or zinc- transporters, it is not possible to make such deductions 
about EfaA from these experiments. It was found that adding manganese 
repressed the induction observed in YE/FCS medium. This suggests that 
foetal calf serum is imposing manganese limitation, perhaps by the 
absorption of manganese onto albumin. However, no uptake studies have 
been carried out with E. faecalis. Such studies would require a knockout 
mutation of efaA. Many Cluster 9 proteins were originally identified as 
adhesins. FimA has been shown to mediate adhesion to the salivary pellicle 
(Fenno et al, 1995) and fibrin monolayers (Bumette-Curley et al, 1995). 
PsaA is involved in adhesion to mucosal or other cells (Berry and Paton, 
1996). SsaB facilitates adhesion to salivary-coated hydroxyappatite 
(Ganeshkumar et al, 1988). The later hypothesis that these proteins are metal 
ion transporters does not sit well with the adhesion theory. It is difficult to 
see how the proteins could have a dual role as metal ion transporters and 
adhesins. It is feasible that a metal ion transporter could act as an adhesin by 
binding to a metal ion complexed to a host protein. If the ligand is firmly 
bound, it will not be transported and the cell will be adhered to the host 
protein. However most metal ions in human serum will be only loosely 
bound to albumin or transferrin. It would seem more likely that it is the 
metal transported by cluster 9 proteins that has the direct effect on adhesion 
or other virulence factors. Manganese is required for glucan-associated 
adhesion in some mutans group streptococci and both manganese and zinc
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are required for pneumococcal transformation (Bauer et al, 1993, Dintilhac et 
al, 1997). Therefore even though these proteins may not be direct adhesins, 
they could still have an important role in virulence. Metal ions, and therefore 
metal ion transporters, could indirectly affect virulence: the metal may be a 
cofactor for a virulence protein, may be a growth-limiting element, or may 
regulate the expression of virulence proteins. This last possibility is looking 
increasingly likely with the identification of multiple Fur homologues and a 
DtxR protein in E. faecalis. It is likely that the metal ion response seen with 
efaA occurs as part of a global regulation of many virulence proteins by a 
DtxR homologue in E. faecalis. The bacteria may use the environmental 
metal ion concentration to sense when they are inside a host and therefore 
that they need to synthesise a different set of proteins in order to survive in 
this environment. It is conceivable that EfaA has a transport or adhesion 
function that is totally unrelated to metal ion transport, and it is necessary to 
determine its precise function carefully before drawing any conclusions 
about its role in E. faecalis endocarditis.
Some preliminary RT-PCR studies were also carried out on the efm operon. 
No antibodies are available for efmA, so no western blotting was possible. 
Similarly no details of an E. faecium housekeeping gene were available in the 
databases at this juncture, so it was possible only to look for a crude response 
and no quantification of this response was possible. Initial results showed 
problems with non-specific primer binding and primer-dimers so the one step 
RT-PCR strategy had to be modified. The initial reverse transcription step 
was carried out with only the reverse primer (JCF7R). Then the PCR reaction
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was hot-started after the addition of the high fidelity enzyme mix and the 
forward primer (JCF7F). This action eliminated all of the extra bands seen 
previously, but it was still not possible to see any variation in response to the 
metal ion concentration. Figures 8.12-8.15 illustrate the results seen.
Figure 8.12 RT-PCR Results for E. faecium UB1 efmA Grown in 1 % YE 
supplemented with Manganese. PCR products were analysed on a 0.8 % 
agarose gel and stained with ethidium bromide and viewed under UV light. 
Lane 1, marker, lane 2, lOpM Mn, lane 3, 5 juM Mn, lane 4, 1 pM  Mn, lane 
5, 0.5 pM  Mn, lane 6, 0.1 juM Mn, lane 7, yeast extract supplemented with 1 
% foetal calf serum, lane 8, yeast extract grown cells, lane 9 no template 
control.
1 2 3  4 5 6 7 8 9
500 bp
Figure 8.13 RT-PCR Results for E Faecium UB1 EfmA when Cells 
Grown in 1 % YE Supplemented with Zinc. PCR products were analysed 
on a 0.8 % agarose gel and stained with ethidium bromide and viewed under 
UV light. Lane 1, marker, lane 2, 10 jliM Zn, lane 3, 5juM Zn, lane 4, 1 juM 
Zn, lane 5, 0.5pM  Zn, lane 6, 0.1 pM  Zn, lane 7, yeast extract supplemented 
with 1% foetal calf serum, lane 8, yeast extract, lane 9, no template control.
1 2 3 4 5 6  7 8  9
500 bp
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Figure 8.14 RT-PCR Results for E. faecium  UB1 efm A  when Cells are
Grown in 1 % YE Containing Magnesium. PCR products were analysed 
on a 0.8 % agarose gel and stained with ethidium bromide and viewed under 
UV light. Lane 1, marker, lane 2, 10 jliM Mg, lane 3, 5 juM Mg, lane 4, 1 juM 
Mg, lane 5, 0.5pM  Mg, lane 6, 0.1 juM Mg, lane 7, yeast extract 
supplemented with 1% foetal calf serum, lane 8, yeast extract grown cells, 
lane 9 no template control.
1 2 3 4 5 6 7 8 9
500 bp
Figure 8.15 Agarose Gel showing Results of RT-PCR of E. faecium UB1 
efmA Cells are Grown in Yeast Extract Medium Containing Variable 
Concentrations of Copper, lane 1, 10 pM  Cu, lane 2, 5 juM Cu, lane 3, 1 
pM  Cu, lane 4, 0.5 pM  Cu, lane 5, 0.1 pM  Cu, lane 6, yeast extract 
supplemented with 1% foetal calf serum, lane 7, yeast extract grown cells, 
lane 8 no template control, lane 9, marker.
1 2 3 4 5 6 7 8 9  500
b p
These results are surprising as there is clearly a SirR promoter box upstream 
of the efm operon and thus it would be predicted that efm would respond to 
both iron and manganese concentrations (see chapter 5). Although problems 
with non-specific binding were experienced, adapting the PCR technique 
eliminated these. Therefore it is unlikely that these would account for the 
results seen. Comparison with transcription of a housekeeping gene may 
have revealed more subtle variations in efmA transcription. However large 
variations were seen in efaA transcription, and it is probable that efmA would 
show equally dramatic results when tested under appropriate conditions.
178
It is possible that the yeast extract medium selected as the minimal medium 
in these experiments was inappropriate. E. faecium was very slow growing 
even in rich medium such as BHI, but in yeast extract it would take 
approximately six hours to reach early log phase growth. This strongly 
suggests that E. faecium requires a different medium to optimise growth. 
The long growth curve would indicate that the cells were under stress and 
possibly were expressing different proteins from normal, which might 
indicate different metal ion requirements. Further investigations of metal ion 
requirements in E. faecium  might require a different growth medium.
It is possible that the metal ion concentrations used in these experiments 
were not high enough to elicit a response in efmA transcription. Hill et al 
(1998) used concentrations of 20 pM for all the metal ion species that they 
added to their staphylococcal cells. These experiments were carried out in 
different media (yeast extract as opposed to RPMI used by Hill et al) and 
with a different species of bacterium. However, it is still possible that the 
repressor binds to the SirR box with greater affinity than to the DtxR box 
(which occurs in E. faecalis and mitis-group streptococci), and needs higher 
concentrations of metal ions to release its hold. If this were the case it would 
imply that E. faecium has a higher requirement for manganese than E. 
faecalis. Perhaps this could be because E. faecium has a higher requirement 
for metal ions to synthesise enzymes to cope with oxidative stress. I f  this is 
the case it might explain why E. faecium is less pathogenic than E. faecalis. 
If E. faecium is less able to cope with oxidative stress, and hence has a higher 
requirement for metal ions, it will be less able to survive in the hostile
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environment of the host. It would be interesting to test this hypothesis 
further. It would also be interesting to investigate the other metal ion 
dependent repressors in E. faecium , and to compare their relative sensitivities 
to metal ions.
In conclusion therefore, it has been shown that the efa operon is regulated by 
the concentration of manganese and zinc in the growth medium. This is in 
agreement with the predictions of Dintilhac et al (1997) and the identification 
of a metal ion promoter box found upstream of the efa operon which shows 
homology to the DtxR box (see chapter 6). However it was not possible to 
confirm that the efm operon is responsive to metal ions. Clarification of this 
unexpected finding, and further work on the function of these operons must 
still be carried out.
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9 Insertional Inactivation of the efaA Gene in E. faecalis
In this section of work, efforts were made to inactivate efaA by insertional 
mutagenesis. The subsequent ‘knockout mutation’ was to be used in animal 
studies to determine whether efaA had an effect on virulence.
Until recently enterococci were regarded as non-transformable. Their tough 
cell walls are mostly impermeable to large molecules such as DNA. In 
addition the different restriction-modification systems in gram-positives were 
incompatible with many common E. coli plasmids, rendering them inactive. 
However advances in molecular biology in recent years and the advent of 
electroporation have enabled transformation of many ‘non-transformable’ 
species, including enterococci.
Electroporation involves applying a high transmembrane voltage across the 
cell, which overcomes the natural barrier function of the membrane, allowing 
pores to open up and the passage of ions and water soluble molecules across 
the membrane (Weaver, 1993). Electroporation does not heat up the cells, as 
dramatic membrane rearrangements occur instantaneously, however some 
cell death is inevitable as membranes will rupture and chemical imbalances 
occur across cells due to the uncontrolled influx and efflux through pores 
(Weaver, 1993). The amount of voltage needed to open up membranes is 
usually expressed as field strength and is defined as voltage applied over the 
distance between the two electrodes (kV/cm). The electric field required to 
transform a cell depends on the cell radius. Larger, mammalian cells require
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lower field strengths than smaller, bacterial cells (Weaver, 1993). Usually 
bacteria require field strengths of between 5 and 20 kV/cm (Miller, 1994).
Even with such high field strengths enterococci can remain resistant to 
transformation, so agents which disrupt cell wall synthesis are often used 
(e.g. glycine, threonine, lysosyme, penicillin G) (Weaver, 1993; Miller, 
1994; Dunny et al, 1991). The many different protocols for transforming 
enterococci depend on different combinations and concentrations of these 
cell-wall-active agents. The most effective transformation results in 
enterococci are seen with glycine (Dunny et al 1991). Sucrose (0.5 M-0.625 
M) is then added to the recovery medium to stabilise the cells (Miller, 1994).
Several plasmids were used in an attempt to transform E. faecalis EBH1. 
They were all ‘shuttle vectors,’ that is plasmids which have been designed to 
exist in more than one species, e.g. E. coli and Streptococcus spp. They will 
usually contain an origin of replication for both the species that they inhabit. 
Plasmids that contain only one origin of replication, such as the E. coli one, 
are designated ‘integrative vectors.’ In order to survive in their other host, 
they must combine with the chromosome. The target sequence for such 
recombination is usually the gene sequence of interest, which has been 
inserted into the plasmid. When the plasmid combines with the chromosome 
at its designated target, it will disrupt transcription of the gene. Either a 
small portion of the plasmid may combine with the chromosome, or the 
entire plasmid may be incorporated. The latter plasmids are designated 
‘suicide vectors.’
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Figure 9.1 Plasmid Maps of pVA838 and pVA891 coordinates (kb) are 
shown on the inside o f each map. The approximate location of the 
erythromycin resistance (EmR) and the chloramphenicol resistance (CmR) 
are indicated. The streptococcal segments o f each plasmid are shown in 
thick lines.
9 0 /  9.2 kb
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p V A 8 3 8
0 /5 .4  kbo -
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Figure 9.1 shows the plasmid maps of two shuttle vectors used in the course
of these experiments. Plasmid pVA838 (Macrina et al, 1982) is a 9.2 Kb 
shuttle vector designed for use in E. coli and S. sanguis. It confers 
erythromycin resistance and chloramphenicol resistance in E. coli, but only 
erythromycin resistance in streptococci. It is able to replicate in both species. 
Its derivative, pVA891 (Macrina et al, 1983) is the product of Clal cleavage 
and self-ligation of pVA838. The resulting plasmid is 5.4 Kb and contains 
only 1.5 Kb of streptococcal sequence (corresponding to the erythromycin 
gene). All other streptococcal genes, including the plasmid replication
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machinery have been removed, so the plasmid must combine with the 
chromosome in order to survive. A 405 bp portion of efaA was ligated into 
pVA891 to enable the plasmid to pair with efaA on the chromosome and 
combine with the chromosome via a single crossover (Campbell-like 
recombination). The mechanism of this event is illustrated in figure 9.2
Figure 9.2 Single Crossover Recombination, homologous recombination 
results in a ‘single crossover’ reaction in this case. The plasmidpVA891, 
containing a 405bp portion o f efaA and erythromycin resistance (EmR), is 
inserted into the E. faecalis chromosome, leaving it flanked by the duplicated 
target sequences, i.e. the 405 bp portion o f efaA. The efaA gene is now 










G. M. Dunny (see 2.23) supplied the electroporation protocol. Cells were 
grown in glycine-containing medium to destabilise their cell walls. They 
were further washed in magnesium chloride, which has been found to
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increase transformation efficiencies, probably by decreasing extracellular 
polysaccharide (Berthier et al, 1996). They were then subjected to 
electroporation with a field strength of 12.5 kV/cm. Initial attempts were 
unsuccessful, so some modifications were made to the protocol. E. faecalis 
EBH1 is a clinical isolate and these can prove difficult to transform. Failure 
of some clinical isolates to electroporate may be due to resident plasmids, 
which can interact with transformed plasmids and inactivate them (Berthier 
et al, 1996). The plasmid content of E faecalis EBH1 has never been studied, 
but it is highly probable that it contained both plasmids and transposons, all 
of which might interact unfavourably with pVA891. Some enterococcal 
strains are acknowledged to be untransformable by electroporation (Teng et 
al, 1998), even when they are naturally transformable. Interestingly a study 
with naturally competent Haemophilus influenzae cells showed that they 
were several orders of magnitude less efficient than non-competent cells for 
electroporation (Miller, 1994). Furthermore variations in the thickness of the 
peptidoglycan layer between different strains will likely affect the ability to 
transform them. The laboratory strain, OG1RF was accordingly substituted 
for EBH1, but attempts were still unsuccessful.
An electroporation apparatus was borrowed from Flowgen, which was able 
to apply field strengths up to 3.5 kV/cm. Electroporation using very high 
field strengths has proved successful in untransformable Lactobacillus spp 
(Flowgen, personal communication). The apparatus was also capable of a 
biphasic electrical pulse. The first pulse was high voltage, to open pores in- 
the membrane, while the second was lower voltage to encourage the DNA to
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enter the cells. Again this approach proved unsuccessful. There was a 
considerable problem with arcing at higher field strengths, resulting in 
increased cell death. Additionally a potential problem at these field strengths 
is the degradation of DNA, due to increased heat passed into solution from 
the high voltage. Both factors prompted a search for alternative protocols.
The poor results suggested that transformation efficiency was low. To 
investigate transformation further, plasmid pVA838 was utilised. Attempts 
were made to transform pVA838 into both E. faecalis OG1RF and S. 
gordonii Challis by electroporation. In both cases pVA838 was successfully 
transformed (albeit with a low efficiency, data not shown). Some work was 
carried out on optimising the electroporation, but it was found that the 
original protocol gave the optimum results (data not shown). As mentioned 
previously, restriction-modification systems can be a significant barrier to 
transformation. The efficiency of transformation with plasmid DNA into 
Campylobacter jejuni increases by at least four orders of magnitude when 
plasmid DNA is prepared from Campylobacter instead of E. coli (Miller, 
1994). To clarify whether restriction-modification systems were causing an 
incompatibility problem, pVA838 was prepared from E. coli XL1, S. 
gordonii Challis and E. faecalis OG1RF. The plasmid preparations were 
transformed into E. faecalis OG1RF. The transformation frequencies are 
shown in Table 9.1. The plasmid preparation from E. faecalis transformed 
back more efficiently than plasmids prepared from S. gordonii or E. coli. 
The restriction-modification systems therefore present a significant problem
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in mutagenesis and this may partly explain the low success rate with 
pVA891 efaA, which had been extensively subcultured in E. coli.
Table 9.1 Transformation efficiency of pVA838 into E. faecalis OG1RF.
plasmid pVA838 was prepared from E. coli XL1, S. gordonii Challis and E. 
faecalis OG1RF and was transformed into E. faecalis. Transformation 
efficiency was defined as the fraction o f  surviving cells transformed 
(reviewed by Miller, 1994)
Source of Plasmid dVA838 Transformation Freauencv
E. coli XL1 1.42x1 O'7
S. gordonii Challis 9.64x1 O'7
E. faecalis OG1RF 1.21 x 1(T
As attempts with pVA891 were unsuccessful, a second plasmid, pAULA, 
was used. This 9.2 Kb shuttle vector was developed for use in E. coli and 
Listeria spp (Schaferkordt and Chakraborty, 1995). It contains an origin of 
replication from both E. coli and S. aureus, but the gram-positive replicon is 
temperature sensitive. At the permissive temperature (30°C) the plasmid 
may be transformed and will replicate in gram positives. If  the temperature 
is then increased to 42°C, the plasmid is no longer able to replicate and must 
combine with the chromosome via a single crossover in order to survive. 
The 405 bp efaA fragment was inserted into the plasmid to act as a target for 
recombination. The advantage of this system is that the initial stage in the 
mutation process, transformation, is separated from later recombination with 
the chromosome, enabling troubleshooting at each stage. The results 
obtained, however, were not encouraging. Whilst a limited number of 
colonies were obtained at the permissive temperature, no colonies were seen 
when the temperature was raised to 37 °C, indicating that the colonies seen at 
the lower temperature were most likely to be spontaneous erythromycin
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resistant mutants, and not transformants. This implies that pAULA is not 
stable in enterococci, but further testing would be required to confirm this.
Figure 9.3 Plasmid M ap of pAULA the positions o f the lac a  fragment, the 
erythromycin resistance gene (EmR) are marked. The origins o f replication 
are also shown, where ori = E. coli origin o f  replication and orirs = 
temperature sensitive gram positive origin o f replication.
U = u n i v e r s a l  p r i m e r  
R m r e v e r s e  p r i m e r
As it was not possible to optimise the rate of transformation to any greater 
degree it was decided to look at more efficient methods of recombination, in 
order to compensate for poor transformation efficiency. Integrative plasmids 
may combine with the chromosome by two different mechanisms (see figure 
9.4). Firstly a ‘Campbell-like’ single crossover can occur, which will result 
in the incorporation of the entire plasmid into the chromosome at the target 
site and duplication of the target sequence. Alternatively the chromosomal
H p a  i 
Sp h
H p a  t
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target may be replaced by a double crossover with a portion of linear DNA. 
In order for this to occur the antibiotic resistance gene must be flanked by 
DNA homologous to the target gene.
Figure 9.4 Comparison of Double and Single Crossover Recombination
showing the two possible scenarios for integration offoreign DNA into a 
chromosome. Diagram a shows the results o f a single crossover reaction, 
where both target DNA and plasmid are incorporated into the chromosome, 
leading to duplication o f the target sequence. In diagram b a double 
crossover occurs resulting in replacement o f the target sequence on the 
chromosome with the target sequence from the plasmid (containing the 
antibiotic resistance marker, AbR). After Teng et al, 1998.
Figure 9.4a Figure 9.4b
AbR
Chromosome
It is acknowledged that bacterial strains tend to show a preference for one 
particular type of recombination (Fenno et al, 1993). This can depend on the 
method of transformation and the modification procedures that occur inside 
the strain. Transforming DNA can often be modified by the cell and may be 
nicked into a linear fragment. Campbell recombination requires a circular 
DNA molecule and so tends to occur in strains undergoing natural
Chromosome
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transformation (e.g. conjugation), where DNA is processed before transport 
then reformed and ligated inside the cell. Electroporation requires uptake of 
intact DNA without intermediate binding and processing and so double 
crossovers are often the preferred mechanism of integration (Fenno et al, 
1993). Plasmid transformed into S. gordonii Challis has been shown to 
undergo Campbell-type recombination when it is naturally transformed and 
double crossover recombination when it is electroporated (Fenno et al, 1993). 
It would therefore seem advisable to use a construct that could integrate via a 
double crossover, to see if this was more successful.
The amount of homologous DNA needed to construct a mutant can be an 
important factor. Berry and Paton (1996) used only 254 bp homologous 
DNA to construct a psaA mutant. However work by Fenno et al (1993) 
showed that specific allellic replacement in the fim  operon was five times 
more efficient with plasmids containing 6 Kb homologous DNA than with 
those containing only 3 Kb. The 405 bp fragment used in previous 
experiments may not have been big enough for targeting.
A new plasmid was therefore constructed, capable of integration into the 
chromosome via a double crossover. The pBluescript clone of the efa operon 
was used, which contains 1.9 Kb of the efa operon (named pSK+: GP19). It 
was cleaved at a unique Sphl site located 560 bp into the clone. The ends 
were flushed with T4 polymerase. An erythromycin resistance gene 
(ermPiM) was cleaved from a plasmid (pSLERY, provided by H. F. 
Jenkinson), using Ndel. The sticky ends were filled by Klenow enzyme. The
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erythromycin gene was blunt-ligated into the pSK+: GP19 clone and the 
resulting construct was used in electroporation experiments.
Figure 9.5 Construction of the pBluescript:GP19 (ermAM) Integrative 
Plasmid. PlasmidpSK+: GP19 was cut with Sphl and then treated with T4 
polymerase. PlasmidpSLERY was cut with Ndel then was treated with 
Klenow enzyme. The ErmAM fragment from pSLERY (1 kb) was blunt 
ligated topSK+: GP19/Sphl overnight.. Lane 1, Molecular weight marker, 
Lane 2, pSK+ : GP19 cut with Sphl and treated with T4 polymerase, Lane 3, 
pSLERY cut with Ndel and treated with Klenow, Lane 4, pSLERY cut with 
Ndel, Lane 5, pSK+ : GP19 cut with Sphl, Lane 6, pSLERY cut with Ndel, 
Lane 7, pSK+ : GP19, uncut, Lane 8, Molecular weight marker. Lane A, 
pSK+: GP19 cleaved with Ndel, Lane B, pSK+: GP19ermAM cleaved with 
Ndel.
1 2 3 4 5 6 7  8 A B
A new strain of E. faecalis was used in these experiments. E. faecalis JH2-2 
is known to transform well with the protocol developed by Cruz-Rodz and 
Gilmore (1990, see section 2.24), so was used in subsequent experiments to 
ensure optimum transformation efficiencies. Transformation with this 
plasmid appeared to be much more successful (see Table 9.2), with initial 
results suggesting that this construct was allowing recombination.
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Table 9.2 Time Constants and Viable Count (cfu/ml) following 
electroporation o f E. faecalis JH2-2 with pSK+:GP19 (ermAM). Cells were 
electroporated according to section 2.24. The time constants were noted. The 
samples were incubated for 48 h then the number o f colony forming units on 
erythromycin-containing media was noted. The number o f viable cells 
following electroporation was determined to be 6.2 x 107 cfu/ml.
Volume Plasmid Used
m







Initial colony blotting results were also promising, with several colonies 
showing a response to the ermKM probe. Five colonies were chosen for 
more complete study. However western blotting results were less successful. 
All five strains still showed a band corresponding to the efaA protein (Figure 
9.6).
Figure 9.6 Western Analysis of Cell Wall Extracts from Potential E.
faecalis efaA Mutants. Cell wall extracts were subjected to SDS-PAGE gel 
electrophoresis then were probed with rabbit-anti-efaA serum diluted 1:20 in 
TBS. Blots were developed with protein A conjugated to horseradsh 
peroxidase. Lane 1, molecular weight marker, lane 2, E. faecalis EBH1 
control, Lane 3, E. faecalis JH2-2 control, Lanes 4 and 5, E. faecalis JH2-2 
potential mutant strains.
71 kD
37 kD  ^
EfaA
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It is worth considering whether the transformation itself was unsuccessful, or 
whether the screening process was ineffective. Time constraints prevented a 
repeat of this experiment, but any further attempts would have required a 
more foolproof screening process, as colonies that looked promising on 
colony blots did not contain the inactivated efaA gene. Chromosomal PCR 
might be a solution to this problem. It would be possible to perform two 
PCR reactions, the first with primers for the ermAM gene, where a product 
would only be visible in mutant strains. As a control a second PCR could be 
performed using primers for a region of the efaA gene spanning the Sphl site 
where the ermAM gene was inserted. Mutant strains would show a PCR 
product 1 Kb larger than wild type strains. This technique should enable a 
large number of colonies to be screened, before further tests, such as western 
and southern blotting could be carried out on more promising strains to 
confirm results.
After the laboratory work for this project had finished, Singh et al (1998) 
published a report of the generation of an efa mutant in strain OG1RF. The 
vector used was a derivative of pBluescript (SK-), with ~730 bp of efaA 
inserted and an enterococcal ampicillin resistance gene inserted into the 13- 
lactam resistance gene. The plasmid would have to be incorporated into the 
chromosome via single crossover recombination, resulting in duplication of 
the target sequence. The success of this contrasts with the conclusions drawn 
in this work about the efficacy of single crossover recombination in this 
species. It is also surprising that such a small region of homology was 
needed to target the plasmid to the efaA gene on the chromosome.
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The method used for electroporation in this study is unclear. The text states 
that the competent cells were prepared using a protocol published by 
Friesenegger et al (1991). This technique involves growing E. faecalis cells 
to stationary phase in Todd-Hewitt broth, then carrying out sequential washes 
of the cells in decreasing volumes of 10% glycerol. However the text states 
that electroporation was carried out according to the protocol of G.M. Dunny 
(Dunny et al, 1991, see section 2.23). It is difficult to see how these two very 
different protocols could be combined. For example, the protocol used by 
Dunny et al (1991) requires the cells to be grown in media containing 
glycine. It is not evident if glycine was used by Singh et al (1998). When 
preparing competent cells, the method of Friesenegger et al (1991) does not 
use glycine or any other growth inhibitor. In addition, it is not clear which 
buffer was used for electroporation. The Friesenegger protocol uses 10% 
glycerol whilst the Dunny protocol requires sucrose and magnesium chloride. 
The two methods require completely different recovery media: Dunny et al 
(1991) used BHI broth containing sucrose, whilst Friesenegger et al (1991) 
used Todd Hewitt broth without sucrose. Without clarification of these 
discrepancies, it is not possible to ascertain the method of insertional 
mutagenesis of efaA used by Singh et al (1998).
Although the method adopted by Singh et al (1998) was successful, it is not 
easy to compare their results with those obtained in this work. The use of 
different plasmids and electroporation techniques is likely to have accounted 
for their success, but without further clarification of the exact methods used it
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is not possible to come to any meaningful conclusions about the best 
technique to employ in further mutation experiments.
In conclusion therefore, the process of insertional mutagenesis in Enterococci 
is a fast-developing field. Many new techniques are being developed to 
improve transformation efficiency and the last few years have seen some 
dramatic improvements. However the optimum method for this process has 
not been clarified and it appears to vary depending on the strain of 
enterococcus. Some strains still remain untransformable and others are 
poorly transformable by electroporation. These will require other methods to 
mutate them and some recent research has looked at these other methods of 
transformation, particularly in other species of enterococcus. For example, 
electroporation of E. faecium strains has proved even more troublesome than 
E. faecalis. Conjugation has recently shown great promise as an alternative 
to electroporation in poorly transformable enterococci (Teng et al, 1998). 
Shuttle vectors containing an origin of conjugal transfer {oril) have been 
used to transfer DNA from E. coli to gram-positive species. The transfer 
requires another plasmid (IncP) to be present in E. coli cells. Teng et al 
(1998) have shown that it is possible to knockout the autolysin gene in E. 
faecalis using this method, and have managed to transfer a conjugal plasmid 
from E. coli to E. faecium SE34, a strain which showed poor transformation 
efficiency by electroporation. Conjugation could therefore provide a realistic 
answer to mutation in E. faecium. Any further work on the efin operon may 
require insertional inactivation one or more genes, and it would certainly be 
worth using conjugation as a method of generating these mutants.
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10 General Conclusions and Future Directions.
The work described in the previous chapters has allowed detailed study of 
the efa and efin operons in E. faecalis and E. faecium, respectively. The 
entire operons have been sequenced and analysed and have revealed several 
areas that would merit further study. Manganese has been shown to regulate 
the transcription of efaA, but it was not possible to establish a similar 
regulation mechanism with efmA. Three E. faecalis Fur homologues have 
been described, together with a DtxR homologue, raising interesting 
questions concerning metal ion regulation of enterococcal genes.
It is clear that any further work on Cluster 9 proteins should focus on their 
ability to respond to metal ions. In particular it is important to establish 
whether efa and efin are metal-ion-transporters, or whether they are simply 
upregulated under specific metal ion depleted conditions. This is important, 
since without this information it is not possible to determine whether these 
proteins are adhesins, or whether they indirectly affect adhesion. Without 
resolving this issue it will be difficult to define the role of these operons in 
IE.
It is important to establish the role of transition metals in enterococcal 
metabolism and in particular the role of manganese and zinc, which have 
been underestimated until now. The data presented in this project emphasise 
the importance of metal ions to enterococci, not only in specific reactions but 
also in regulation of cellular processes. Methods to restrict access of 
manganese and zinc to enterococcal cells may prove to be an effective
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method of killing these organisms and therefore may provide a new target for 
therapy. Thus it is legitimate to study further metal ion dependence in these 
bacteria. The full sequences of the E. faecalis Fur homologues need to be 
identified, together with their consensus binding sites. Footprint analysis or 
gel shift mobility assays will be of use in identifying proteins that are 
controlled by Fur or DtxR. Studies like this will determine the extent of 
metal ion regulation in E. faecalis. The relative importance of iron and 
manganese to enterococci needs to be qualified. The gram-positive 
bacterium lactobacillus has been shown to require little or no iron in its 
metabolism (reviewed by Weinberg, 1997), but it is considered to be 
unusual. Enterococci are likely to require some iron, but whether or not they 
require more manganese than iron needs to be determined.
The adc operon in E. faecalis should be investigated for its ability to respond 
to zinc, and for any role it may have in IE. The predicted molecular weight 
of mature E. faecalis AdcA is 55 kD. The three prominent antigens 
previously identified in E. faecalis IE were 37, 40 and 73 kD (Aitchison et al, 
1987). This suggests that AdcA is not strongly expressed during E. faecalis 
endocarditis, but this needs to be confirmed experimentally. However an 
area of investigation that is likely to show more promise is the study of 
competence. The adc operon in S. pneumoniae has been shown to have an 
indirect role in competence (Dintilhac and Claverys, 1997). Cells deficient 
in adc were unable to undergo transformation. Zinc was later shown to be 
required by competence stimulating peptide to induce expression of 
competence genes (Dintilhac et al, 1997). It would be very interesting to
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determine whether zinc was required for transformation in enterococci, as 
this might enable us to understand further the mechanisms by which 
enterococci acquire antibiotic resistance.
Any further studies of the cluster 9 proteins in E. faecalis and E. faecium  will 
require the insertional inactivation of these genes. The work carried out in 
this project has established the best method for carrying out mutation of 
genes in E. faecalis. However it has been shown that such inactivations are 
certainly not easy to carry out, and in some strains they are impossible. 
Further work on insertional inactivation is likely to require the use of 
transposons, especially in E. faecium. Whilst the double crossover 
experiments showed great promise in E. faecalis, it is acknowledged that E. 
faecium  is almost impossible to transform by plasmid mutagenesis and it 
would be much more effective to use transposons in any work involving E. 
faecium.
In summary, therefore, the work carried out in this study has revealed many 
possible opportunities to study E. faecalis and E. faecium pathogenesis. In 
particular, the field of metal ion transport and regulation has shown great 
promise for further work. Future studies in this area should greatly increase 
our understanding of these highly problematic bacteria, and are likely to 
reveal many potential drug therapy targets.
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